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 Development of tissue engineering to address the clinical shortage of donor 
organs for transplantation has advanced the study of biomaterials.  Such biomaterials are 
currently being explored for a variety of applications including combination products in 
which both biological and biomaterial components together are introduced to the host 
upon implantation.  Significant progress has been made in the development of new 
biomaterials and modifications to improve biocompatibility, and in the understanding of 
the host inflammatory response elicited upon introduction of a biomaterial.  However, 
investigation of the potential of biomaterials to increase the specific immune response 
against antigens associated with the biological component, through adjuvant effect, is yet 
to be fully explored.   
 The objective of this thesis research was to evaluate the adjuvant effect of 
biomaterials by focusing on their effects on dendritic cell (DC) phenotype upon contact.  
As DC maturation is manifest of adjuvant effect and leads to initiation of adaptive 
immune response, the predisposition of biomaterials to induce DC maturation in vitro 
would be predicative of how biomaterials would perform in vivo upon implantation.  
Specifically, the differential effects of two model biomaterials used in combination 
products, agarose and 75:25 poly(lactic-co-glycolic acid) (PLGA) were evaluated.  These 
biomaterials were chosen for comparison since adjuvant effect has been observed with 
PLGA (Ertl et al., 1996; Walker et al., 1998; Raghuvanshi et al., 2001; Matzelle and 
Babensee, 2004), whereas agarose has been shown to induce minimal inflammatory 
response (Starke et al., 1987; Rahfoth et al., 1998).  It was hypothesized that these 
biomaterials would exhibit differential effects on DC maturation, and this biomaterial-
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induced maturation would be mediated by receptors and mechanisms similar to those 
used by DCs in response to pathogen-induced activation of these cells.   
 Following initial characterization of agarose and PLGA in microparticle (MP) and 
film forms to be used, cell culture system was established for deriving DCs from human 
peripheral blood mononuclear cells.  Treatment of immature DCs (iDCs) with MPs or 
films of PLGA resulted in maturation of DCs as measured by increased expression of co-
stimulatory and MHC molecules, allostimulatory capacity, and induction of delayed type 
hypersensitivity.  The extent of PLGA-induced maturation phenotype was in between that 
of iDCs and DCs matured with a known DC maturation stimulant, lipopolysaccharide 
(LPS).  Moreover, PLGA MP-induced DC maturation was demonstrated to require direct 
contact between DCs and PLGA MPs, and not mediated by autocrine effects of pro-
inflammatory cytokine, tumor necrosis factor α (TNFα).     
 As phagocytosis by DCs may contribute to their maturation, molecular aspects of 
MP phagocytosis by DCs were evaluated.  Treating iDCs with PLGA or polystyrene 
fluorospheres of approximately 3 µm in diameter resulted in the internalization of the 
particles as evidenced by confocal laser scanning micrographs.  This uptake of 
fluorospheres by DCs was decreased by pretreatment of cells with cytochalasin D or by 
incubation with the fluorospheres at 4°C, and was sensitive to EDTA and trypsin 
pretreatments in a dose-dependent manner.  In agreement with previous studies, treatment 
of iDCs with PLGA MPs but not with polystyrene MPs led to increased release of TNFα, 
which was dependent on the ratio of PLGA MPs to DCs.   
 The differential effects of agarose and PLGA were established by directly 
comparing DC maturation in response to agarose or PLGA films.  These experiments 
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revealed that DCs treated with PLGA film expressed higher levels of co-stimulatory and 
MHC class II molecules, were more allostimulatory, and secreted higher amounts of pro-
inflammatory cytokines.  These results imply that PLGA but not agarose is a stimulus of 
DC maturation.  In contrast, activation of nuclear transcription factor, nuclear factor κ B, 
(NFκB) measured 24 hrs after the initial stimulation of DCs with agarose or PLGA films 
revealed that while both agarose- and PLGA-treated DCs increased activation of NFκB 
above that of iDCs, agarose-treated DCs showed higher activation of all members of 
NFκB transcription factor family.  While this difference was not explored in the study 
presented herein, it is hypothesized that PLGA-induced activation of NFκB peaks at 
earlier time point, and is waned by 24 hrs, whereas agarose induces NFκB activation at a 
later time point, still measurable at 24 hrs post-treatment.   
 To further investigate the mechanisms of PLGA-induced DC maturation, roles of 
various receptors that are involved in signaling for DC maturation and uptake of MPs 
were assessed.  In particular, efforts were focused on the elucidation of the role of Toll-
like receptors 2 (TLR2) and 4 (TLR4) as ligation of these receptors by endogenous and 
exogenous adjuvants has been shown to lead to DC activation.  While the expression of 
CD14, CD36, CD51, DC-SIGN, mannose receptor, TLR2, and TLR4 on human iDCs 
was confirmed by flow cytometry, blocking of these receptors using antibodies or known 
ligands to these receptors within the range tested was not able to block LPS- or PLGA 
MP-induced maturation.  In addition, blocking TLR2, TLR4, or CD14 either alone or in 
combination was unable to reduce LPS- or PLGA-induced DC maturation.  Pretreatment 
of DCs with TLR2 antibody alone resulted in enhanced expression of CD83 and CD86 as 
well as secretion of TNFα without any additional maturation stimulus, suggesting that 
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deciphering the role of these receptors by in vitro blocking experiments was difficult 
using these particular antibodies.   
 To circumvent this technical difficulty, PLGA-induced maturation of DCs derived 
from bone marrows of commercially available murine model with a mutation in toll-like 
receptor 4 gene, Tlr4Lps-d, C3H/HeJ strain, was assessed.  Prior to evaluating the role of 
TLR4 on PLGA-induced DC maturation, maturation of murine DCs in response to PLGA 
was confirmed using bone marrow-derived DCs from wild type C57BL6 mice.  Bone 
marrow-derived DCs of C57BL6 mice increased expression of CD86 in response to 
treatment with LPS, PLGA MP, or PLGA film.  In addition, DCs treated with PLGA 
MPs or films secreted significantly higher amounts of pro-inflammatory cytokines, TNFα 
and IL-6, than did iDCs.  Upon confirming that murine DCs respond to PLGA as do 
human DCs, experiments were repeated using DCs from C3H/HeJ mice, and compared to 
those using DCs from its control with the same haplotype, C3H/HeOuJ mice.  As 
expected, DCs from C3H/HeJ mice treated with LPS did not show any difference in 
expression of maturation markers as compared to iDCs, whereas DCs from C3H/HeOuJ 
mice showed increased CD86 expression with LPS treatment.  Increase in CD86 
expression was not induced in response to PLGA MPs or PLGA film for DCs from either 
of the strains.  Similarly, DCs from C3H/HeOuJ mice secreted higher amounts of TNFα 
and IL-6 as compared to DCs from C3H/HeJ mice in response to LPS.  However, DCs 
from neither strain responded to treatment with PLGA MPs or film, in accord with results 
from marker expression.  The lack of response in C3H/HeOuJ animals as compared to 
C57BL6 animals is perhaps attributed to the particular haplotypes of these animals, as 
MHC molecules regulate cytokine production. 
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 Collectively, these results establish the differential adjuvant effects of agarose and 
PLGA on the level of DC maturation, and begin to elucidate the mechanisms of 
biomaterial adjuvant effect.  In addition, assays developed herein provide methods to 
screen for biomaterials to be used in combination products, such that biomaterials with 
desired levels of adjuvanticity as measured by DC maturation effects may be selected for 
given application.   






Despite advancements in transplantation biology, shortage of donor organs 
remains a limiting factor in the treatment of tissue loss or end-stage organ failure.  To 
address this clinical demand, tissue engineered constructs, comprised of cells of 
autologous, allogeneic, or xenogeneic in origin, seeded onto a biomaterial scaffold, have 
emerged as potential alternative with hopes of achieving biological integration as a 
functional organ (Langer and Vacanti, 1993; Atala, 2004; Kulig and Vacanti, 2004; 
Tseng et al., 2005).  While such engineered constructs, some of which have already been 
approved by federal agencies but most of which are still in the research and 
developmental stages, have shown promise, success has been in part limited by the host 
immune and inflammatory responses towards the device (Babensee et al., 1998; Llull, 
1999; Lavik and Langer, 2004).  Unlike the response against transplanted organs, the 
presence of the biomaterial component in a tissue engineered device and its associated 
inflammatory responses may have an adjuvant effect and potentiate the specific immune 
response against the cellular component of the device, thereby compromising device 
effectiveness (Babensee et al., 1998).  The use of biomaterials in diverse applications in 
which the intended functions for the biomaterial and its adjuvant effect differ 
substantiates the need to understand the host responses associated with the biomaterial for 
appropriate material design and selection depending on the application.  For example, 
biomaterials with minimal adjuvant effect are desirable for tissue engineering 
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applications, whereas those with high adjuvant effect are desirable for non-viral vaccine 
delivery systems to improve antigen immunogenicity.   
The objective of this thesis research was to evaluate the adjuvant effect of 
biomaterials by focusing on their effects on dendritic cell phenotype upon contact, 
as maturation of dendritic cells is manifest of adjuvant effect, and leads to activation 
of the adaptive immune response.  In particular, the effect of biomaterial contact on 
dendritic cell maturation and receptors and mechanisms involved in this biomaterial-
induced maturation were investigated.  It was hypothesized that biomaterial contact 
with immature dendritic cells induces their maturation via receptors and 
mechanisms similar to those used in response to pathogen-induced activation of 
these cells, enhancing their T cell stimulatory capacity.  While host response against 
biomaterials and the application of biomaterials as vaccine adjuvants have been studied 
extensively, the adjuvant effect of biomaterials on dendritic cell maturation in the context 
of combination products remains largely unexplored.  Biomaterials such poly(lactic-co-
glycolic acid) (PLGA) are capable of producing an adjuvant effect when used as a carrier 
vehicle for model antigens, as measured by production of cytokines by T cells (Newman 
et al., 1998; Stivaktakis et al., 2005), as well as by increase in the production of antigen-
specific antibody (Matzelle and Babensee, 2004) depending on the form of the 
biomaterial (Bennewitz and Babensee, 2005) and processes of biomaterial carrier 
formulation (Jaganathan et al., 2004).  Because adjuvants act on dendritic cells and 
induce their co-stimulatory activity to effect increased antigen immunogenicity, the 
understanding of the effect of biomaterial adjuvants on dendritic cell maturation is central 
to the appropriate design of biomaterials for use in wide range of applications. 
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To address the above central hypothesis, two specific aims were pursued.     
 
Specific aim 1: Demonstrate that biomaterial contact induces dendritic cell 
maturation in vitro and in vivo.   
 The working hypothesis for this aim was that biomaterial contact promotes 
maturation of dendritic cells in vitro and in vivo to become efficient antigen presenting 
cells as characterized by increased expression of co-stimulatory and MHC molecules, 
cytokine secretion, and allogeneic T cell stimulatory capacity.  For this aim, immature 
dendritic cells were generated in vitro, and treated with biomaterials commonly used in 
tissue engineering, namely 75:25 poly(lactic-co-glycolic acid) or agarose.  These 
particular biomaterials were chosen for comparison as PLGA has been shown to have 
adjuvant effect (Ertl et al., 1996; Walker et al., 1998; Raghuvanshi et al., 2001; Matzelle 
and Babensee, 2004), whereas agarose has been shown to induce minimal inflammatory 
response (Starke et al., 1987; Rahfoth et al., 1998).  Through comparison of these two 
biomaterials, which seemingly have dissimilar adjuvant effect, we aimed to substantiate 
the differential biomaterial adjuvanticity, by focusing on the maturation of dendritic cells.  
Dendritic cell maturation was assessed by cell morphology, surface marker expression, 
cytokine release, and allostimulatory activity in a mixed lymphocyte reaction.  Further, 
biomaterial-induced dendritic cell maturation in vivo was measured as delayed type 




Specific aim 2: Identify mechanisms/ receptors involved in the biomaterial-induced 
dendritic cell maturation. 
Several aspects of dendritic cell maturation mechanisms upon biomaterial contact 
were investigated.  Contribution of direct biomaterial contact and phagocytosis, role of 
known pattern recognition receptors for biomaterial-induced dendritic cell maturation, 
and subsequent cellular functions including the activation of nuclear transcription factor 
NFκB and release of inflammatory cytokines were evaluated.  It was hypothesized that 
dendritic cell maturation and its mechanisms are dependent on the form of the 
biomaterial in contact with the cells and is in part mediated by the recognition of the 
biomaterial surface or adsorbed proteins by pattern recognition receptors on dendritic 
cells.   
 
Collectively, these studies begin to elucidate the mechanisms of differential 
biomaterial adjuvant effect.  Results presented herein provide unique characterization 
approaches for evaluation of host response to biomaterials by focusing on the adjuvant 
effect, in particular, at the level of dendritic cell maturation, an essential step in 
orchestrating subsequent adaptive immune responses.  Especially with the advances in 
combination product development, understanding the interaction between innate 
inflammation against biomaterials and adaptive immunity against biological components 




RESEARCH SIGNIFICANCE  
 
 In 2002, in the United States alone, almost 81,000 people were on the waiting list 
for an organ transplant, while the actual number of total transplants was less than 23,000 
(Transplant Statistics: National Reports, Scientific Registry of Transplant Recipients).  
To address current limitations of organ transplantation such as sourcing and 
compatibility, tissue engineering has evolved as a potential alternative to organ 
transplantation (Langer and Vacanti, 1993; Stock and Vacanti, 2001); however, the 
recipient immune response elicited against a tissue engineered device remain a hindrance 
to the successful integration of engineered grafts (Babensee et al., 1998; Llull, 1999; 
Lavik and Langer, 2004).  Such response likely includes both specific adaptive immune 
response against the cellular and biological components of a device as well as nonspecific 
inflammatory response against the carrier matrix, often composed of biomaterials 
(Babensee et al., 1998).  In particular, biomaterials have been widely explored for drug 
delivery devices and tissue engineered constructs in which the biomaterial component 
serves various functional and structural purposes (Peppas and Langer, 1994).  Current 
research efforts in biomaterial sciences center on the development of new biomaterials 
and modifications of biomaterials, to improve biocompatibility, target specificity, and 
other physicochemical properties (Langer and Tirrell, 2004).  However, for combination 
products in which drug, device, or biologics are present in combination, the added 
existence of biological components requires that biomaterial properties be appropriately 
studied in the context of both the biomaterial and biological components. 
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 The host response to combination products is one such important property that is 
greatly influenced by the simultaneous introduction of biomaterial and biological 
components.  The interplay between immune and inflammatory responses elicited against 
the biological and the biomaterial components, respectively, can lead to augmented 
reaction against the entire product, resulting in unexpected device failure (Babensee et 
al., 1998).  In particular, the potential of biomaterials to enhance the specific immune 
response against antigens from the biological component, through their adjuvant effect, 
may determine selection and design of an appropriate material for use in combination 
products.  The research presented herein addresses the adjuvant effect of biomaterials by 
focusing on biomaterial effects on maturation of dendritic cells (DCs), professional 
antigen presenting cells that bridge innate and adaptive immunity.   
 While study of biomaterials in the context of tissue engineering and vaccine 
adjuvants has revolved around inflammatory capacity of materials and production of 
immunogen-specific antibodies, respectively, the effect of biomaterials on DCs is yet to 
be fully characterized.  The objective of this thesis research was to evaluate the adjuvant 
effect of biomaterials commonly used in combination products, in particular, their effects 
on DC maturation, and receptors and mechanisms involved in this biomaterial-induced 
maturation.  Since the inception of this research project, a few investigational studies 
addressing the role of biomaterials in DC maturation have been reported (Kempf et al., 
2003; Sun et al., 2003; Jilek et al., 2004; Waeckerle-Men et al., 2004).  However, while 
these studies have focused on applications of biomaterial/ DC interaction for vaccine 
delivery to enhance protective immunity, this research project is unique in that we seek to 
apply the knowledge of biomaterial effect on DC phenotype as screening protocols for 
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biomaterial development for combination products where varying degrees of adjuvant 
effect are required.  This application includes tissue engineering, where enhanced 
immune response against the construct is undesirable.   
 To this end, differential effects of two model biomaterials used in combination 
products, agarose and poly(lactic-co-glycolic acid) (PLGA), on DC maturation was 
demonstrated; treatment of DCs with synthetic polymer PLGA resulted in DC 
phenotypes consistent with maturation, whereas treatment with agarose did not.  This 
finding is significant in that it establishes differential effects of biomaterials, 
substantiating the maturation effect observed with PLGA.  Understanding of biomaterial 
adjuvant effect on DC maturation and its mechanisms, will aid in the definition of design 
and selection criteria for tissue engineering biomaterials that promote host integration.  
Moreover, this knowledge can be translated into the development of biomaterial-centered 
immunomodulatory strategies to control host acceptance of tissue engineered grafts to 







 Innate and adaptive immune responses  
Innate immunity 
Innate immunity is the first line of defense upon invasion of a host by a pathogen 
that compromises the epithelium, and is mediated by cells and components of the 
immune system already existing as a part of the host defense mechanism.  These 
pathogens are encountered by tissue-resident phagocytic cells such as the macrophages 
which recognize molecular patterns associated with the pathogens through their surface 
receptors (Medzhitov and Janeway, 1997).  This recognition initiates the innate immune 
response through attempts to clear the pathogen via phagocytosis and release of cytokines 
and chemokines.  These released factors not only directly affect the infected cells, but 
also have local and systemic effects.  For example, some of the cytokines secreted by 
macrophages and their function include IL-1 which activates the lymphocytes, tumor 
necrosis factor α (TNFα) which activates the vascular endothelium for increased 
permeability to allow cell recruitment to the site of infection, and IL-12, which activates 
natural killer cells to release cytotoxic contents of their granules onto infected cells 
(Janeway et al., 2001).  These cytokines, particularly IL-8, also help attract monocytes 
and neutrophils from the circulation to the infected tissue to initiate the inflammatory 
response.    
The recognition of pathogens by the cells of innate immunity is accomplished by 
a set of germline encoded receptors known as pattern recognition receptors (PRRs) 
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(Medzhitov and Janeway, 1997).  These receptors are expressed on epithelial and antigen 
presenting cells (APCs) and recognize conserved molecular structures on pathogens, 
termed pathogen associated molecular patterns (PAMPs) (Medzhitov and Janeway, 
1997).  The recognition of PAMPs by APCs, in particular by immature dendritic cells 
(iDCs), leads to the activation of these professional APCs, which in turn activates naïve T 
lymphocytes, resulting in generation of antigen-specific adaptive immunity.  Thus DCs 
have been regarded as the most potent APCs and as a bridge between innate and adaptive 
immunity (Banchereau and Steinman, 1998).     
Another constituent of the innate response includes the complement system.  
Complements are a set of heat-labile plasma proteins that bind to pathogen surfaces, and 
undergo enzymatic cleavage to yield soluble anaphylatoxins and surface-bound 
fragments which mediate inflammatory response and recognition by phagocytes, 
respectively (Janeway et al., 2001).  The three pathways of complement activation are 
determined by the surface present; the classical pathway is initiated by binding of C1q 
directly via pathogen surface or indirectly via antibody: antigen binding to the surface, 
the mannan-binding lectin pathway is initiated by the binding of mannan-binding lectin to 
bacterial or viral surfaces via mannose-containing carbohydrates, and the alternative 
pathway is initiated by spontaneous hydrolysis of C3, and subsequent generation and 
binding of C3b to pathogen surface (Janeway et al., 2001).  All three pathways converge 
at the level of C3 convertase generation, and result in the cleavage of C3 convertase for 
the generation of anaphylatoxins and peptide mediators of inflammation, C3a, C4a, and 
C5a.  The other fragment of C3 lysis, C3b, is deposited on pathogen surface for 
opsonization, and is further amplified by the alternative pathway.  Successive stages of 
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the complement cascade common to all pathways lead to the formation of membrane 
attack complex, composed of C5b, C6, C7, C8, and C9, which creates a pore in the 
pathogen membrane, resulting in its lysis.   
 
Adaptive Immunity 
Activation of APCs such as DCs upon detection of pathogens enables APCs to 
present the antigen to naïve T lymphocyte, in turn activating them for initiation of the 
adaptive immune response (Janeway et al., 2001).  While adaptive immune response is 
slower in generation, it provides specificity and memory, via clonal expansion of antigen-
specific T lymphocytes.  Whereas innate immunity recognizes invading pathogens via 
PRRs for conserved structures on pathogens, cells of adaptive immunity can recognize a 
wide repertoire of antigens owing to its ability for recombination of somatic receptor 
genes.  On recognition of a particular antigen presented by APCs in the lymph node, 
naïve lymphocytes become lymphoblasts and clonally expand.  These cells then 
differentiate into effector cells; B cells secrete antibodies, a secreted form of its receptor 
(B cell receptor), and T cells function to kill infected cells (CD8+ cytotoxic T cells) or 
activate other cells of the immune system (CD4+ helper T cells).  This activation of 
lymphocytes however, not only requires the initial recognition of antigens presented by 
APCs, but also a co-stimulatory signal which can only be provided by professional APCs 
such as macrophages and DCs.  Similarly for B cells, stimulation occurs through the 
recognition of antigen via B cell receptor, but for activation, signal from activated T cell 
is also required.  While most effector cells undergo apoptosis after a particular antigen 
has been eradicated, immunological memory is provided by the few memory cells that 
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persist, which facilitates a quick response in an event there is another encounter with the 
same antigen (Janeway et al., 2001).     
In comparison to humoral immunity implemented by antibodies which can only 
reach pathogens in blood and extracellular fluid, cell-mediated immune response can 
directly affect infected host cells (Janeway et al., 2001).  Cytotoxic T lymphocytes 
expressing CD8 on cell surface can recognize infected host cells expressing viral antigens 
on their surface.  Other T lymphocytes expressing CD4 on their surface are helper T 
cells, and depending on subset, Th1 or Th2, can either activate macrophages to effect 
antibacterial mechanisms or activate B cells for antibody production.  The recognition of 
antigens by T cells and their activation require that the antigens be processed into 
peptides that are presented in the context of major histocompatibility complex (MHC) 
molecules by APCs.  The 2 classes of MHC molecules, MHC class I and II, present 
peptides of a particular origin, and are recognized by CD8+ and CD4+ T cells, 
respectively.  In general, antigens derived in the cytosol, typically of viral origin, are 
presented in the context of MHC class I, whereas those derived in intracellular vesicles, 
typically of bacterial origin, are presented in the context of MHC class II molecules.  The 
control of immunity is provided by the ability of only professional APCs to produce co-
stimulatory signal (Banchereau and Steinman, 1998).  The major co-stimulatory 
molecules expressed on APCs are CD40 and B7 molecules, CD80 (B7.1) and CD86 
(B7.2).  Expression of B7 is stimulated by the interaction between CD40 on APCs with 
CD40 ligand (CD40L) on T cells, further driving T cell stimulation and proliferation 
(O'Sullivan and Thomas, 2003).  For the delivery of co-stimulatory signal, B7 molecules 
interact with CD28 on T cells, to stimulate clonal expansion of naïve T cells (Janeway et 
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al., 2001).  This proliferation is tightly controlled by a negative regulator, CTLA-4, a 
CD28-related protein, whose expression increases upon T cell activation.  Binding of B7 
to CTLA-4 is with higher avidity than the avidity of B7 to CD28, and this ligation sends 
inhibitory signal to activated T cells.  This inhibitory signal controls proliferation by 
regulating the production of IL-2, autocrine T cell growth factor, and desensitizing naïve 
T cells to further stimulation by APCs.  For the proper induction of adaptive immunity, T 
cells can become activated only when they receive signal 1 (presentation of antigenic 
peptide in the context of MHC molecule) and signal 2 (co-stimulation from an APC).  T 
cells receiving signal 1 without signal 2 undergo anergy, being unable to further respond 
to any signal.  Similarly, tolerance to antigens by suppression of antigen-specific 
response upon rechallenge with the particular antigen is regulated by Th3 and T 
regulatory cells, both subsets which produce profile of cytokines such as IL-4, IL-10 and 
transforming growth factor-β (TGF-β) that inhibit the development of Th1 responses and 
is associated with suppressed inflammatory T cell responses.   
 
Dendritic cells  
Immature dendritic cells and antigen capture 
Dendritic cells are professional APCs, and differ from other APCs in that they can 
initiate primary immune responses, and give rise to immunological memory (Banchereau 
et al., 2000).  Endogenous DCs arise from precursors in the bone marrow, and travel 
through the blood to home to peripheral tissues where they dwell as iDCs with low 
surface expression of MHC and co-stimulatory molecules (Banchereau and Steinman, 
1998).  Immature DCs serve as sentinels by capturing antigens, surveying the 
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surrounding microenvironment (Banchereau et al., 2000).  Dendritic cells can ingest 
antigens by fluid phase uptake or macropinocytosis and receptor-mediated endocytosis, 
providing them with high capacity for uptake of soluble antigens as well as specificity 
(Sallusto and Lanzavecchia, 1994).  Dendritic cells have also been shown to internalize 
particles of latex (Reece et al., 2001), PLGA (Walter et al., 2001; Lutsiak et al., 2002; 
Newman et al., 2002), and polystyrene, depending on proteins adsorbed to particle 
surface (Thiele et al., 2003).   
Pattern recognition receptors expressed on DCs include C-type lectins such as 
mannose receptor (Sallusto et al., 1995; Avrameas et al., 1996), DEC205 (Kato et al., 
1998a), and dendritic cell-specific intercellular adhesion molecule-3-grabbing 
nonintegrin (DC-SIGN) (Geijtenbeek et al., 2000) which bind to carbohydrate-conjugated 
molecules, scavenger receptors, which are involved in internalization of polyanionic 
ligands (Peiser et al., 2002), and Toll-like receptors (TLRs), a family of receptors whose 
ligation leads to upregulation of co-stimulatory molecule expression and release of pro-
inflammatory cytokines and DC maturation (Medzhitov, 2001; Kaisho and Akira, 2002).   
To date, more than 10 TLRs have been identified (Medzhitov et al., 1997), and it 
is thought that there may be 10 to 15 TLRs in the mammalian species (Iwasaki and 
Medzhitov, 2004).  Some of the PAMPs that TLRs recognize include bacterial 
lipoproteins and lipoteichoic acids (TLR2), double stranded RNA (TLR3), LPS (TLR4), 
flagellin (TLR5), single stranded viral RNA (TLR7) and unmethylated CpG DNA 
(TLR9).  Toll-like receptors recognize multiple PAMPs of not only bacterial and viral 
origin, but also molecules that may exist in the host.  Strategic anatomical expression of 
TLRs within the host does not allow encounter of host molecules with TLRs.  In this 
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manner, triggering of TLR activation due to recognition of host molecules is prevented.  
For example, TLRs 3, 7, 8, and 9 which recognize viral nucleic acids are expressed in 
intracellular compartments where host nucleic acids normally do not exist (Heil et al., 
2003; Lee et al., 2003; Matsumoto et al., 2003).  Similarly, TLR5 which recognizes 
flagellin is expressed on the basolateral side of the intestinal endothelial epithelia, thereby 
precluding encounter with commensal bacterial flagellin localized to the apical side 
(Gerwirtz et al., 2001).  Toll-like receptors contain an extracellular leucine-rich repeat 
domain, a single transmembrane domain, and a cytoplasmic domain homologous to the 
IL-1 receptor, which is necessary for signaling (Kaisho and Akira, 2001).  The 
cytoplasmic domain, called Toll/ IL-1 receptor homology domain, associates with an 
adaptor protein, myeloid differentiation factor 88 (MyD88), resulting in the activation of 
MAP kinase cascades and activation of nuclear factor κ B (NFκB), a transcription factor 
which controls the expression of many genes involved in the inflammatory response 
including IL-12 and TNFα (Kaisho and Akira, 2001).  However, MyD88-independent 
pathway of TLR activation by LPS has also been observed, and can lead to DC activation 
(Kaisho and Akira, 2001).   
While many of the C-type lectins have been implicated in endocytosis and 
recognition of pathogens, the presence of signaling motifs in their cytoplasmic domains 
suggest that C-type lectins may play a role in signaling in DCs (Figdor et al., 2002).  In 
particular, Dectin-1, C-type lectin which recognizes β-glucans, has been shown enhance 
TLR2-mediated signals to activate NFκB and with TLR2, synergistically produce IL-12 
(Gantner et al., 2003).  Similarly, galactose/ N-acetylgalactose lectin has been observed 
to increase mRNA expression of TLR-2, as well as activate NFκB and MAP kinase 
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signaling pathways (Kammanadiminti et al., 2004).  Such cooperation between lectins 
and TLRs suggest tailored response against specific pathogens (Gantner et al., 2003).  
 
Maturation of dendritic cells and migration to secondary lymphoid organs 
Dendritic cells mature in response to infection or “danger” signals, such as 
antigens from necrotic cells or pro-inflammatory cytokines (Matzinger, 1994; 
Banchereau et al., 2000).  Maturing DCs migrate to the T cell areas of the draining lymph 
node, where they present the previously internalized and processed antigens in context of 
MHC molecules for T cell activation (Matzinger, 1994; Banchereau and Steinman, 1998; 
Basu et al., 2000; Bethke, 2002).   
Function of DCs correlates with their migration, and the ability of DCs to migrate 
is dependent on the expression of adhesion molecules (Banchereau and Steinman, 1998).  
Migration of maturing DCs to draining lymph node via the afferent lymph is mediated by 
downregulation of receptor for or unresponsiveness to MIP-3α, expressed at sites of 
inflammation, and upregulation of expression of chemokine receptor CCR7 on DCs, 
whose corresponding chemokine ligands, MIP-3β and SLC are expressed by cells in the 
secondary lymphoid organs (Sallusto et al., 1998; Chan et al., 1999; Sozzani et al., 1999).  
As both MIP-3β and SLC can attract mature DCs and naïve T lymphocytes, these 
chemokines likely facilitate the encounter of these two cell types for the initiation of the 
adaptive immune response (Gunn et al., 1998; Ngo et al., 1998). 
Maturation stimuli for DCs demonstrated in vitro include endogenous adjuvants 
or molecules that are produced only in the presence of “danger” to the host.  Dendritic 
cells are activated in response to poly-mannuronic acid of pathogenic source via TLRs 2 
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and 4 (Flo et al., 2002).  In addition, heat shock proteins (Basu et al., 2000; Bethke, 
2002), and degraded proteins that only appear upon tissue injury such as oligosaccharides 
of hyaluronan also activate DCs via TLR 4 (Termeer et al., 2000; Johnson et al., 2002; 
Termeer et al., 2002).  Upon maturation, DCs lose receptors for phagocytosis and 
endocytosis, downregulate pinocytosis, upregulate the expression of MHC and co-
stimulatory molecules such as CD40, CD80, and CD86, and reorganize their cytoskeleton 
and increase motility (Sallusto et al., 1995; Winzler et al., 1997; Banchereau and 
Steinman, 1998; Banchereau et al., 2000).  The antigen capturing capacity of DCs is 
irreversible as the removal of maturation stimulus does not result in the recovery of 
pinocytosis by these cells (Sallusto et al., 1995).  Maturation of DCs as typified by these 
changes are thought to be regulated by the same signaling pathways that are activated 
during inflammation and cell stress, including the activation of the transcription factor, 
NFκB and MAP kinase, in particular, p38 and JNK (Rescigno, 1998).  Translocation of 
NFκB from the cytosol to the nucleus upon phosphorylation of IκB for the activation of 
gene transcription is essential for DC maturation (Rescigno et al., 1998; Yoshimura et al., 
2001).  Of the 5 known members of NFκB family of transcription factors, RelB has been 
shown to be required for DC maturation (Wu et al., 1998; Zanetti et al., 2003), and its 
activity has been recently demonstrated to be negatively regulated by NFκB2, also known 







Dendritic cell subsets 
Several subsets of DCs exist in various species.  In humans, differences in subsets 
can be categorized by precursor populations, anatomical localization, function, and final 
outcome of the immune response (Banchereau et al., 2000).  Two types of DC precursor 
cells in blood are myeloid monocytes (pDC1) and CD4+CD3-CD11c- plasmacytoid 
precursors (pDC2) (Rissoan et al., 1999).  Monocytes or pDC1 can differentiate into 
myeloid DCs (DC1) following transmigration through the endothelium and phagocytosis 
of subendothelial collagen (Randolph et al., 1998) or in culture with GM-CSF and IL-4 
(Sallusto and Lanzavecchia, 1994; Romani et al., 1996), and mature in response to CD40 
ligation or endotoxin stimulation (Cella et al., 1996).  In contrast, pDC2 found in blood or 
tonsil differentiate in culture into immature DCs in presence of IL-3, and mature in 
response to CD40 ligand stimulation (DC2) (Grouard et al., 1997; Olweus et al., 1997).  
Dendritic cells derived from pDC1 and pDC2 preferentially induce Th1 or Th2 
differentiation, respectively, via differential DC production of cytokines (Rissoan et al., 
1999).  Differentiation of Th1 is driven primarily by IL-12, where as Th2 is driven 
primarily by IL-4 (Abbas et al., 1996).  While DC1-induced Th1 differentiation is 
mediated by increased production of IL-12 in response to CD40 ligand stimulation, DC2-
induced Th2 differentiation is mediated by mechanisms independent of IL-4 or IL-12 








Immunological adjuvants are often incorporated in vaccines where the antigen 
alone is not immunogenic enough to elicit protective immunity.  Adjuvants are classified 
by their modes of action: particulate and immunostimulatory (Singh and O'Hagan, 1999).  
Particulate adjuvants, including polymeric microparticles, are internalized by APCs, 
thereby activating them, inducing an immune response (Singh and O'Hagan, 1999).  
Particulate adjuvants also enhance the immune response by creating a depot of antigen at 
the site of injection to prolong exposure (Hunter, 2002).  Complete or incomplete 
Freund’s adjuvant (CFA/ IFA), an oil emulsion with or without killed bacteria, 
respectively, are commonly used adjuvants but are limited to experimental animal models 
due to their toxicity (Alving, 2002).  To date, aluminum hydroxide, aluminum phosphate, 
and calcium phosphate are the only adjuvants approved for clinical use.  Polymeric 
microparticles are currently under investigation as possible adjuvants (Ertl et al., 1996; 
Seferian and Martinez, 2001; Suckow et al., 2002; Jaganathan et al., 2004).  
Immunomodulatory adjuvants are often of pathogenic source, including bacterial DNA 
and lipopolysaccharides (LPS), and enhance the immune response by activating APCs 
through MHC and co-stimulatory molecules or by affecting cytokine release (Singh and 
O'Hagan, 1999).  Many of these adjuvants as well as natural adjuvants such as 







Host response associated with biomaterial implants 
Protein adsorption 
 The implantation of a medical device leads to the host response against the injury 
caused by the implantation procedure as well as against the material itself (Anderson, 
1988).  Upon introduction to the body, proteins in the plasma and interstitial fluid 
immediately adsorb to material surface; thus the response of the inflammatory cells to the 
implant is through the adsorbed proteins present on the most outer surface of the implant, 
directed by the biomaterial surface properties, not against the naked biomaterial surface 
itself (Tang and Eaton, 1995).  For polymeric biomaterials, albumin, fibrinogen, 
fibronectin, vitronectin, immunoglobulins, and components of the complement system 
are commonly found to be adsorbed to the surface (Tang and Eaton, 1995).  The 
adsorption of these proteins to biomaterial surface is influenced by surface properties 
such as hydrophobicity, charge, chemistry, and microtopology (Mrksich et al., 1996; 
Shen and Horbett, 2001; Thiele et al., 2003).  Polymorphonuclear cells (PMNs) such as 
neutrophils and monocytes, adhere to the adsorbed proteins on material surface via their 
adhesion molecules and receptors to adsorbed proteins, initiating inflammation 
(Anderson, 1988; Tang and Eaton, 1995).  In general, hydrophobic polymeric surfaces 
have been shown to adsorb more proteins than do hydrophilic surfaces, and hence induce 
increased PMN adhesion and influence cell behavior (Collier et al., 1997; Otto et al., 
2003).  In particular, implantation of polyester terephthalate (PET) surface pre-adsorbed 
with albumin has been shown to passify biomaterial surface, resulting in fewer adherent 
cells as compared to non-coated PET surface.  In contrast, adsorption of fibrinogen to 
PET surface plays an important role in the inflammatory response against the implanted 
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PET; lack of inflammatory response against the surface in animals with low fibrinogen 
can be reconstituted by coating the implanted PET with fibrinogen or by injection of the 
animals with fibrinogen prior to implantation of non-coated PET (Tang and Eaton, 1993).  
In addition, fibrinogen has been shown to be the predominant component of adsorbed 
proteins on vascular grafts (Pankowsky et al., 1990) as well as on polymer surfaces for a 
variety of surface chemistry upon incubation in plasma (Nimieri et al., 1994).  The role of 
fibrinogen in inflammatory response against biomaterials has also been corroborated by 
the positive relationship between monocyte adhesion to polymeric surfaces and the 
amount of adsorbed fibrinogen present on these surfaces (Shen and Horbett, 2001).  
Further, initiation of the inflammatory response has been shown to be caused by the 
change in the conformation of fibrinogen bound to biomaterial surface (Hu et al., 2001).  
A similar observation of conformational change has been observed for vitronectin using 
atomic force microscopy (Zhang et al., 2004).   
 
Complement activation 
 For biomaterial-induced complement activation, the alternative pathway has been 
most characterized (Kazatchkine and Carreno, 1988), but classical pathway has also been 
implicated (Tengvall et al., 1996; Lhotta et al., 1998).  Spontaneous binding of C3b to a 
material surface is covalent, and is linked by the hydroxyl or amine groups on the 
material surface and the carbonyl group in the thioester binding site of C3b (Gorbet and 
Sefton, 2004).  Thus materials with nucleophiles on the surfaces promoting binding of 
C3b to the surface is thought to be complement-activating as this will result in the 
formation of C3 and C5 convertases, driving the complement activation (Gorbet and 
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Sefton, 2004).  While mannose-binding lectin pathway of complement activation has not 
yet been observed in biomaterial-induced complement activation, it is probable that 
materials containing carbohydrates or surfaces adsorbed with proteins with exposed 
carbohydrate modifications may activate the complement cascade via this pathway.  
Other factors that influence the activation of complement pathways include the type of 
base polymer material, as polymers of different backbone with same surface hydroxyl 
group density exhibited different levels of complement activation (Labarre et al., 2002) 
and molecular mobility of the material substrate (Berglin et al., 2004).   
 Recently, the sequence of events of plasma protein adsorption and complement 
activation on polystyrene has been shown to occur simultaneously; while this initial 
activation of complements was via the classical pathway, alternative pathway of 
complement activation followed, resulting in the deposition of C3b atop the initially 
deposited layer of plasma proteins (Andersson et al., 2005).  Moreover, there are 
interactions amongst components of the complement system and the coagulation cascade, 
further complicating the events at the material-tissue/ blood interface.  One result of 
complement activation is the activation of platelets and procoagulant phenotype; 
however, the complement proteins that result in biomaterial-induced activation of 
platelets are yet to be elucidated (Gorbet and Sefton, 2004). 
 Because protein adsorption directs cell adhesion to material surface and 
subsequent cell behavior, modifications of material surface to control protein adsorption 
to preferentially guide cell behavior to improve biocompatibility, enhance graft 
integration, and induce tissue regeneration have become one of the focuses of 
biomaterials research.  To minimize protein adsorption to material surface, grafting of 
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polymeric surfaces with poly(ethylene glycol) (PEG) to render the surface more 
hydrophilic (Noh et al., 1998) has been successful (reviewed in (Alcantar et al., 2000)).  
Other efforts to minimize adsorption of protein to biomaterial implants include 
microstructuring to change the surface wettability (Rupp et al., 2004) and plasma 
deposition to inhibit fibrinogen and monocyte adhesion (Shen et al., 2001).  In addition, 
biomimetic polymers containing biological signals to promote selective host response 
such as macrophage behavior and tissue repair are in development (Kao and Lee, 2001; 
Baier Leach et al., 2003).   
 
Acute and chronic inflammation 
 Following the immediate adsorption of proteins to material surface, the host 
response against biomaterial implants include acute and chronic inflammatory responses, 
granulation tissue formation, and fibrosis (Anderson, 1988; Tang and Eaton, 1995).  
During acute inflammation which lasts from minutes to days, phagocytes migrate to the 
area of inflammation mediated by adhesion molecules, where their function is 
phagocytosis and biochemical killing of invading pathogens by release of reactive 
oxygen species (Ratner et al., 1996).  The recognition of the biomaterial implant by 
neutrophils is mediated by the opsonization of the surface by IgG, fibrinogen, or 
components of the complement system (Tang et al., 1993).  Degree of release of reactive 
oxygen species has been shown, on a glass surface, to vary depending on the presence of 
a particular opsonins (Liu et al., 1997).  Upon adhesion, neutrophils attempt to 
phagocytose the implant but fail due to the size of the implant, and undergo frustrated 
phagocytosis and release reactive oxygen species which can cause degradation of the 
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biomaterial (Labow et al., 2001).  The extent of inflammatory response elicited by the 
release of reactive species by neutrophils depends on the ability of a material to be 
phagocytosed; large particles that cannot be phagocytosed result in increased neutrophils 
release of enzyme (Henson, 1971).  This oxidative degradation of implanted material may 
not only release particles of the bulk material but also leach constituents of the material to 
the surrounding area, which can cause deleterious effects even at distal sites if leached 
systemically. 
 Chronic stage of inflammation is characterized by the presence of monocytes, 
macrophages, and lymphocytes, at as early as 1 day after the implantation (Ratner et al., 
1996).  Similar to neutrophils, monocytes and macrophages are also phagocytic, and may 
result in degradation of the implant at the material interface, leading to corrosion and 
generation of particulate degradation byproduct.  Activation of these inflammatory cells 
by a biomaterial is again in part dependent on the size and the form of the implant or the 
likelihood of the implanted material to be phagocytosed.  In particular, wear debris from 
the prosthetic implant are internalized by macrophages, resulting in release of 
inflammatory cytokines and proteolytic enzymes, leading to implant failure (Affalato et 
al., 2001).  In contrast with the higher neutrophil release of oxidative species with large 
particles, culturing of these phagocytes with sterile ultra high molecular weight 
polyethylene particles with size and morphology similar to wear particles produced in 
vivo has shown increased cytokine production by cells cultured with particles of 
phagocytosable size, while cells cultured with larger particles secreted less cytokines 
(Matthews et al., 2000).  Further, macrophages can also release chemotactic factors, 
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reactive oxygen species, growth factors, and cytokines to orchestrate wound healing and 
affect proliferation and function of multiple cell types (Anderson, 1988).   
 
Granulation Tissue and Foreign body reaction  
 Release of soluble factors by macrophages which characterized the chronic 
inflammation lead to the proliferation of fibroblasts and endothelial cells surrounding the 
implant, forming granulation tissue (Ratner et al., 1996).  The repair process initiated by 
the formation of granulation tissue may occur as soon as 3-5 days after the implantation, 
and is characterized by angiogenesis and migration of fibroblasts to form a loose 
framework of connective tissue (Ratner et al., 1996).  The fibroblasts in the network 
originally produce proteoglycans, then collagen, which mechanically strengthen the 
connective tissue.  Neovascularization and formation of fibrovascular tissue are 
differentially affected at the material/ tissue interface.  In particular, surface roughness 
and nanostrucutures of PLGA has been shown to influence adhesion and proliferation of 
endothelial and vascular smooth muscle cells (Miller et al., 2004; Xu et al., 2004) and in 
vivo infiltration of fibrovascular tissue into tubes also made of PLGA was observed upon 
subcutaneous implantation (Day et al., 2004).   
 In the subsequent stages of healing, foreign body reaction as characterized by 
components of granulation tissue and presence of foreign body giant cells (FBGCs) ensue 
(Anderson, 1988).  In an attempt to phagocytose the biomaterial implant, monocytes and 
macrophages adhere to the implant and fuse, forming FBGCs (Ratner et al., 1996).  This 
cellular adhesion to biomaterial and subsequent fusion of macrophages are influenced at 
least in part by surface properties (Shen and Horbett, 2001; Collier et al., 2004; Dadsetan 
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et al., 2004), and the consequent adsorbed proteins and their orientation (Kao et al., 1999; 
Collier and Anderson, 2002), as well as the cytokine environment surrounding the 
biomaterial implant (Kao et al., 1995).  The degree of foreign body reaction is influenced 
by the surface roughness of the biomaterial; foreign body reaction on smooth surfaces are 
characterized by the presence of macrophages of one to two cells in thickness, while 
rough surfaces primarily present foreign body reactions composed of macrophages and 
FBGCs (Anderson, 1988).  Formation of FBGCs in vitro is induced by IL-4 (McInnes 
and Rennick, 1988) and IL-13 (DeFife et al., 1997).  In experimentally induced in vitro 
FBGC formation by IL-4, the initial adhesion of monocytes is mediated by β2 integrins, 
whereas the fusion of the macrophages is mediated by β1 (McNally and Anderson, 2002).  
In addition, mannose receptor, whose expression is increased upon IL-4 or IL-13 
addition, also plays a role in the fusion of macrophages (McNally et al., 1996; DeFife et 
al., 1997).  More recently, subcutaneous implantation of biomaterial in animals lacking 
CC chemokine ligand, CCL2/ MCP1 has been shown to have altered macrophage fusion 
and reduced FBGC formation, implicating a role for CCL2/ MCP1 in the fusion of 
macrophages for the formation of FBGCs (Kyriakides et al., 2004).  It is of particular 
interest to note that the in vitro methods for the generation of FBGC formation from 
peripheral blood mononuclear cells, either with GM-CSF and IL-4 (Kyriakides et al., 
2004) or IL-4 alone (Dadsetan et al., 2004) are very similar to those used to induce 







 Development of fibrous capsule around the biomaterial to wall off the implant 
marks the later stages of wound healing (Tang and Eaton, 1995; Ratner et al., 1996).  
While in an ideal restoration, tissue surrounding the implant would be regenerated by 
parenchymal cells, but replacement of tissue by fibrotic capsule and connective tissue is 
more common (Anderson, 1988; Tang and Eaton, 1995).  In the case of organ substitutes, 
the generation of fibrotic overgrowth, especially if not well vascularized, impedes 
exchange of nutrients and waste between the microenvironment and the cells, and is to be 
minimized.  As with many other aspects of host response against biomaterial implants, 
modification of biomaterial surface to control fibrosis around implants include 
modification of surface with biomimetic peptide (Johnson et al., 1997), PEG (Sawhney et 
al., 1993), and phosphorylcholine (Malik et al., 2001).   
 Other cellular responses to biomaterials include the upregulation of heat shock 
proteins (HSPs), of which HSP 70 and 90 are the most studied (Kato et al., 1998b; 
Santoro, 2000; Weber et al., 2001; Parcellier et al., 2003).  The expression of some HSP 
is constitutive, while other HSP may be induced by heat shock and other cytotoxic 
conditions.  Heat shock proteins protect the cells, often via their function as molecular 
chaperones, by stabilizing the folding of proteins damaged due to stress (Santoro, 2000; 
Weber et al., 2001; Parcellier et al., 2003).  The differential mRNA expression of some 
HSPs by several cell types in contact with various biomaterials (Kato et al., 1998b; 
Klinge et al., 2002; Wang et al., 2003) suggest that contact with polymer may provoke 




Biomaterials in combination products 
 Various tissue engineering strategies such as immunoisolation and 3-dimensional 
constructs composed of a carrier matrix or scaffold seeded with viable functional cells 
have shown promise in reparative medicine (Langer and Vacanti, 1993).  The biomaterial 
component of the device serves not only as a scaffold for the cells but also guides cell 
growth, maintenance of differentiation state, tissue regeneration, and vascularization, 
especially with the addition of growth factors (Chapekar, 2000; Langer, 2000; 
Humatcher, 2001).  To achieve these functions, a biomaterial must be biocompatible and 
possess controllable microstructure, degradability, porosity, and mechanical and physical 
strength and integrity.  Moreover, these biomaterials must be readily available, 
reproducible, processable, and withstand appropriate sterilization processes for clinical 
applications (Marler et al., 1998; Kim et al., 2000; Langer, 2000).   
 Both natural and synthetic biomaterials have been explored for use in tissue 
engineering.  Biomaterials of natural origin are advantageous in that they may contain 
amino acid sequences that promote desirable cellular function, but may face difficulties 
in production including reproducibility between batches and scale-up (Langer and 
Vacanti, 1993; Angelova and Hunkeler, 1999; Kim et al., 2000).  Major advantage of 
synthetic biomaterials is the ability to control physicochemical properties including 
molecular weight, hydrophobicity, composition, and degradability; however, synthetic 
materials do not have intrinsic biological recognition and may be less biocompatible 
compared to the naturally occurring materials (Angelova and Hunkeler, 1999; Kim et al., 
2000; Langer, 2000).  
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 In other combination product application such as drug delivery, various 
biomaterials have been explored.  In particular, micro- and nanoparticles of biomaterials 
as adjuvants is an attractive approach as particle internalization can target the delivery of 
the associated antigen to APCs.  In addition, control of polymer degradation rate enables 
controlled release, making polymer particles an ideal vehicle for drug delivery (Jiang et 
al., 2005).  To this end, several natural and synthetic materials with immunomodulating 
properties including PLGA, chitosan, and ethylene imine have been investigated (Storni 
et al., 2005).  For induction of mucosal immunity, properties of biomaterials that promote 
adhesion to mucous membranes such as charge can enhance the mucosal protective 
immunity via uptake of the antigens by M cells, specialized APCs in the mucosa, 
resulting in production of IgA (Kuntz and Saltzman, 1997; Brayden and Baird, 2004).        
 
Poly(lactic-co-glycolic acid) 
 Poly(lactic-co-glycolic acid) (PLGA) is synthetic polyester composed of variable 
molar ratios of lactic and glycolic acid.  It is biodegradable via bulk hydrolysis and 
biocompatible as its degradation products, lactic and glycolic acids, can be metabolized 
and excreted (Athanasiou et al., 1996).  Rate of PLGA hydrolysis can be controlled by its 
geometric size, ratio of lactic to glycolic acid, and molecular weight of the polymer 
(Hutchinson and Furr, 1986; Eldridge et al., 1991; Mikos and Temenoff, 2000).  For drug 
delivery applications, hydrolysis rate can be exploited for controlled release (Newman et 
al., 1998).  The immune response supported by PLGA as an adjuvant, as measured by 
antibody responses against antigens delivered with PLGA, has been evaluated as at least 
comparable if not greater than that elicited by known adjuvants such as alum and 
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Complete Freund’s Adjuvant (Ertl et al., 1996; Walker et al., 1998; Raghuvanshi et al., 
2001).  Micro- and nanoparticles of PLGA have also been shown to elicit cell-mediated 
immune response which cannot be induced by alum (Newman et al., 1998).  Furthermore, 
particle size and the mode of antigen association with the polymer (adsorption or 
entrapment) affect the immunogenicity of PLGA (O'Hagan et al., 1993), presumably due 
to differential phagocytosis by APCs.  Microspheres of PLGA have been shown to be 
phagocytosed by macrophages and DCs, and retained in the phagosomal vesicle (Walker 
et al., 1998).  Recently, studies investigating the effects of PLGA microspheres as drug 
delivery vehicles and their uptake by DCs have been reported.  In the murine system, 
PLGA microspheres were shown to enhance antigen presentation by DCs (Sun et al., 
2003), and clinical grade human DCs generated in the absence of plasma or serum were 
able to ingest PLGA microspheres without changing surface expression of co-stimulatory 
and MHC molecules (Waeckerle-Men et al., 2004).   
 Because of the biodegradability of PLGA, and the ability to control this 
degradation, as well as its mechanical strength, this polymer has also been extensively 
researched for tissue engineering applications (Jain, 2000).  Adjuvant effect of PLGA in 
the context of tissue engineering has been shown; delivery of PLGA microparticles or 
scaffolds by injection or implantation, respectively, with a model shed antigen has 
resulted in increased production of antigen-specific antibody (Matzelle and Babensee, 
2004), and this increased humoral response was dependent on the form of PLGA 
(Bennewitz and Babensee, 2005).  As materials such as PLGA is explored for both 
vaccine delivery and tissue engineering applications where adjuvant effect and associated 
increase in immunity is or is not desirable, respectively, understanding of biomaterial 
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adjuvant effect is paramount to the development of materials for use in combination 
products.   
 
Agarose 
Agarose is a polysaccharide isolated from seaweed, composed of repeating β-D-
galactopyranosyl and 3,6-anhydro-α-L-galactopyranosyl units.  It gels thermoreversibly 
due to hydrogen bond formation, facilitated by alignment of the agarobiose molecules 
(Shoichet et al., 1996).  Agarose has been commonly used as a food ingredient stabilizer, 
and as a biomaterial for tissue engineering, including 3-D culture of chondrocytes (Benya 
and Shaffer, 1982; Sun et al., 1986), neural cells and nerve regeneration (Bellamkonda et 
al., 1995), and immunoisolation of islets for bioartificial pancreas (Iwata et al., 1992).  
Host response against implanted agarose has been studied in several applications.  
Injection of sterile agarose beads into the trachea of mice resulted in minimal local 
inflammatory reaction (Starke et al., 1987), and bronchoalveolar lavages from mice 
inoculated with sterile agarose beads contained low levels of inflammatory cytokines 
with little cellular response, which consisted of mononuclear cell infiltration only around 
the beads (van Heeckeren et al., 2000).  In another application, animals receiving agarose 
gel alone into created defects penetrating the cartilage showed no immune cell infiltration 
or inflammation in the synovium after 12 months (Rahfoth et al., 1998), demonstrating 
low immunogenicity of agarose.  Agarose has also been used as carrier vehicle for the 
delivery of cytokines for wound healing (Rollwagen et al., 1993; Spargo et al., 1994) as 
well as for corticosteroid-producing adrenal cells for reduction of inflammation (Cadic-
Amadeuf et al., 1992).  While these studies vary in the physical properties of agarose 
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used, the concentration of agarose and the site of implantation, they collectively suggest 
that agarose elicits minimal humoral and cellular response in vivo. 
 
Summary 
 In efforts to improve compatibility of biomaterials used in combination products 
and implants, the host response to biomaterials has been studied at various phases, from 
the initial stages of protein adsorption to the resulting consequences on the adaptive 
immunity.  Despite progress in understanding the effect of biomaterials alone on the 
immune and inflammatory responses, particular concern remains in the case of 
combination products comprised of biological and biomaterial components.  When 
introduced to the host, inflammatory response against the biomaterial and immune 
response against the biological or cellular component may act in concert, leading to 
deleterious effects.  The presence of biomaterial can enhance the adaptive immune 
response through its adjuvant effect mediated by the maturation of DCs.  While many of 
the studies of immune and inflammatory responses in the context of biomaterials to date 
have focused on these responses separately, the understanding of the link between how 
the innate response of inflammation against biomaterials interact with and influence the 




CHARACTERIZATION OF MICROPARTICLES AND FILMS OF 
POLY(LACTIC-CO-GLYCOLIC ACID) AND AGAROSE 
 
INTRODUCTION: 
 The use of biomaterials in biomedical applications in which the biomaterial 
together with biological components encounter the host defense mechanism necessitates 
the clarification for the role of the biomaterial in supporting or not supporting the 
immune response associated with the biological component.  In particular, for 
biomaterials used in tissue engineered devices and combination products where the 
biomaterial serves both structural and functional purposes, the interaction between 
inflammatory and immune responses elicited by the biomaterial and the biological 
components, respectively, may result in unexpected detrimental effects when 
concurrently imposed (Babensee et al., 1998).  To understand the adjuvant effect of the 
biomaterial in potentiating the immunological response against the biological component, 
the effect of biomaterial contact on dendritic cell maturation was investigated.  In 
particular, microparticles (MPs) and films of two model biomaterials currently explored 
in these applications, poly(lactic-co-glycolic acid) (PLGA) and agarose, were prepared 
and characterized for subsequent testing of their adjuvant effect by measuring the extent 
of dendritic cell maturation induced.  While the characterizations of these biomaterials 
are not novel, it is of importance, especially as most MPs and films were made in-house, 
to fully understand the effect of the biomaterial and its properties on dendritic cell 





Preparation of poly(lactic-co-glycolic acid) microparticles  
 Poly(lactic-co-glycolic acid) MPs were prepared by a single emulsion solvent 
evaporation technique adapted from a previously described method (Wake et al., 1998).  
Briefly, for small MPs (~3 µm diameter) 500 mg of PLGA (molar ratio: 75:25, inherent 
viscosity: 0.69 dL/g in trichloromethane) (Birmingham Polymers, Birmingham, AL) was 
dissolved in 20 ml dichloromethane (DCM) (Sigma, St. Louis, MO) overnight at room 
temperature.  On the second day, the PLGA-DCM solution was added to 200 ml 0.3% v/v 
aqueous poly(vinyl alcohol) (88% hydrolyzed) (PVA) (Sigma), and homogenized for 2 
min at approximately 9000 rpm using a PowerGen Homogenizer 700 (Fisher Scientific, 
Pittsburgh, PA).  Immediately after homogenization, 200 ml 2% (v/v) aqueous 
isopropanol (Sigma) was added to initiate precipitation, and the mixture stirred overnight 
at room temperature to evaporate the solvent.  Resulting MPs were collected by 
centrifugation at 1000 rpm for 10 minutes, washed twice in 2% isopropanol, and three 
times in distilled deionized H2O (ddH2O).  Microparticles were resuspended in ddH2O 
and their size distribution characterized using a Coulter Multisizer II (Coulter 
Corporation, Miami, FL).  To make larger MPs (~30 µm diameter), same procedures as 
described above were used, with an exception of a lower homogenization speed of 950 
rpm.  Resulting MP suspension was collected by centrifugation 1000 rpm for 5 minutes, 
then washed twice in 2% isopropanol.  Upon washing with isopropanol, the MPs were 
successively filtered using a 70 µm cell strainer, then through a 40 µm cell strainer 
(Becton Dickinson, Franklin Lakes, NJ).  Resulting filtrate was filtered again using a 20 
µm nylon mesh (Spectrum Laboratories, Inc., Rancho Dominguez, CA).  This time the 
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MPs in the membrane retentate were collected by washing the mesh with at least 50 ml 
ddH2O.  The resulting MP suspension was washed 3 times with ddH2O.  For both size 
MPs, MP suspension was UV sterilized for 1 hr, and stored at 4°C for no longer than 3 
days prior to use.   
 
Preparation of poly(lactic-co-glycolic acid) film 
 Poly(lactic-co-glycolic acid) films were fabricated using a previously described 
casting technique without a porogen (Ishaug et al., 1997).  Briefly, 10% w/v 75:25 PLGA 
was dissolved in DCM overnight at room temperature.  The PLGA-DCM solution was 
poured onto a 50 mm or 100 mm Teflon Petri dish (Cole-Parmer, Vernon Hills, Illinois).  
Upon evaporation of the solvent and drying, the film was punched into an appropriate 
size and washed for 1 hr in ddH2O, changing water every 15 min.  The film was dried 30 
min per side in a sterile laminar flow hood and UV sterilized for 30 min per side prior to 
use.  
 
Preparation of agarose microparticles 
 Microparticles of polystyrene coated with agarose (agarose MPs), of 2 µm and 30 
µm in diameter, were purchased from Micromod (Micromod, Rostock-Warnemuende, 







Preparation of agarose film 
 Agarose (type V; sulfate content of ≤ 0.30%, gel strength of ≥800 g/ cm2 at 1.0%, 
and gel point of 42°C±1.5°C at 1.5%) was purchased from Sigma.  This particular 
agarose was chosen as it had a high gel point, enabling it to remain in the hydrated gelled 
state at temperature of 37°C, temperature used for cell culture.  Aqueous solution of 3% 
w/v agarose in ddH2O was prepared and heated using a microwave until boiling and 
visible homogeneity was reached.  The film was prepared by dispensing 1 ml of agarose 
solution into a well of a 6 well plate (Corning, Corning, NY), and allowed to solidify at a 
temperature of 4°C for at least 30 min, and brought back to room temperature for another 
30 min prior to use.   
 
Scanning electron microscopy (SEM)  
Morphology of MP surface was analyzed by scanning electron microscopy (SEM) 
at Integrated Microscopy and Microanalytical Facility at Emory University.  Samples of 
agarose or PLGA MPs were prepared by placing a drop of MP suspension on a silicon 
chip and lyophilized.  Sample of PLGA film was prepared by mounting a piece of 
excised film on a silicon chip.  Silicon chip with lyophilized MPs or PLGA film was 
mounted onto an aluminum specimen stub with silver paste, degassed for 30 min, and 
coated with 1 nm chromium using a turbo-pumped sputter system (Denton DV-602, 
Denton Vacuum, Moorestown, NJ).  Micrographs were captured using ISI DS-130 




For agarose film, cryo-high resolution SEM (HRSEM) was performed to image 
the film in the hydrated state.  Small piece of agarose film was excised and fit into a gold 
planchette, and plunge frozen in liquid ethane at -183°C to form vitreous ice, and 
immersed in liquid nitrogen to maintain temperature below -170°C.  The specimen was 
then placed onto a Gatan 3500 CT cryostage precooled to <-170°C and the surface of the 
specimen fractured with a pre-cooled blade.  For some samples, the specimen surface was 
etched by raising the temperature from -170°C to -125°C or -105°C for 5 minutes, to 
remove surface exposed ice by sublimation.  Samples were coated in a Denton DV-602 
chromium coater (Denton, Moorestown, NJ), at a pressure of 2x10-7 torr, for a final 
coating of 2 nm in thickness.  After coating, the specimen was transferred to a DS-130F 
field emission scanning electron microscope (Topcon), and images recorded.    
 
X-Ray photoelectron spectroscopy (XPS) 
 Chemical compositions of biomaterial surfaces were analyzed by XPS at Georgia 
Institute Technology Microelectronics Research Center.  Spectra of biomaterial MPs and 
films were obtained on a Surface Science Laboratories X-100 spectrometer (Surface 
Sciences Laboratories, Mountain View, CA) with monochromatized A1 Kα X rays using 
10 kV.  For MPs, specimens were prepared by adding a drop of MP suspension to a glass 
cover slip, dried overnight, resulting in a mound of MPs, which was then lyophilized 
(Shakesheff et al., 1997).  Specimens were placed under a nickel mesh, and 5 eV flood 
gun was used to assist with the compensation for differential charging.  Atomic 
percentages of elements were derived from low resolution spectra (spot size 400 µm).  
High resolution C1s spectra (spot size 200 µm) were obtained and resolved using curve 
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fitting routines provided by the manufacturer, and the binding energy scale was adjusted 
to place the hydrocarbon peak at 284.6 eV.  For angle resolved XPS, the takeoff angle 
(defined as the angle between the beam and the surface normal) was varied to allow 
measurements at different depths from the film surface.  The limits of detection of angle 
resolved XPS is approximately 0.1 atom % in concentration and 10-250Å in depth 
(Ratner et al., 1996), with maximum depth achieved at a takeoff angle of 0°.  
 
Advancing water contact angle measurements 
 Ambient air-water-substrate advancing contact angles for agarose and PLGA 
films were measured using a Ramé-Hart goniometer (Ramé-Hart Instrument Co., 
Mountain Lakes, NJ) in Dr. Andrés García’s laboratory at Georgia Institute of 
Technology with technical assistance from Dr. Ben Keselowsky.  To ensure flat surface, 
PLGA film was prepared by pouring PLGA-DCM solution onto a cleaned cover slip 
placed in Teflon Petri dish.  Upon polymerization as described in a previous section, 
excess film around the cover slip was excised.  For agarose specimens, 3% agarose 
solution was dispensed onto a cleaned glass slide, and after solidification, the film was 
peeled off.  The side exposed to the glass slide was used for contact angle measurements 
to ensure a flat surface, as the side exposed to the air during solidification was domed due 
to surface tension.  Values reported represent the average and standard deviation of three 






Gas chromatography-mass spectrometry (GC-MS) 
 Electron ionization GC-MS was carried out at Georgia Institute of Technology 
Mass Spectrometry laboratory using VG Instruments 70SE (ThermoElectron 
Corporation, San Jose, CA) interfaced to a Hewlett-Packard 5890 gas chromatograph 
(Agilent Technologies, Palo Alto, CA) in the electron ionization mode.  The electron 
energy was 70 eV, and the mass resolution was 1000.  Spectra were recorded over a 






Characterization of PLGA microparticles  
Morphology of the PLGA MPs was visualized by SEM.  Both sizes of PLGA 
MPs had a smooth surface, with occasional pits (Figures 4-1a, b).  Size distribution of the 
MPs as determined by SEM micrographs was in agreement with those determined by a 
Coulter Counter, either ~ 3 or ~ 30 µm.  Results of surface chemical compositions are 
summarized in Table 1, and corresponding XPS spectra are shown in Figure 4-2.  For 
both PLGA crystals and PVA powder specimens, experimental values of percentage of 
carbons bonded in C-C form were higher than theoretical values (Table 1, Figures 4-2a 
and 4-2b, respectively).  Further, PLGA MPs contained higher amounts of C-C bonded 
carbons as compared to PLGA crystals (Table 1).  No residual DCM was detected within 
the depths analyzed by XPS.  In addition, DCM was not detected by GC-MS, as indicated 
by the lack of base or M+ peaks at mass: charge ratios (m/z) of 49 and 84, respectively 












(a) (b) (c) (d)
Figure 4-1: Scanning electron micrographs of PLGA MPs (3 µm (5,000x) (a), 30 
µm (1,500x) (b)) and films (top surface (15,100x) (c), bottom surface (15,100x) 
(d)).  Microparticles of both sizes show smooth surface with occasional pits.  Top 
surface of PLGA films present smoother surface as compared to the bottom surface. 
Material C-C C-O O-C=O contact angle
PLGA crystals (theoretical) 24.7% 37.3% 37.3%
PLGA crystals (experimental) 34.6% 30.4% 35.0%
PVA powder (theroretical) 50.0% 44.6% 5.4%
PVA powder (experimental) 54.6% 40.5% 4.9%
PLGA MPs (experimental) 65.9% 20.9% 13.2%
PLGA film (experimental) 27.4% 30.4% 42.3% 71.6° ± 2.0°
Table 1: Elemental composition in the C1s region of XPS spectra at 55° take off 
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Figure 4-2: XPS spectra of PLGA crystals (a), PVA powder (b), PLGA film (c), 
and PLGA MPs (d).
Jagged lines represent original XPS experimental data, thin smooth lines represent 
calculated curve from curve fitting; the curve from original XPS data may be 
obscured by the calculated curve when there is a good fit.  Bold smooth curves 







Figure 4-3: GC-MS measurements of PLGA MPs and PLGA film.  
PLGA MP analyzed with probe temperature at 132°C (a) and 450°C (b).  PLGA film 
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Characterization of PLGA films 
 Surface morphology of PLGA films as determined by SEM showed a smooth 
surface.  In particular, the top surface (Figure 4-1c), which was exposed to the air during 
polymerization, was smoother than the bottom surface (Figure 4-1d), which was exposed 
to the casting Teflon dish.  The chemical composition of the surface is summarized in 
Table 1, and XPS spectra of C1s scan is shown in Figure 4-2d.  Unlike the MPs, PLGA 
film presented lower amounts of carbon bonded in C-C form, and increased C-O and 
C=O forms, a profile more like the PLGA crystals.  Depth profile of chemical 
composition of PLGA film was measured by varying the take off angles of XPS.  
Throughout the depths examined, no chlorine was present.  In addition, these values 
indicated that the ratio of C:O was higher than expected theoretical values, and increased 
at depths closer to the exposed surface (Table 3).  While no chlorine was detected within 
the analytical sensitivity of XPS, GC-MS results revealed presence of residual chlorine 
from DCM, especially at the low probe temperature of 227°C, as indicated by peaks at 
m/z= 49 and 84 (Figure 4-3c).  Advancing contact angle measurements for air-water-
PLGA was 71.6°±2°, indicating hydrophobicity (Table 2), and in agreement with 




Characterization of agarose microparticles 
 Agarose microspheres of both sizes presented relatively smooth surfaces with 
some irregularities (Figures 4-4a and 4-4b, respectively).  On the surface of the 2 µm 
MPs, the type of carbon present was all singly bonded to oxygen (Table 2, Figure 4-5c).  
However, in contrast, 30 µm MPs showed lower levels of carbon bonded in the C-O form 
and higher levels in the C-C form (Figure 4-5d).  Although agarose microspheres were 
submitted for analysis by matrix assisted laser desorption/ ionization (MALDI) mass 
spectrometry, no spectrum was obtained due to high molecular weight and polydispersity 















Figure 4-4: Scanning electron micrographs of agarose MPs (2 µm (40,100x) (a), 
30 µm (3,010x) (b)) and agarose film (etched (10,000x) (c), non-etched (10,000x) 
(d)).  Microparticles of both sizes show smooth surface with some irregularities (2a, 
2b).  Film surfaces, etched (c) and non-etched (d), are smooth with some protrusions.
(a) (b) (c) (d) 
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Characterization of agarose films 
 Surface morphology of agarose film was imaged using cryo-HRSEM to preserve 
the hydrated state of the film.  The film surfaces of both etched and non-etched presented 
some irregular protruding structures (Figures 4-4c and 4-4d, respectively).  Surface 
chemical compositions analyzed by XPS revealed that all of the carbon present on the 
film surface was bonded in the C-O form (Table 2, Figure 4-5b), and similar to PLGA 
film, with decreasing depth, increased C:O ratio was observed (Table 3).  Advancing 
contact angle measurement for agarose film was not possible as the surface of film wetted 
when contacted with a drop of ddH2O indicating hydrophilicity.  No successful spectrums 





Table 2: Elemental composition in the C1s region of XPS spectra at 55° take off 
angle and advancing water contact angle for agarose
Material C-C C-O O-C=O contact angle
agarose powder (theoretical) 0.0% 100.0% 0.0%
agarose powder (experimental) 0.0% 100.0% 0.0%
agarose MPs (experimental) 0.0% 100.0% 0.0%
agarose film (experimental) 0.0% 100.0% 0.0% surface wets
Table 3: Variation in C:O ratios for PLGA and agarose films as a function of 
XPS take off angle



















Figure 4-5: XPS spectra of agarose powder (a), agarose film (b), 2 µm MPs (c), 
and 30 µm MPs (d).
Jagged lines represent original XPS experimental data, thin smooth lines represent 
calculated curve from curve fitting; the curve from original XPS data may be 
obscured by the calculated curve when there is a good fit.  Bold smooth curves 
represent individual carbon environments from curve fitting as indicated.  
































































DISCUSSION:   
 Characterizations of PLGA and agarose MPs and films prepared in our laboratory 
for treatment of dendritic cells are reported herein.  These biomaterials, in MP or film 
form, are cultured with dendritic cells to evaluate their associated adjuvant effect by 
measuring the extent of dendritic cell maturation induced upon contact with the material.  
Thus while characterizations of PLGA and agarose have been reported elsewhere, this 
assessment serves as a basis for the subsequent work presented.   
Scanning electron microscopy revealed smooth surface on both PLGA films and 
MPs, in accord with other studies (Feng and Huang, 2001; Liu et al., 2003; Bouissou et 
al., 2004; Croll et al., 2004).  The experimental values of chemical composition of PLGA 
MPs as determined by XPS showed higher amounts of carbon bonded in the C-C form as 
compared to theoretical values for PLGA crystals (Table 1, Figure 4-2d).  This may be 
attributed to residual PVA, a surfactant used in the emulsification process in the 
fabrication of PLGA MPs.  While the exact amount of residual PVA on PLGA MPs was 
not quantified in this study and is difficult to estimate, it has been shown that particles 
with higher amounts of surface PVA are phagocytosed at a lower level, perhaps due to 
increased surface hydrophilicity at the surface (Meese et al., 2002; Sahoo et al., 2002).  
Residual chlorine from DCM was not detected on PLGA MPs as measured by XPS or 
GC-MS.  The surface of PLGA film showed chemical composition similar to that 
expected for PLGA crystals (Table 1, Figure 4-2c), and similar to values reported by 
others (Croll et al., 2004).  Unlike with the PLGA MPs, the fabrication procedure for 
PLGA film does not require any additional agents other than the polymer itself and the 
solvent, DCM, which may have resulted in its chemical composition more closely 
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resembling that of PLGA crystals than did the PLGA MPs.  Angle resolved XPS was 
performed on PLGA film to evaluate the presence of DCM at various depths.  Within the 
analytical sensitivity/ detection limits of XPS of 250Å in depth and 0.1 atom % (Ratner et 
al., 1996), DCM was not detected, as determined by the absence of chlorine (Table 3).  
However, DCM was detected by GC-MS (Figures 4-3c, d), suggesting that the DCM was 
present in the film, at depths deeper than was reachable by XPS analysis.  Angle resolved 
XPS also revealed an increase in the ratio of C:O closer to the surface, a phenomenon 
also observed by others, perhaps due to hydrocarbon contamination from the sample 
introduction, nearer the surface (Meese et al., 2002).  Advancing water contact 
measurements on PLGA film showed hydrophobic surface, in agreement with previously 
reported values (Meese et al., 2002; Karp et al., 2003). 
Scanning electron micrographs of agarose MPs presented surface with relatively 
smooth features with some irregularities (Figures 4-4a, 4b).  These irregularities may be 
due to the coating, as these microspheres are of polystyrene base, covalently coated with 
agarose per proprietary methods by the manufacturer.  Cryo-HRSEM analysis of agarose 
film showed that the surface of agarose film is also flat with some occasional protrusions, 
similar to what has been previously reported, using cryo-HRSEM, for the surface of 
frozen double distilled water (ddH2O) under high pressure (Menger et al., 2004).  The 
resemblance of surface structure of agarose film to ddH2O is not surprising as the agarose 
film is composed of 97% ddH2O and only 3% agarose.  The chemical analysis of agarose 
film surface by XPS high resolution C1s scan showed that for MPs of both sizes, only 1 
peak corresponding to C-O was present, in accord with theoretical values (Figures 4-5a, 
b, Table 2).  However, while 2 µm MPs showed composition as expected of agarose 
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(Figure 4-5c), 30 µm MPs had some carbon bonding in the C-C form (Figure 4-5d).  This 
increase in C-C environment may be attributed to exposure of polystyrene base due to 
reduced coverage of the MPs by agarose.  Similar to PLGA film, C:O ratio of agarose 
film also increased with decreasing depth from the film surface, as measured by angle 
resolved XPS.  Water contact angle measurements on agarose film were not possible as 
the surface wetted when contacted with a drop of water indicating hydrophilicity.  This 
hydrophilicity of agarose film is not surprising as the film is composed of 3% (w/w) 
agarose in water. 
 Characterization of biomaterials to be tested for adjuvant effect via dendritic cell 
maturation, namely agarose and PLGA MPs and films, are reported.  The increased use 
of these two particular biomaterials in combination products and tissue engineering 
applications implies a need to fully understand the material itself and their effects on the 
host immune system.  Especially as most of the MPs and films to be tested are made in 
our laboratory, while utmost care is taken into their fabrication, quality control for these 
MPs and films may not be as regulated as for commercially available products.  In 
subsequent studies evaluating the effect of biomaterial on dendritic cell maturation, MPs 




POLY(LACTIC-CO-GLYCOLIC ACID) MODERATELY ENHANCES 
MATURATION OF HUMAN MONOCYTE-DERIVED DENDRITIC CELLS∗ 
 
INTRODUCTION:  
 Tissue engineering has become an attractive approach for the development of 
functional tissue or organ substitutes where no suitable alternative exists or to reduce 
morbidity associated with current procedures.  Success of such engineered constructs 
depends on the viability of functional cells and the physiological integration of the device 
into the host living system.  As such, implanted tissue engineered devices must not only 
be accepted by the host immune system but also elicit minimal inflammation to avoid 
replacement of the seeded cells with or formation of excessive fibrotic or granulation 
tissue.  The response against an implanted tissue engineered device may be comprised of 
a specific immune response against the cellular component, similar to transplanted organ 
allograft or xenograft rejection depending on the cell source, as well as a nonspecific 
inflammatory response against the biomaterial component of the device (Babensee et al., 
1998).  While encapsulation and other immunoisolation strategies were originally 
developed to prevent the detection of the implanted cells by host immune surveillance, 
antigens or other cellular components shed or secreted from the implanted cells may 
escape through the membrane, resulting in indirect recognition by the host immune cells 
and immune stimulation (Babensee and Sefton, 2000).  This recognition and the ensuing 
immune stimulation may be intensified by the presence of a biomaterial component 
through induction of an innate immune response, recruiting antigen presenting cells (e.g., 
                                                 
∗ Modified from Yoshida M, Babensee JE.  Poly(lactic-co-glycolic acid) enhances maturation of human 
monocyte-derived dendritic cells.  J Biomed Mater Res A. 2004 Oct 1;71A(1):45-54. 
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macrophages and dendritic cells) and inducing their activation which would lead to the 
activation enhancement of the adaptive response (Matzelle and Babensee, 2004).  In this 
way, the biomaterial component can act as an adjuvant in the immune response towards 
associated shed cell antigens from a tissue engineered construct (Matzelle and Babensee, 
2004).  The elevation of specific immune response against the antigens associated with 
the device will lead to compromised effectiveness or failure of the device (Babensee et 
al., 1998).  While a polymer often used in tissue engineering, poly(lactic-co-glycolic 
acid) (PLGA), acted as an adjuvant in the enhancement of the humoral response against a 
co-delivered model antigen (Matzelle and Babensee, 2004), an understanding of the 
mechanism of this observed biomaterial adjuvant effect, especially on the cellular level, 
remains largely unexplored.    
 The basis for the action of adjuvants is the role of innate immunity in stimulating 
adaptive immune responses.  Dendritic cells recognize pathogens through conserved 
structures, uniquely characteristic of microbial pathogens, through their cognate binding 
receptors resulting in their maturation such that they become efficient antigen presenting 
cells (Janeway and Medzhitov, 1998).  For example, constituents of mycobacteria, the 
active component of the strong adjuvant complete Freund’s adjuvant (CFA), induce the 
maturation of DCs as exemplified by induction of pro-inflammatory cytokine secretion 
(e.g., IL-12) and upregulation of major histocompatibility complex (MHC) and co-
stimulatory molecules (Tsuji et al., 2000).  Concomitant with these characteristics of 
mature DCs is the prolonged expression of antigen-MHC on the surface of DCs, again 
supporting the stimulation of T cells (Cella et al., 1997).  Adjuvants may also function 
through the prolonged retention of the antigen in the vicinity of the inflammatory 
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stimulus – the depot effect – typical of controlled release devices for antigen delivery for 
vaccines (Zhao and Leong, 1996).  
 Dendritic cells play a central role in bridging the innate and adaptive immunity.  
Dendritic cells are professional antigen presenting cells capable of initiating an adaptive 
response (Banchereau and Steinman, 1998).  Immature DCs efficiently serve as sentinels 
surveying the surrounding microenvironment by capturing and internalizing antigens 
(Banchereau et al., 2000).  These DCs have also been shown to internalize particles of 
latex (Reece et al., 2001), polystyrene (Thiele et al., 2003), and PLGA (Lutsiak et al., 
2002; Newman et al., 2002).  Maturation of DCs is precipitated by infection with 
pathogens or “danger” signals, such as necrotic tissues and their byproducts, and result in 
the presentation of the previously internalized and processed antigens in the context of 
MHC molecules for activation of naïve T lymphocytes (Matzinger, 1994; Banchereau 
and Steinman, 1998; Gallucci et al., 1999).  These functional changes associated with DC 
maturation are correlated to the phenotypical changes including the downregulation of 
receptors involved in antigen internalization and adhesion as well as increased expression 
of MHC and co-stimulatory molecules such as CD40, CD80, and CD86 (Winzler et al., 
1997; Banchereau and Steinman, 1998; Banchereau et al., 2000).  An understanding of 
the mechanism of the biomaterial adjuvant effect will lead to selection of or design 
criteria for biomaterials for applications in tissue engineering or non-viral vaccine 
delivery by considering the effect of the biomaterial on associated immune responses.  
Specifically, biomaterials will be selected or designed to not support DC maturation 
where immune responses are undesirable, as for tissue engineered devices, while selected 
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or designed to support DC maturation where immune responses are desired, as for non-
viral delivery vehicles for vaccines.   
 In this study, the effect of PLGA contact on the maturation of human peripheral 
blood monocyte-derived DC was examined as one possible explanation for the PLGA 
adjuvant effect previously observed (Matzelle and Babensee, 2004).  The extent of 
maturation was assessed by changes in cell morphology, surface marker expression, 
allostimulatory capacity, and the ability of DCs to elicit delayed type hypersensitivity 
reaction as compared to appropriate controls.  Results indicate that PLGA is a stimulus of 
DC maturation and that the form in which the biomaterial is presented to the DCs (MP vs 
film) influences the extent of maturation induced.   
 
METHODS: 
Poly(lactic-co-glycolic acid)  microparticle and film preparation 
 Poly(lactic-co-glycolic acid) microparticles (MPs) were prepared by a single 
emulsion solvent evaporation technique adapted from a previously described method 
(Wake et al., 1998).  Briefly, 500 mg of PLGA (molar ratio: 75:25, inherent viscosity: 
0.69 dL/g in trichloromethane) (Birmingham Polymers, Birmingham, AL) was dissolved 
in 20 ml dichloromethane (DCM) (Sigma, St. Louis, MO) overnight at room temperature.  
On the second day, the PLGA-DCM solution was added to 200 ml 0.3% v/v aqueous 
poly(vinyl alcohol) (PVA) (Sigma), and homogenized for 2 min at 9000 rpm.  
Immediately after homogenization, 200 ml 2% (v/v) aqueous isopropanol (Sigma) was 
added to initiate precipitation, and the mixture stirred overnight at room temperature to 
evaporate the solvent.  The resulting MPs were collected by centrifugation at 1000 rpm 
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for 10 minutes, washed twice in 2% isopropanol, and three times in distilled deionized 
H2O (ddH2O).  The MPs were resuspended in ddH2O and their size distribution 
characterized using a Coulter Multisizer II (Coulter Corporation, Miami, FL).  Prior to 
use, MP suspension was UV sterilized for 1 hr, and stored at 4°C for no longer than 3 
days.   
 Poly(lactic-co-glycolic acid) films were fabricated using a previously described 
casting technique without a porogen (Ishaug et al., 1997).  Briefly, 10% w/v 75:25 PLGA 
was dissolved in DCM overnight at room temperature.  The PLGA-DCM solution was 
poured onto a 50 mm Teflon Petri dish (Cole-Parmer, Vernon Hills, Illinois).  Upon 
evaporation of the solvent and drying, the film was punched into appropriate size, and 
washed for 1 hr in ddH2O, changing water every 15 min.  The film was dried 30 min per 
side in a sterile laminar flow hood, and UV sterilized for 30 min per side prior to use.  
For culturing with cells, the film was secured to the bottom of the tissue culture plate 
with a segment of sterile silicone tubing (Cole-Parmer).  The effective endotoxin content 
of a 4 mm PLGA film was determined to be 0.35 ± 0.12 EU/mL (Tachiyama et al., 1986).  
Previous study has shown that a minimum E. coli endotoxin concentration of 100 EU/mL 
was required for DC maturation (Jotwani et al., 2003). 
 
Dendritic cell culture 
 Human blood was obtained from volunteers with informed consent, according to a 
protocol approved by the Institutional Review Board of Georgia Institute of Technology, 
#00A018.  Dendritic cells were derived from human peripheral blood mononuclear cells 
(PBMCs) using a previously described method with some modifications (Romani et al., 
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1996).  Peripheral blood mononuclear cells were isolated from heparinized whole blood 
(333 U heparin/ ml blood) by differential centrifugation using Histopaque (Sigma).  Cell 
layer containing mononuclear cells was collected and washed in phosphate buffer saline 
(PBS), and erythrocytes lysed with ammonium chloride (155 mM NH4Cl, 10 mM 
KHCO3, 0.1 mM EDTA), and washed again twice with PBS.  Resulting PBMCs were 
resuspended at a concentration of 5x106 cells/ ml in RPMI-1640 containing 25 mM 
HEPES and L-glutamine (Gibco BRL, Grand Island, NY) with 100 U/ ml penicillin-
streptomycin (Cellgro, Herndon, VA) and 1% (v/v) heat inactivated filter sterilized 
autologous plasma (DC media).  Cells were plated at in a volume of 10 ml/ plate in a 
100x20 mm tissue culture plate (Becton Dickinson, Franklin Lakes, NJ) and incubated 
for 2 hrs in at 37˚C with 95% relative humidity and 5% CO2 to select for adherent 
monocytes.  After the incubation, plates were washed 3 times with warm DC media to 
remove non-adherent cells.  The adherent cells were supplied with 10 ml DC media and 
incubated overnight without any cytokines.  On day 1 of culture, media was replaced with 
fresh DC media containing 1000 U/ ml GM-CSF and 800 U/ ml IL-4 (R&D Systems, 
Minneapolis, MN).  These cells were cultured for 4 days with one third of the media 
exchanged on day 3 of culture.  On day 5 of culture, loosely- and non-adherent cells 
containing DCs were collected by centrifugation for 10 min at 1100 rpm, resuspended in 
DC media with 1000 U/ ml GM-CSF and 800 U/ ml IL-4, and plated in a 6 well plate 
(Corning, Corning, NY) at a concentration of 5x105 cells/ well in 3 ml with or without 
stimulants.  For the induction of mature DCs (mDCs), 1 µg/ ml lipopolysaccharide (LPS) 
(E. Coli 055:B5) (Sigma) was added, and cells with no additional maturation stimulants 
were used as iDCs.  The effect of treatment of iDCs with PLGA was tested by adding 
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PLGA MPs at various MP: cell ratios (0.01:1, 0.1:1, 1:1) or plating cells on to a PLGA 
film previously positioned at the bottom of the plate well using a segment of silicone 
tubing.  Two days later, on day 7 of culture, the cells were collected for further analysis. 
 
Cell morphology 
 Morphology was monitored throughout the duration of culture by phase contrast 
microscopy of cells in culture or light microscopy of Cytospin preparations (Cytospin 
Cytocentrifuge, Thermo Shandon, Pittsburgh, PA) stained with Differential Hematology 
Stain (Astral Diagnostics, West Deptford, NJ).   
 
Cell surface marker expression 
 The levels of surface marker expression were monitored throughout the culture 
using flow cytometry (Ding et al., 1999).  Cells were harvested, and resuspended in 
Hank’s HEPES buffer (120 mM NaCl, 10 mM KCl, 10 mM MgCl2, 10 mM glucose, 30 
mM HEPES) containing 1% (v/v) human serum albumin (HSA) and 1.5 mM CaCl2, and 
stained with mouse anti- human monoclonal antibody against CD14 (clone UCHM1; 
IgG2aκ), CD40 (clone B-B20; IgG1κ), CD80 (clone BB1; IgMκ), CD86 (clone BU63; 
IgG1κ) (Southern Biotech, Birmingham, AL), CD83 (clone HB15a; IgG2b) (IO Test 
Immunotech Beckman Coulter, Marseille, France) HLA-DQ (clone TU169; IgG2aκ), or 
HLA-DR (clone TU36; IgG2aκ) (Becton Dickinson Pharmingen, San Diego, CA) for 1 
hr at 4°C, and analyzed using BD LSR flow cytometer (Becton Dickinson, San Jose, 
CA).  Data analysis was performed using WinMDI 2.8 (Scripps Research Institute, La 
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Jolla, CA) and BD FACS DiVa Option 2.0 (Becton Dickinson Biosciences, San Jose, 
CA).     
 
Transwell assay 
 The requirement for direct cell contact with PLGA MPs for DC maturation as 
measured by CD86 expression was determined using a transwell apparatus (24 mm 
diameter, 0.4 µm pore size, polyester membrane, Corning) based on a previously 
published protocol (Tsuji et al., 2000).  Immature DCs on day 5 of culture were 
resuspended in DC media containing 1000 U/ ml GM-CSF and 800 U/ ml IL-4, and 
plated in the lower well of the apparatus with or without various maturation stimulants.  
On the upper well, media with or without cells or maturation stimulants were added.  
Upon 2 days of co-culture, cells on the lower wells were assessed for CD86 expression 
by flow cytometry as an indicator of DC phenotype. 
 
TNFα blocking assay 
 In addition to transwell assays, in vitro blocking experiment was performed to 
evaluate the role of soluble factors released, namely TNFα, on DC maturation in 
response to treatment with PLGA.  Immature DCs on day 5 were resuspended at a cell 
density of 1x106 cells/ ml, and plated at 1 ml/ well in 24 well plates (Corning).  These 
cells were either left untreated or treated with 1 µg/ ml LPS or 5:1 MP: cell ratio of 
PLGA MPs for 2 hrs at 37°C, and then 20 µg/ml isotype (IgG1κ isotype, clone 107.3, no 
sodium azide, low endotoxin, Becton Dickinson Pharmingen) or 20 µg/ml TNFα 
blocking (clone 1825.12, R&D Systems, Minneapolis, MN) antibodies added for 
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additional 22 hrs.  Cells were collected by centrifugation and assessed for CD83 and 
CD86 expression, while the cell culture supernatant was collected, cleared and stored at -
20°C until analysis by ELISA for TNFα content per manufacturer’s directions (R&D 
Systems, Minneapolis, MN). 
 
Mixed lymphocyte reaction (MLR) 
 Allostimulatory capacity of DCs to stimulate T cell proliferation in response to 
mismatches in MHC molecules was assessed using an allogeneic MLR, as previously 
described (Coligan et al., 1994).  On day 7 of DC culture, allogeneic T cells were isolated 
from PBMCs by negative selection using Pan T cell magnetic isolation (Miltenyi 
Biotech, Auburn, CA) according to manufacturer’s protocols, and purity checked by flow 
cytometry using anti-CD3 monoclonal antibody (clone SK7; IgG1, Becton Dickinson 
Pharmingen) staining.  These cells were used as responder cells.  T cells were 
resuspended in RPMI-1640 with 25 mM HEPES and L-glutamine (Gibco BRL) with 100 
U/ ml penicillin-streptomycin (Cellgro) and heat inactivated filter sterilized 10% (v/v) 
human AB serum (Biowhittaker, Walkersville, MD) (complete RPMI-10 media) and 
plated at a concentration of 1x105 cells/ well in a 96-well flat-bottomed plate (Corning).  
Dendritic cells cultured in GM-CSF and IL-4 with or without stimulants were 
resuspended at 1.6x105 cells/ ml, and treated with 25 µg/ ml mitomycin C (Sigma) for 30 
minutes to prevent their proliferation.  Upon extensive washing with complete RPMI-10 
media, DCs were resuspended in complete RPMI-10 media and added to responder cells 
in triplicates at graded DC: T cell ratios.  Cells were co-cultured for 4 days, with the 
addition of 10 µM 5-bromo-2-deoxyuridine (BrdU) for the last 24 hrs of culture.  
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Dendritic cell-induced T cell proliferation was measured using BrdU colorimetric cell 
proliferation ELISA (Roche Applied Science, Indianapolis, IN) according to 
manufacturer’s directions.   
 
PLGA MP-mediated Delayed Type Hypersensitivity (DTH) Reaction  
 Delayed type hypersensitivity reaction protocol was adapted from a previously 
published method (Gallucci et al., 1999), and approved by Georgia Institute of 
Technology Institutional Animal Care and Use Committee #A02028.  NIH guidelines for 
the care and use of laboratory animals (NIH Publication #85-23 Rev. 1985) were 
observed.  C57BL6 male mice (6-8 wks old) (Charles River Laboratories, Wilmington, 
MA) were primed on day 0 with 100 µl of PBS, 1:1 dilution of complete Freund’s 
adjuvant (CFA) (Sigma) in PBS, or PLGA MPs (1.69x108/ ml) each with or without 100 
µg ovalbumin (OVA) (Sigma), as model antigen (6 mice/ group).  After 21 days, the 
animals received a booster with 100 µl of the same carrier vehicle containing 0 or 100 µg 
OVA.  In the case of CFA, incomplete Freund's adjuvant (IFA) (Sigma) was used in 
place of CFA.  One week later, on day 28, the mice were challenged with an intradermal 
injection with 10 µg OVA in the left hind footpad in 10 µl PBS.  On day 30, thickness 
and width of each hind footpads (challenged and contralateral unchallenged) were 
measured with an electronic digital caliper (Control Company, Friendswood, TX).  The 
degree of DTH response was calculated as percent swelling, determined as the thickness 
of the challenged footpad over divided by the thickness of the contralateral unchallenged 




Statistical Analysis  
 Statistical analysis was performed using general linear model ANOVA with 
Minitab software (Version 13.20, Minitab Inc., State College, PA), and pairwise 
comparison to control group (iDC or isotype) as appropriate, was made, with p-values of 





Immature dendritic cells cultured with PLGA microparticles or film show phenotypes 
consistent with maturation 
 To assess the effect of PLGA contact on DC maturation, human PBMC-derived 
iDCs were treated with PLGA MPs or films.  Culture of peripheral blood monocytes with 
GM-CSF and IL-4 led to detachment of cells and formation of cell clusters, hallmarks of 
DC development, as observed using phase contrast microscopy (data not shown).  As 
shown in Figure 5-1, morphology of iDCs treated with PLGA MPs or film was similar to 
that of DCs matured by LPS, with the presence of dendritic processes.  Further, addition 
of PLGA MPs to iDCs led to the association, possibly internalization, of the MPs with 










a b d c 
Figure 5-1: Dendritic cells treated with PLGA MPs or film possess cell 
morphology similar to DCs matured with LPS.   
Immature DCs derived from peripheral blood monocytes in the presence of GM-CSF 
and IL-4 (a), cultured with PLGA MPs (c) or film (d) showed similar morphology to 
that of DCs matured by LPS (b), with the presence of dendritic processes.  PLGA MPs 




Maturation of DCs is accompanied by an increase in expression of several cell 
surface markers including co-stimulatory molecules such as CD40, CD80, and CD86, and 
MHC class II molecules such as HLA-DQ and HLA-DR, and a marker of mDCs, CD83 
(Zhou and Tedder, 1996; Banchereau and Steinman, 1998).  To determine whether cell 
contact with PLGA MPs or film mediate phenotypical maturation of DCs, iDCs were 
treated with PLGA MPs or film for 2 days, and surface molecule expression was 
measured by flow cytometry and compared to the appropriate controls (Figure 5-2).  As 
seen in Figure 5-2a, addition of LPS to iDCs resulted in a marked increase in the 
expression of co-stimulatory and MHC class II molecules, as well as in CD83, indicative 
of DC maturation.  Upon exposure of iDCs to PLGA MPs or film, expression of CD40, 
CD80, CD86, CD83, HLA-DQ, and HLA-DR was increased compared to the control 
iDCs, in a dose-dependent manner (data not shown), but not to as great an extent as 
expressed by LPS-matured DCs.  Further, cells treated with MPs expressed slightly 
higher levels of the maturation markers examined compared to cells treated with the film.  
Analysis of fold increase in marker expression due to biomaterial treatments indicated 
that CD83, CD86, and HLA-DQ were most significantly enhanced upon PLGA MP or 





Figure 5-2: Dendritic cells treated with PLGA MPs or film moderately increase 
expression of co-stimulatory and MHC class II molecules.
Treatment of DCs with PLGA MPs or film resulted in shift of gMFI histograms 
indicating increased expression of maturation markers.  This experiment was repeated 
three times with similar results, and representative histograms are shown (a).  Fold 
increase in gMFI values for each treatment group as compared to that of iDC control 
revealed that treatment of DCs with PLGA MPs or film increase expression of CD83, 
CD86, and HLA-DQ at a statistically significant level (b). mean±SD, n=3, *: p<0.05. 















































































































































































































































































































































Upregulation of PLGA microparticle-induced CD86 expression by dendritic cells 
requires direct cell contact with biomaterial 
  To address whether the biomaterial-induced DC maturation requires direct 
contact between iDCs and PLGA MPs or whether soluble factors released by DCs in 
contact with PLGA MPs are sufficient to induce DC maturation, a transwell apparatus 
was used.  As shown in Figures 5-3a, iDCs cultured with LPS regardless of direct or 
indirect contact exhibited higher level of CD86 expression as compared to iDCs, 
confirming solubility of LPS.  Dendritic cells not in direct contact with PLGA MPs 
(samples iDC+PLGA MP/iDC, PLGAMP/iDC) expressed a similar level of CD86 as 
compared to iDCs without any maturation stimulants (samples media/iDC or iDC/iDC).  
In contrast, only iDCs cultured in direct contact with PLGA MPs (sample 
media/iDC+PLGA MP) showed upregulation in CD86 expression.  Fold increase in 
expression of CD86 by differentially treated DCs validated the above conclusions at a 





Figure 5-3: PLGA MP-induced DC maturation requires direct cell contact with 
PLGA MPs. 
Only DCs in physical contact with PLGA MPs (media/iDC+PLGA MP) expressed 
higher levels of CD86, while DCs cultured with PLGA MPs separated by the 
transwell membrane (iDC+PLGA MP/iDC, PLGAMP/iDC) did not increase CD86 
expression.  The contents of the upper and lower wells of a transwell apparatus are 
indicated on the figures as “upper/ lower”.  This experiment was repeated three times 
with similar results, and representative results are shown (a). Fold increase in gMFI
values for each treatment group as compared to that of none/iDC control confirmed 
findings from the histograms (b). mean±SD, n=3. *: p<0.05, compared to none/iDC.
iDC/ iDC iDC + LPS/ iDC iDC + PLGA MP/ iDC
media/ iDC + LPS media/ iDC + PLGA MP









none/iDC iDC/ iDC none/ iDC
+ LPS






















































































Figure 5-4: Increase in TNFα secretion induced by PLGA MPs or LPS is 
abrogated by the presence of anti-TNFα blocking antibody.
Dendritic cells treated with PLGA MPs or LPS increased secretion of TNFα as 
compared to iDCs.  This increase was not affected by the addition of isotype control 
antibody but was abrogated in the presence of TNFα neutralizing antibody. mean±SD, 




































































































While transwell assays indicated that DC maturation in response to PLGA MPs required 
direct contact between DCs and PLGA, blocking experiment was performed to confirm 
that PLGA MP-induced DC maturation was not mediated by autocrine effects of TNFα 
secreted by DCs cultured directly with PLGA MPs.  As shown in Figure 5-4, DCs treated 
with LPS or PLGA MPs increased release of TNFα, which was not affected by the 
addition of isotype antibody.  However, in the presence of TNFα blocking antibody, the 
amount of TNFα measured in the cell culture supernatant was significantly decreased.  In 
addition, increase in CD83 and CD86 expression by DCs in response to PLGA MP-
treatment was not reduced by the presence of TNFα neutralizing antibody (Figure 5-5).  
Pretreatment of iDCs with anti-TNFα antibody slightly decerased CD83 expression, 
while none of the other pretreatments resulted in alteration in the expression of CD83 or 








Figure 5-5: PLGA MP-induced DC maturation is not mediated by TNFα. 
Immature DCs left untreated or treated with PLGA MPs were incubated in the 
presence of isotype antibody or TNFα neutralizing antibody.  Increase in CD83 and 
CD86 expression by PLGA MP-treated DCs was not reduced by the presence of 
TNFα blocking antibody. This experiment was repeated three times with similar 
results, and representative results are shown (a).  Fold increase in gMFI values for 
anti-TNFα treated groups as compared to that of isotype antibody treated controls 
revealed that pretreatment of iDCs with the neutralizing antibody slightly decreased 
the expression of CD83 while none of the other treatments affected DC marker 















































































































Dendritic cells cultured with PLGA microparticles are moderately allostimulatory in a 
mixed lymphocyte reaction 
 As mDCs are effective stimulators of T lymphocyte proliferation, the 
allostimulatory capacity of DCs treated with PLGA was measured by an allogeneic MLR.  
Immature DCs exposed to LPS (mDCs), PLGA MPs or film, or no additional stimulants 
(iDCs) were used as stimulators and allogeneic T lymphocytes were used as responders at 
various stimulator: responder ratios.  As shown in Figure 5-6, LPS-matured DCs were 
highly allostimulatory in a stimulator: responder ratio-dependent manner, while control 
iDCs induced little or no T lymphocyte proliferation.  Dendritic cells treated with PLGA 
MPs were capable of stimulating an MLR, but to a lesser extent than LPS-matured DCs.  
However, cells treated with PLGA film did not induce significant T cell proliferation 




















LPS (1 ug/ml) (mDC)
PLGA MP
PLGA film
Figure 5-6: Dendritic cells cultured with PLGA MPs are moderately 
allostimulatory in an MLR.
Dendritic cells matured with LPS are highly allostimulatory, whereas iDCs are not.  
Dendritic cells treated with PLGA MPs elicited a moderate proliferation of allogeneic 
T cells, but DCs cultured on PLGA film were not significantly allostimulatory above 
that of iDCs.  This experiment was repeated four times with similar results, and 















PLGA microparticles elicit a moderate delayed type hypersensitivity reaction in mice 
As DCs exposed to PLGA MPs were capable of upregulating co-stimulatory and 
MHC class II molecules and stimulating allogeneic T lymphocyte proliferation in vitro, 
the ability of PLGA MPs to stimulate DCs to become antigen presenting cells in vivo to 
initiate a T cell-mediated response was assessed using a DTH reaction against a model 
antigen.  Animals were primed with CFA, PBS, or PLGA MPs with or without OVA, and 
boosted 3 weeks later with the same carrier vehicle (except IFA in place of CFA).  A 
week later, the animals were challenged with an intradermal injection in the footpad with 
OVA in PBS.  The degree of swelling was measured 2 days after the challenge.  
Ovalbumin delivered with PLGA MPs induced a similar level of DTH as OVA delivered 






























Figure 5-7: PLGA MPs elicit a moderate DTH reaction in mice.
Ovalbumin delivered with PLGA MPs induced a similar level of DTH as OVA 
delivered with the strong adjuvant, CFA.  Results are reported as % swelling 
(thickness of challenged footpad (mm) / thickness of unchallenged contralateral 
footpad (mm) x 100%).  Each symbol represents an animal, and the mean % swelling 






















 Immunorecognition of cellular components shed from a tissue engineered 
construct may result in failure of an implanted device. Previously, PLGA, a commonly 
used biomaterial in tissue engineered devices, was shown to act as an adjuvant to 
heighten the adaptive immune response towards associated antigens (Matzelle and 
Babensee, 2004).  Dendritic cells function as a bridge between innate and adaptive 
immunity wherein adjuvants exploit the fact that the innate immune response prods the 
slower acting adaptive immune response due to its effects on the maturation of DCs such 
that they become efficient antigen presenting cells and T cell stimulators. Therefore, we 
focused on the extent of PLGA-induced maturation of DCs as a possible explanation for 
the observed adjuvant effect of PLGA (Matzelle and Babensee, 2004).  In this study, we 
observed that 75:25 PLGA MPs or films enhanced the maturation of human monocyte-
derived DCs as assessed by characteristic cell morphology, upregulation of cell surface 
marker expression, allostimulatory capacity, and DTH induction in vivo. 
 Exposure of iDCs to LPS led to expected, marked increase in cell surface marker 
expression as compared to untreated iDCs indicating DC maturation.  Treating iDCs with 
PLGA MPs resulted in an increase in expression of cell surface markers to a level 
between that of untreated iDCs and LPS-matured DCs. Culturing iDCs on PLGA film 
resulted in an increase in surface marker expression but to a lesser extent than the 
increase observed for cells treated with PLGA MPs. In this study, iDCs cultured with 
PLGA MP most significantly increase CD83, CD86, and HLA-DQ.  Since CD40 
upregulates CD86 expression (Banchereau and Steinman, 1998), it is possible that PLGA 
MP-induced maturation of DCs may be regulated by CD40. Likewise, iDCs treated with 
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PLGA MPs were similar in their allostimulatory efficiency as compared to that of cells 
matured with LPS.  In contrast, iDCs cultured on PLGA film did not elicit a high 
proliferation of T lymphocytes, suggestive of lower induction of maturation.  These 
results imply that the form in which the biomaterial is presented to DCs (MPs vs film) 
may play a role in the extent of DC maturation, suggesting a role of particle 
internalization in DC maturation. 
 While it has been shown that PLGA MPs can be phagocytosed by DCs (Lutsiak et 
al., 2002; Newman et al., 2002), internalization of PLGA MPs by DCs was not 
ascertained in the study presented herein, although association of MPs with cells was 
observed.  Since internalization of particles may enhance DC maturation (Sallusto et al., 
1995; Singh and O'Hagan, 1999), PLGA presented in a MP form may be more capable of 
stimulating DC maturation compared to PLGA presented as a flat surface.  In the DC 
culture system used in the study presented here, PLGA MPs were likely internalized by 
DCs, as the particles were small in size, with an average diameter of 4 µm.  Further, 
phagocytosis of fluorescent microspheres of similar size was confirmed by confocal laser 
microscopy (data not shown).  Cytospin preparations (Figure 5-1c) and phase contrast 
micrographs (data not shown) demonstrate the association of the PLGA MPs with the 
DCs.  Given the phagocytosable size of the PLGA MPs used here and the transwell assay 
results indicating the direct biomaterial contact requirement for DC maturation, it is 
speculated that the phagocytosis of PLGA MPs contributed to the greater extent DC 
maturation as compared to treatment with PLGA film (exemplified especially in the MLR 
results).  Additional studies are underway to evaluate the actual contribution of MP 
phagocytosis on DC maturation by inhibiting phagocytosis with pharmacological agents, 
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and also by comparing the degree of maturation of DCs upon culturing with MPs of 
phagocytosable or non-phagocytosable size with equal total biomaterial surface area 
exposed to the cells (CHAPTER7). However, the biomaterial effect on DC maturation 
does not appear to be due only to biomaterial phagocytosis since treatment with PLGA 
films induced phenotypical maturation of DCs and preliminary results indicate that there 
is a differential effect depending on the type of biomaterial used (Babensee and Paranjpe, 
2005). 
 Results reported herein support other studies which have showed that PLGA MPs 
can be internalized by DCs, localize to the phagosomal vesicles (Walter et al., 2001), and 
lead to their maturation (Thiele et al., 2001).   On the contrary, a recent report in the 
murine system examining the adjuvant effect of PLGA in mediating DC maturation in the 
presence of an antigen has shown that while PLGA particles were able stimulate an 
antigen-specific in vivo immune response, they were unable to activate DCs in vitro (Sun 
et al., 2003).  The differences in the results from this study may be due to the model 
system used, presence or absence of an antigen, differences in in vitro methods for DC 
culture and co-culture with MPs, PLGA particle properties, and the ratio of particles to 
cells.  The ability of PLGA MPs to mediate adjuvant effect in vivo was measured by the 
induction of DTH response, a T helper 1 (Th1) cell mediated immune response.  The 
DTH results reported herein demonstrated that the delivery of OVA with PLGA MPs can 
elicit a similar level of DTH response as OVA delivered with CFA, a strong adjuvant.  
This implies that PLGA MPs contribute to the activation of T cells, and hence the 
development of DCs as efficient antigen presenting cells in vivo for the presentation of 
co-delivered OVA to prime T lymphocytes.  While these results suggest that PLGA MPs 
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can support a Th1 response in vivo, the ability of the PLGA MPs to elicit a Th2 response 
was not examined in this study.  Other studies investigating the nature of Th response 
induced by PLGA MPs have shown that OVA peptide encapsulated in PLGA MPs elicit 
a Th1 immune response whereas the co-delivery of soluble/adsorbed OVA with PLGA 
MPs result in a Th2 immune response (Matzelle and Babensee, 2004).  The disparity 
between the two results may be due to the differences in the form of the antigen used 
(peptide vs protein), the mode of antigen co-delivery (encapsulated vs adsorbed), and the 
method of determining the nature of the Th response (serum IgG isotypes levels vs 
cytokines secreted by in vivo primed lymphocytes following in vitro second challenge 
with antigen).  Controlling helper T cell polarization via DC phenotype as directed by 
biomaterials is an attractive approach to improve host tolerance to a tissue engineered 
device.  Stimulated DCs release a cytokine profile for the polarization of T cells to Th1, 
Th2 or regulatory T cells which is dependent on the activation by a particular pathogen 
and other inflammatory tissue factors (Kalinski et al., 1999).  Previous study has shown 
that DCs generated in vitro which secreted IL-10 (a regulatory and Th2 cytokine), but not 
IL-12 (a Th1 cytokine), prevented allograft rejection in a mouse model, suggesting that 
polarized cytokine production plays a role in tolerogenicity (Gao et al., 1999).  Further, 
co-stimulatory molecules CD80 and CD86 may regulate Th1/ Th2 polarization (Coyle 
and Gutierrez-Ramos, 2001).  The role of Th1/ Th2 polarization and the regulatory T cell 
cytokine profile in acceptance of transplants and induction of tolerance is incompletely 
understood.  Nonetheless, controlling of Th polarization through the biomaterial effects 
on DC phenotype is an intriguing strategy for inducing acceptance of tissue engineered 
devices.  The characterization of cytokine profile produced by lymphocytes in the MLR 
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supported by biomaterial-treated DCs will provide insight into whether biomaterials can 
differentially drive tolerance for the host acceptance of a tissue engineered construct. 
 The experiments presented herein support the premise that the PLGA adjuvant 
effect is (at least partially) explained by its ability to support DC maturation.  The extent 
of DC maturation was dependent on the form in which the biomaterial was presented to 
iDCs; higher level for PLGA presented as phagocytosable MPs vs nonphagocytosable 
film, although treatment with the PLGA film did induce phenotypical maturation.  In 
addition, PLGA MPs were capable of eliciting a modest DTH reaction, indicating in vivo 
maturation of DCs such that they become efficient antigen presenting cells.  This study 
serves as an initial effort in understanding the mechanisms of the adjuvant effect 
associated with biomaterials used in tissue engineering and the role of DCs in mediating 
such an effect.  The elucidation of cellular mechanisms involved in the immune response 
against a tissue engineered construct will provide insight into design criteria for 
biomaterials, as well as immunomodulatory strategies, for enhanced integration of the 








 Dendritic cells (DCs) are professional antigen presenting cells (APCs) central in 
the control of the immune response by bridging the innate and adaptive immunity 
(Banchereau and Steinman, 1998; Banchereau et al., 2000).  In the immature state, DCs 
reside in peripheral tissues where they monitor the surrounding microenvironment by 
capturing and internalizing antigens by pinocytosis as well as by receptor-mediated 
endocytosis (Banchereau and Steinman, 1998).  Dendritic cells undergo a maturation 
process upon encountering a stimulus such as infection by pathogens or “danger” signals, 
including byproducts of necrosis and inflammation or tissue damage, and present the 
previously internalized and processed antigens in the context of MHC molecules for 
activation of naïve T lymphocytes (Matzinger, 1994; Banchereau and Steinman, 1998; 
Gallucci et al., 1999).  In addition to particulates that DCs may encounter endogenously, 
synthetic materials including particles of latex (Matsuno et al., 1996; Reece et al., 2001), 
polystyrene (Thiele et al., 2003), and poly(lactic-co-glycolic acid) (PLGA) (Lutsiak et al., 
2002; Newman et al., 2002) have been shown to be phagocytosed by DCs.  The 
maturation of DCs result in functional and associated phenotypical changes, such as the 
decrease in the expression of endocytic and adhesion receptors, increase in the expression 
of MHC and co-stimulatory molecules (Winzler et al., 1997; Banchereau and Steinman, 
                                                 
∗ Modified from Yoshida M, Babensee JE.  Molecular aspects of microparticle phagocytosis by dendritic 
cells.  Manuscript to be submitted to Journal of Biomaterials Science. Polymer edition.   
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1998; Banchereau et al., 2000), and loss of phagocytic activity (Sallusto and 
Lanzavecchia, 1994).   
The use of polymeric microspheres and nanospheres for vaccines and controlled 
drug delivery systems have prompted the understanding of the role of DCs and their 
phagocytic capacity in mediating the immune response against co-delivered antigens 
(Matsuno et al., 1996; Reece et al., 2001; Lutsiak et al., 2002; Newman et al., 2002; Prior 
et al., 2002).  Uptake of polymeric particles is dependent on material properties including 
size, hydrophobicity, and surface charge (Tabata and Ikada, 1991).  While biomaterial 
particle internalization by DCs has been observed, the details of uptake mechanism 
remain unclear, although PLGA nanosphere uptake by human DCs has been shown to be 
inhibited by pretreating the cells with cytochalasin B (Lutsiak et al., 2002).  Other studies 
have demonstrated that endocytosed PLGA microspheres localize to the endosomal 
compartments and the cytoplasm (Audran et al., 2003), and endocytosed latex 
nanospheres either remain as singular beads near the surface, or as small aggregates, co-
localized with MHC class II molecules (Reece et al., 2001).  Moreover, recent reports 
have focused on the role of adsorbed proteins and opsonins on biomaterial particle 
surface on DC phagocytosis (Thiele et al., 2003).  While uptake of polymer particles 
coated with adsorbed proteins may occur via receptors, reports of receptor-mediated 
uptake to date has been focused on microparticles (MPs) of more biological origin such 
as starch, mannan (Artursson et al., 1998), and zymosan (Ezekowitz et al., 1985).   
We have previously shown that PLGA exerts an adjuvant effect in the context of 
tissue engineering, as measured by the increase in the specific humoral response against a 
co-delivered model antigen (Matzelle and Babensee, 2004) which was dependent on the 
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physical form of PLGA (Bennewitz and Babensee, 2005).  As a possible explanation of 
this observed adjuvanticity, the effect of PLGA contact on the maturation of human 
peripheral blood monocyte-derived DCs was investigated.  The effects of films as well as 
MPs of PLGA were studied, with MPs serving as a model of degradation product 
generated from implanted tissue engineered scaffolds, in addition to being a common 
vaccine and controlled drug delivery system.  Culturing of human DCs with PLGA MPs 
resulted in increased allostimulatory capacity and surface expression of co-stimulatory 
and MHC molecules, which was contact-dependent (Yoshida and Babensee, 2004).  As 
these results suggest that PLGA MPs are stimuli of DC maturation and that the MPs were 
internalized, we sought to further investigate the molecular basis for polymer MP uptake 
by human DCs and to determine to what extent particle phagocytosis played a role in DC 
maturation.  To visualize the internalization of these microspheres by DCs, model 
fluorospheres of polystyrene, available commercially, or coumarin 6-loaded PLGA MPs 
were used for validations via flow cytometry and assessment of molecular aspects of this 
phagocytosis.  Maturation of DCs upon culturing with polystyrene or PLGA MPs was 
further evaluated by quantifying the release of the autocrine maturation cytokine, TNFα, 





Poly(lactic-co-glycolic acid) microparticle preparation  
Preparation of PLGA MPs has been described in detail elsewhere (Yoshida and 
Babensee, 2004).  Briefly, PLGA (molar ratio: 75:25, inherent viscosity: 0.69 dL/g in 
trichloromethane) (Birmingham Polymers, Birmingham, AL) dissolved in 
dichloromethane (DCM) (Sigma, St. Louis, MO) was added to 0.3% v/v aqueous 
poly(vinyl alcohol) (PVA) (Sigma), and homogenized.  For fluorescently labeled PLGA 
MPs, coumarin 6 (Sigma) dissolved in DCM was added to the homogenization mixture.  
Precipitation was initiated with isopropanol (Sigma) and the solvent was evaporated 
overnight under constant stirring.  Resulting MPs were collected by centrifugation and 
washed extensively with isopropanol followed by double distilled water.  Size 
distribution of MPs was determined using Coulter Multisizer II (Coulter Corporation, 
Miami, FL) with a peak diameter of approximately 3 µm.  Prior to use, MPs were 
sterilized by UV radiation for 1 hr, and stored at 4°C for no longer than 3 days.  
 
Dendritic cell culture 
Dendritic cells were derived from human peripheral blood mononuclear cells 
(PBMCs) as previously described (Yoshida and Babensee, 2004).  Human blood was 
obtained from volunteers with informed consent, according to a protocol approved by the 
Institutional Review Board of Georgia Institute of Technology, #00A018.  Briefly, 
PBMCs were isolated from heparinized whole blood by centrifugation using Histopaque 
(Sigma).  Cell layer containing mononuclear cells was washed in phosphate buffer saline 
(PBS), erythrocytes lysed, and washed again twice with PBS.  Resulting PBMCs were 
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resuspended at a concentration of 5x106/ ml in RPMI-1640 containing 25 mM HEPES 
and L-glutamine (Gibco BRL, Grand Island, NY) with 100 U/ ml penicillin-streptomycin 
(Cellgro, Herndon, VA) and 10% heat inactivated filter sterilized fetal bovine serum 
(FBS) (Gibco BRL) (DC media).  Monocytes were selected by plastic adherence for 2 hrs 
at 37˚C with 95% relative humidity and 5% CO2.  Upon washing the plates with warm 
DC media to remove non-adherent cells, the remaining adherent monocytes were 
resuspended in 10 ml DC media with 2000 U/ ml GM-CSF and 1600 U/ ml IL-4 
(Peprotech, Rocky Hill, NJ) and left undisturbed in an incubator at 37˚C with 95% 
relative humidity and 5% CO2 until day 5 of culture.  On day 5, loosely- and non-
adherent cells containing iDCs were collected, resuspended in DC media with 1000 U/ ml 
GM-CSF and 800 U/ ml IL-4, and used as iDCs in the various experiments described 
below.   
 
Blocking of dendritic cell fluorosphere uptake  
To visualize the uptake of microspheres by DCs, iDCs collected on day 5 were 
resuspended at a concentration of 5x105/ ml and plated into a 6 well plate.  Prior to the 
addition of fluorospheres, iDCs were treated with or without varying concentrations of 
EDTA (Gibco BRL), varying concentrations of trypsin (Spectrum Chemical, New 
Brunswick, NJ), 20 µg/ ml cytochalasin D (Sigma), or 5 µl/ ml DMSO (Sigma) for 1 hr at 
37°C.  Alternatively, DCs were incubated for 1 hr at 4°C.  Upon pretreatment, DCs were 
treated with 1:1 MP: cell ratio of 3 µm polystyrene fluorospheres (Fluoresbrite Plain YG 
microspheres, Polysciences, Warrington, PA) (FYG microspheres) or coumarin 6-loaded 
PLGA MPs (cPLGA MPs), and allowed to incubate for 4 hrs at 37°C in the presence of 
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the pretreatment agents or at 4°C.  After the incubation of the cells with fluorospheres, 
cells were collected by centrifugation, washed 3 times with ice cold Hank’s HEPES 
buffer with 1% human serum albumin (Calbiochem, San Diego, CA) to remove 
extracellularly associated fluorospheres, and assessed for fluorosphere uptake by flow 
cytometry or confocal laser scanning microscopy, as detailed below. 
Flow cytometry assessment of fluorosphere uptake 
Upon washing the DCs to dissociate any non-internalized fluorospheres 
associated on the cell surface, DCs were resuspended in ice cold Hank’s HEPES buffer 
with 1% human serum albumin and analyzed by BD Vantage flow cytometer (Becton 
Dickinson, San Jose, CA).  Data analysis was performed using WinMDI 2.8 (Scripps 
Research Institute, La Jolla, CA).  Dendritic cells were gated based on forward and side 
scatters and those with high fluorescence (FL) in FITC channel were considered as DCs 
with associated fluorospheres.   
 
Confocal laser scanning microscopy of fluorosphere internalization by dendritic cells 
 To visually confirm the DC internalization of microspheres, confocal laser 
scanning microscopy was performed.  Immature DCs on day 5 were washed and placed 
on cover slips previously coated by a total of 15 min incubation in 0.01% poly-L-lysine 
solution (Sigma), and allowed to adhere to the cover slips for 24 hrs at 37°C.  On the 
following day, the non-adherent cells were removed, and the adherent cells were fixed 
using 2% paraformaldehyde (Sigma), then permeabilized with 1% Triton X-100 (Sigma).  
Upon washing, DCs were stained for actin filaments using rhodamine labeled phalloidin 
(Molecular Probes, Eugene, OR), counterstained for the nucleus using Hoechst 33342 
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(Molecular Probes), and visualized using Zeiss LSM 510 Confocal Microscope (Zeiss).  
Z-stack images were also acquired to record changes throughout the cell. 
 
TNFα release by dendritic cells cultured with microspheres 
 On day 5 of culture, iDCs were collected and resuspended at a concentration of 
1x106/ ml, and plated at a density of 1 ml/ well into a 24 well plate.  Dendritic cells 
without any additional stimulants were used as negative controls to yield iDCs, and those 
treated with 1 µg/ ml lipopolysaccharide (LPS) (E. Coli 055:B5) (Sigma) were used as 
positive controls to yield mature DCs (mDCs).  The maturation effect of treatment with 
FYG microspheres or PLGA MPs was evaluated by adding the microspheres at varying 
concentrations to iDCs.  Upon 24 hrs of culturing DCs with the fluorospheres, the cell 
culture media was collected, cleared of cells and MPs, and stored at -20°C until analysis.  
The amount of TNFα in the media was measured using a commercially available ELISA 
kit (R&D Systems, Minneapolis, MN).   
 
Statistical Analysis  
Statistical analysis was performed using general linear model ANOVA with 
Minitab software (Version 13.20, Minitab Inc., State College, PA), and pairwise 
comparison to appropriate control group as indicated was made, with p-values of less 





Three micron fluorospheres are internalized by immature dendritic cells 
 Confocal laser scanning microscopy was used to visualize the internalization of 
FYG microspheres or cPLGA MPs of approximately 3 µm in diameter by iDCs.  Upon 
incubation with the fluorescent particles for 4 hrs, DCs had internalized at least one, if 
not several fluorospheres, as seen by the surrounding of the fluorospheres by the actin 
filaments.  Orthogonal images were captured to confirm that the fluorospheres were 







Figure 6-1: Dendritic cells internalize FYG microspheres (a) or cPLGA MPs (b).  
Dendritic cells cultured with FYG microspheres (a) or cPLGA MPs (b) for 4 hrs at 
37°C were washed and loaded onto poly-L-lysine coated cover slips.  Fixed DCs were 
permeabilized, and stained for actin filaments and nucleus using with rhodamine 
phalloidin and Hoechst 33342, respectively, and analyzed by confocal laser scanning 
microscopy.  Original magnification: (a) 63x, (b) 40x.  This experiment was repeated 
three times with similar results, and representative results are shown.
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To further evaluate the uptake of fluorescent microspheres, the DCs were 
pretreated either with cytochalasin D or incubated at 4°C for 1 hr prior to the addition of 
the fluorospheres.  The uptake of the fluorospheres by DCs as measured by flow 
cytometry was lowered by the pretreatment of the cells with cytochalasin D or incubation 
with fluorospheres at 4°C (Figure 6-2).  Viability was not greatly affected by the 
pretreatment of cells with cytochalasin D (98.91% viability) or incubation at 4°C (98.75 
% viability) as compared to cells left untreated at 37°C (98.05% viability).  As shown in 
Figure 6-2a-c, DCs cultured without any fluorescent particles exhibit a sharp, tall peak at 
a very low FL value, which corresponds to their autofluorescence, without any additional 
peaks at higher FL values.  Dendritic cells cultured with FYG microspheres show distinct 
sharp peaks at higher FL values whereas those cultured with cPLGA MPs show one 
broader peak spanning a wider spectrum of FL values.  Dendritic cells cultured at 37°C 
without any chemical pretreatment show highest fraction of DCs positive for 
fluorospheres (Figure 6-2d).  Dendritic cells incubated with cPLGA MPs or FYG 
microspheres at 37°C without any chemical pretreatment showed mean fluorescent 
intensities (MFI) of 590.72 and 333.84, respectively.  For DCs cultured with FYG 
microspheres, pretreatment of cells at 4°C (MFI: 260.49) or with 20 µg/ ml cytochalasin 
D (MFI: 260.27) statistically significantly decreased the percentage of DCs that were 
positive for fluorescent microspheres.  For DCs cultured with cPLGA MPs, only the 
pretreatment of cells with cytochalasin D (MFI: 270.35), but not incubation at 4°C (MFI: 
574.59), significantly decreased the uptake of the MPs by DCs.  Pretreatment of DCs 
with DMSO, the vehicle used for cytochalasin D, did not affect particle uptake or cell 









Figure 6-2: Pretreatment of DCs with cytochalasin D or incubation at 4°C 
decreases fluorosphere uptake.
On day 5 of culture, iDCs were left untreated at 37°C (a), incubated at 4°C (b), or 
pretreated with 20 µg/ ml cytochalasin D at 37°C (c) for 1 hr, and cultured with 1:1
MP:cell ratio of fluorospheres for 4 hrs.  Fluorescence associated with DCs was 
evaluated by flow cytometry. This experiment was repeated three times with similar 
results, and representative results are shown.  
Figure (d) represents the average of percentage of DCs positive for fluorescence (from 
fluorospheres).  mean±SD, n=3.  *: p<0.05 as compared to cells without pretreatment 
agents, incubated at 37°C.
without fluorospheres (autofluorescence)
with cPLGA MPs
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Pretreatment of immature dendritic cells with EDTA or trypsin decrease fluorosphere 
uptake 
To begin to address the mechanism of fluorosphere uptake by iDCs, iDCs were 
pretreated with varying concentrations of EDTA or trypsin prior to incubation with the 
fluorospheres.  Pretreatment of iDCs with EDTA (Figure 6-3a) or trypsin (Figure 6-3b) 
resulted in decreased uptake of both FYG microspheres and cPLGA MPs in an EDTA or 
trypsin dose-dependent manner.  At higher concentrations, EDTA and trypsin 



























































Figure 6-3: Internalization of fluorospheres by DCs is dependent on extracellular
calcium concentration and sensitive to trypsin.
On day 5 of culture, iDCs were pretreated with indicated concentrations of EDTA (a) 
or trypsin (b) for 1 hr at 37°C.  Fluorospheres were added at a fluorosphere: cell ratio 
of 1:1 for 4 hrs at 37°C.  DCs were washed 3 times in ice cold buffer, and then 
assessed for associated fluorosphere fluorescence by flow cytometry.  mean±SD, n=3.  

























Dendritic cells treated with FYG microspheres or PLGA microparticles secrete TNFα in 
a dose-dependent manner 
 As we have previously observed that exposure of iDCs to PLGA MPs result in 
their maturation as assessed by upregulation of co-stimulatory and MHC class II 
molecules and enhanced allostimulatory capacity (Yoshida and Babensee, 2004), 
secretion TNFα, an autocrine factor for DC maturation, was measured as another 
indicator of DC maturation upon treatment with PLGA MPs.  Dendritic cells cultured in 
the presence of varying MP:cell ratio of FYG microspheres or PLGA MPs secreted 
amounts of TNFα in between the levels secreted by iDCs and mDCs, in a microsphere 
dose-dependent manner (Figure 6-4).  In comparison to DCs cultured with FYG 
microspheres, DCs cultured with PLGA MPs secreted higher amounts of TNFα.  At the 
highest MP:cell ratio of 10:1, amount of TNFα secreted by DCs exposed to PLGA MPs 
was significantly higher than that secreted by iDCs cultured alone, supporting our 
previous studies in which PLGA resulted in a maturation effect on DCs (Yoshida and 



















Figure 6-4: Treatment of DCs with FYG microspheres or PLGA MPs induces 
TNFα secretion in a microsphere dose-dependent manner.
On day 5 of culture, iDCs were left untreated or treated with indicated doses of FYG 
microspheres or PLGA MPs, or with 1 µg/ ml LPS as a positive control.  After 24 hr 
incubation, cell culture media was cleared and stored at -20°C until analysis.  
mean±SD, n=3.   #: p<0.05 compared to iDCs, *: p<0.05 between FYG microsphere 






































 The capture and internalization of antigens by DCs lead to processing and 
presentation of associated peptides to the T lymphocytes for the initiation of the adaptive 
immune response (Banchereau et al., 2000).  Because of this ability of DCs to initiate 
immune response and their ability for phagocytosis, antigen delivery using polymeric 
particles targeted for DC uptake has gained much focus as a strategic approach to 
vaccination (Lutsiak et al., 2002; Audran et al., 2003).  Conversely, these characteristics 
of DCs and similarly, macrophages, may aggravate inflammation and adversely affect the 
local environment of implanted tissue engineered constructs upon internalization of MPs 
generated from these constructs as a consequence of implant degradation.  The effects of 
MPs generated as byproducts of implant breakdown are exemplified by the 
internalization of wear debris from prostheses, such as hip implants, resulting in aseptic 
loosening (Lohmann et al., 2000; Vermes et al., 2000; Bainbridge et al., 2001), as well as 
enhancement of the immune response to cellular antigens released from tissue engineered 
constructs due to an adjuvant effect of the biomaterial component (Matzelle and 
Babensee, 2004; Yoshida and Babensee, 2004).  Hence the understanding of molecular 
aspects of particle uptake by DCs and subsequent effect on the maturation state of DCs is 
paramount to the effective design of vaccines as well as tissue engineered devices.   
In the study presented herein, the molecular aspects of phagocytosis of MPs by 
DCs, namely PLGA MPs, were investigated.  The internalization of PLGA MPs by 
human monocyte-derived DCs was followed and visualized by using model fluorescent 
polystyrene latex microspheres and confirmed using coumarin 6-loaded PLGA MPs of 
approximately 3 µm in diameter.  Orthogonal confocal laser scanning micrographs 
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(Figure 6-1) showed that 3 µm FYG microspheres and cPLGA MPs were indeed 
internalized by DCs, rather than associated on cell surface, implying that PLGA MPs 
used in our previous studies (Yoshida and Babensee, 2004), which were of similar size, 
were also phagocytosed by DCs.  Association or co-localization of PLGA MPs with DCs 
has been previously observed using phase contrast microscopy of DCs in culture and 
light microscopy of Cytospin preparations, but internalization could not be confirmed 
with the assays used (Yoshida and Babensee, 2004).   
Flow cytometry results corroborate the finding from with the confocal microscopy 
experiments that culturing DCs with either FYG microspheres or cPLGA MPs resulted in 
their internalization (Figure 6-2).  Fluorescence peaks resulting from the association of 
FYG microspheres with DCs appeared as sharp distinct peaks, likely corresponding to the 
fluorescence intensity values proportional to the number of fluorospheres internalized by 
DCs; however, DCs cultured with cPLGA MPs exhibited one broader peak.  This is 
likely due to the broader size distribution of PLGA MPs as compared to the FYG 
microspheres.  Although both cPLGA MPs and FYG microspheres had a mean diameter 
of 3 µm, the range of diameter for PLGA MPs and FYG microspheres were 
approximately ± 3 µm and ± 0.5 µm, respectively (data not shown).  It is speculated that 
with the wider range in size distribution, the correlation between the levels of 
fluorescence to the number of cPLGA MPs is not as close as that for FYG microspheres, 
resulting in a broader histogram spanning the FITC fluoresce spectrum. 
The uptake of the fluorospheres by iDCs was decreased by incubation of iDCs at 
4°C or by pretreatment with cytochalasin D (Figure 6-2), an inhibitor of actin 
polymerization including phagocytosis (Goddette and Frieden, 1986).  Thus these results 
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imply that internalization of the fluorospheres is a dynamic process involving actin 
filaments.  Moreover, the uptake of fluorospheres by DCs was trypsin-sensitive and 
dependent on extracellular calcium concentration, as pretreatment of iDCs with trypsin or 
EDTA, respectively, led to decreased fraction of DCs that were fluorosphere-positive 
(Figure 6-3).  These results suggest that the uptake of fluorospheres by DCs is an active 
cellular process requiring Ca2+, and likely receptor-mediated, as protease treatment can 
remove cell surface proteins, including endocytic receptors.  It would be of great interest 
to determine the endocytic receptors involved in the fluorosphere uptake, in particular the 
uptake of PLGA MPs, as it relates to the PLGA-induced DC maturation and its 
mechanisms.  Previous studies investigating receptors involved in DC nibbling showed 
that the treatment of monocyte-derived DCs with pronase, a mixture of proteases, 
resulted in decreased expression of several receptors including scavenger receptors, αv-
integrin, and C-type lectin receptors, as measured by flow cytometry (Harshyne et al., 
2003).  Similar studies to assess receptors involved in the internalization of PLGA MPs 
as well as the receptors involved in the subsequent DC maturation upon contact with 
PLGA MPs are currently underway.   
Our previous study has shown that PLGA presented to DCs as MPs enhanced DC 
maturation, while PLGA presented as a flat surface did so to a lesser degree, supporting 
the notion that phagocytosis of particles may contribute to the biomaterial effects on DC 
maturation (Sallusto et al., 1995; Singh and O'Hagan, 1999).  From the results presented 
herein using fluorospheres and pharmacological agents that inhibit cellular phagocytosis 
activity, it was speculated that internalization of PLGA MPs contributed to the 
maturation of DCs.  However, culturing DCs with PLGA MPs of different sizes that were 
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either small enough or too large to be phagocytosed, with the same total surface area 
exposed to cells, revealed that while increasing the dose of the MPs increased the 
expression level of co-stimulatory and MHC molecules, the size of the MPs did not, 
suggesting that within the range tested, phagocytosis was not the main contributor in the 
PLGA MP-induced DC maturation.  Moreover, as phenotypical changes were observed 
with exposure of DCs to PLGA films, and as there was a differential maturation effect 
depending on biomaterials used (manuscript in preparation; CHAPTER 7) (Babensee and 
Paranjpe, 2005), it is expected that DC maturation upon exposure to PLGA MPs is not 
solely due to phagocytosis.  Further, the secretion of the autocrine factor, TNFα, was 
increased in a PLGA MP dose-dependent manner, which is in agreement with our 
previously reported results of PLGA MP-induced DC maturation, as measured by co-
stimulatory and MHC molecule expression and allostimulatory capacity (Yoshida and 
Babensee, 2004).   Recently, a study investigating the changes in phenotype and 
function of DCs upon loading with PLGA microspheres demonstrated that iDCs cultured 
in serum-free conditions phagocytosed many rhodamine-containing PLGA microspheres, 
in accord with our study, however, without increasing the expression of co-stimulatory 
and MHC class II molecules, nor TNFα secretion (Waeckerle-Men et al., 2004).  The 
disparity between these two studies with regards to DC maturation upon loading with 
PLGA microspheres may be due to several factors.  While the size of the PLGA MPs was 
similar, the composition of PLGA polymer used, methods for microsphere preparation, 
and the dose MPs to DCs were not the same between the two studies.  More importantly, 
DC culturing conditions were different; in particular, in our studies, DCs were cultured in 
the presence of 10% FBS or 1% autologous plasma, while in the other study, DCs were 
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cultured in a serum-free environment.  It is speculated that the presence of serum would 
lead to instantaneous adsorption of proteins onto the PLGA MP surface, and the 
subsequent effects of PLGA MPs may be directed in part by the adsorbed proteins, and 
that various factors in serum may have played a role in the maturation of human 
monocyte-derived DCs upon exposure to PLGA MPs.  Similarly, culturing of murine 
monocytes or human blood monocytes with PLGA microspheres resulted in their 
activation, and opsonization of PLGA microspheres with different chemical end groups 
in serum resulted in increased phagocytosis of these PLGA particles, suggesting a role for 
protein adsorption on particle uptake (Prior et al., 2002).  While the exact factors that 
affect the biomaterial particle phagocytosis remain elusive, the cytokines present in the 
microenvironment may play a role, as expression of co-stimulatory and MHC molecules 
upon uptake of polystyrene fluororescent microspheres of comparable size by murine 
bone marrow-derived DCs can be lowered by pretreatment of cells with IL-10, without 
affecting phagocytic capacity (Faulkner et al., 2000).     
The experiments presented herein begin to address the role of phagocytosis on 
PLGA MP-induced DC maturation, and its associated adjuvant effect.  While our 
previous study made an effort to address the differential effect of PLGA MPs and films 
on DC maturation, further studies are underway to determine the role of various receptors 





DIFFERENTIAL EFFECTS OF AGAROSE AND POLY(LACTIC-CO-
GLYCOLIC ACID) ON DENDRITIC CELL MATURATION∗ 
 
INTRODUCTION: 
 The advent of innovative combination products has raised new regulatory 
concerns previously not considered.  Some such combination products combine 
biomaterials with cells, DNA, or proteins, and include vaccine systems with non-viral 
polymeric carriers and tissue engineered constructs in which cells are delivered with a 
biomaterial scaffold.  As the purpose of the biomaterial varies by application, identifying 
whether the biomaterial, due to its associated adjuvant effect, is intended or not to support 
the host immune response towards the product is essential in designing and choosing a 
material that is most appropriate for a given application.  In tissue engineering 
applications, immune responses are to be minimized to avoid graft rejection whereas 
vaccine strategies aim to enhance the immune response to achieve protective immunity.  
Consequently, a biomaterial with high or low adjuvant effect, respectively, would be 
ideal for such applications.   
 While the host inflammatory response associated with biomaterials has been 
studied in great depth (reviewed in (Tang and Eaton, 1995; Babensee et al., 1998; 
Rihova, 2000)), the adjuvanticity of biomaterials in the context of tissue engineering and 
combination products is not as well characterized.  For example, poly(lactic-co-glycolic 
acid) (PLGA), a biomaterial commonly studied in both tissue engineering and vaccine 
delivery applications, has been shown to act as an adjuvant.  Delivery of a model antigen 
                                                 
∗ Modified from Yoshida M, Babensee JE.  Differential effects of agarose and poly(lactic-co-glycolic acid) 
on dendritic cell maturation.  Manuscript to be submitted to Journal of Leukocyte Biology. 
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with PLGA was shown to result in increased production of antibody against the model 
antigen (Ertl et al., 1996; Walker et al., 1998; Raghuvanshi et al., 2001; Matzelle and 
Babensee, 2004), with the physical form of the PLGA affecting its adjuvant effect 
(Bennewitz and Babensee, 2005).   
 Moreover, because adjuvants act through the maturation of antigen presenting 
cells such as the dendritic cells (DCs) (Singh and O'Hagan, 1999), as characterized by 
increase in co-stimulatory and MHC molecule expression, cytokine secretion, and 
allostimulatory capacity (Cella et al., 1997; Banchereau and Steinman, 1998), the effect 
of PLGA on DC maturation has been studied with varying results, likely due to the 
differences in the DC culturing systems used (Sun et al., 2003; Waeckerle-Men et al., 
2004; Yoshida and Babensee, 2004).  Dendritic cells are professional antigen presenting 
cells central in the control of the immune response by connecting innate and adaptive 
immunity (Banchereau and Steinman, 1998; Banchereau et al., 2000).  In the immature 
state, DCs reside in peripheral tissue and monitor the surrounding microenvironment by 
capturing and internalizing antigens (Banchereau and Steinman, 1998).  Upon 
encountering a stimulus such as pathogen infection or “danger” signals, including 
byproducts of necrosis and inflammation or tissue damage, DCs undergo a maturation 
and present the previously processed antigens in the context of MHC molecules for 
activation of naïve T lymphocytes (Matzinger, 1994; Banchereau and Steinman, 1998; 
Gallucci et al., 1999).  In addition to particulates that DCs may encounter endogenously, 
synthetic materials including particles of PLGA have been shown to be phagocytosed by 
DCs (CHAPTER6) (Lutsiak et al., 2002; Newman et al., 2002).  The maturation of DCs 
result in functional and associated phenotypical changes, such as the decrease in the 
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expression of endocytic and adhesion receptors, increase in the expression of MHC and 
co-stimulatory molecules (Winzler et al., 1997; Banchereau and Steinman, 1998; 
Banchereau et al., 2000), and loss of phagocytic activity (Sallusto and Lanzavecchia, 
1994).   
 Using human monocyte-derived DCs cultured in the presence of serum or 
autologous plasma, we have demonstrated that DCs treated with PLGA express higher 
levels of co-stimulatory and MHC molecules and are more allostimulatory, as compared 
to immature DCs, but to an extent lower than that induced by a lipopolysaccharide, a 
known stimulator of DC maturation (Yoshida and Babensee, 2004).  Recently, 
differential effects of several biomaterials on DC maturation were reported, where some 
biomaterials induced increased DC expression of co-stimuulatory and MHC molecules as 
compared to immature DCs, whereas others did not (Yang et al., 2002; Babensee and 
Paranjpe, 2005).  Such results suggest that inherent differences in the biomaterial itself, 
presumably its chemical composition and physical properties and consequent protein 
adsorption, can affect the state of DC maturation.   
 In this study, we investigated further the differential effects two model 
biomaterials, agarose and PLGA, on DC maturation.  These particular biomaterials were 
chosen for comparison as PLGA has shown adjuvant effect (Ertl et al., 1996; Walker et 
al., 1998; Raghuvanshi et al., 2001; Matzelle and Babensee, 2004), including DC 
maturation (Yoshida and Babensee, 2004) whereas agarose, while not studied with DCs, 
has been shown to induce minimal inflammatory response (Starke et al., 1987; Rahfoth et 
al., 1998).  By comparing these two biomaterials, which seemingly have dissimilar 
adjuvant effect, we aimed to substantiate the differential biomaterial adjuvanticity, by 
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focusing on the maturation of DCs.  Such differential biomaterial effects can be explored 
for the development and design of biomaterials suitable for each specific application, to 
accordingly modulate the host immune response. 
 
METHODS: 
Preparation of poly(lactic-co-glycolic acid) microparticles  
 Poly(lactic-co-glycolic acid) microparticles (MPs) were prepared by a single 
emulsion solvent evaporation technique adapted from a previously described method 
(Wake et al., 1998), reported elsewhere (Yoshida and Babensee, 2004).  Briefly, MPs of 
approximately 3 µm in diameter were formed by homogenizing dichloromethane (DCM) 
containing 2.5% w/v PLGA (molar ratio: 75:25, inherent viscosity: 0.69 dL/g in 
trichloromethane) (Birmingham Polymers, Birmingham, AL) with 0.3% v/v aqueous 
poly(vinyl alcohol) (88% hydrolyzed) (PVA) (Sigma, St. Louis, MO) at 9000 rpm.  
Immediately after homogenization, 2% (v/v) aqueous isopropanol (Sigma) was added to 
initiate precipitation, and the mixture stirred overnight at room temperature to evaporate 
the solvent.  Resulting MPs were collected by centrifugation at 1000 rpm for 10 minutes, 
washed twice in 2% isopropanol, and three times in distilled deionized H2O (ddH2O).  
Microparticles were resuspended in ddH2O and their size distribution characterized using 
a Coulter Multisizer II (Coulter Corporation, Miami, FL).  Prior to use, MPs were UV 
sterilized for 1 hr, and stored at 4°C.  Endotoxin content of PLGA MP suspension was 
determined by chromogenic Limulus Amebocyte Lysate assay (QCL-1000 Chromogenic 
LAL Endpoint Assay, Cambrex, Walkersville, MD), and was below limits of detection 
(absorbance readings below blank sample).   
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 Larger MPs of approximately 30 µm in diameter were prepared in a similar 
manner, with a lower homogenization speed of approximately 950 rpm.  Upon washing 
with isopropanol as described above, MPs were successively filtered using cell strainers 
with mesh size of 70 µm, followed by a 40 µm strainer (Becton Dickinson, Franklin 
Lakes, NJ).  Resulting filtrate was filtered again using a 20 µm nylon mesh (Spectrum 
Laboratories, Inc., Rancho Dominguez, CA).  After this filtration, MPs in the membrane 
retentate were collected by washing the mesh with at least 50 ml ddH2O.  Resulting MP 
suspension was washed 3 times with ddH2O, and UV sterilized and stored at 4°C as 
described above.  Endotoxin content was below limits of detection (absorbance readings 
below blank sample).   
 
Preparation of poly(lactic-co-glycolic acid) film 
 Poly(lactic-co-glycolic acid) films were fabricated using a casting technique 
without a porogen (Ishaug et al., 1997), as previously reported (Yoshida and Babensee, 
2004).  Briefly, 10% w/v 75:25 PLGA was dissolved in DCM overnight at room 
temperature, and poured onto a 50 mm or 100 mm Teflon Petri dish (Cole-Parmer, 
Vernon Hills, Illinois).  Upon evaporation of the solvent and drying, the film was 
punched into an appropriate size, and washed for 1 hr in ddH2O, changing water every 15 
min.  The film was dried 30 min per side in a sterile laminar flow hood and UV sterilized 
for 30 min per side prior to use.  Endotoxin assay was performed on a smaller film of 4.5 





Preparation of agarose microparticles 
 Microparticles of polystyrene coated with agarose (agarose MPs), of 2 µm and 30 
µm in diameter, were purchased from Micromod (Micromod, Rostock-Warnemuende, 
Germany).  Prior to use, the MPs were washed three times in 70% ethanol and three times 
in ddH2O.  Contribution of 2 µm and 30 µm MPs suspension to cell culture endotoxin 
content was 0.0045 EU/ ml and 0.00106 EU/ ml at 1:1 MP: cell ratio, respectively.  
Previous study has shown that minimum E. coli endotoxin concentration of 100 EU/ mL 
was required for DC maturation (Jotwani et al., 2003).   
 
Preparation of agarose film 
 Agarose (type V; sulfate content of ≤ 0.30%, gel strength of ≥800 g/ cm2 at 1.0%, 
and gel point of 42°C±1.5°C at 1.5%) was purchased from Sigma.  This particular 
agarose was chosen as it had a high gel point, enabling it to remain in the hydrated gelled 
state at temperature of 37°C, temperature used for cell culture.  Aqueous solution of 3% 
w/v agarose in ddH2O was prepared and heated using a microwave until boiling and 
visible homogeneity was reached.  The film was prepared by dispensing 1 ml of agarose 
solution into a well of a 6 well plate (Corning, Corning, NY), and allowed to solidify at a 
temperature of 4°C for at least 30 min, and brought back to room temperature for another 
30 min prior to use.  Endotoxin content of 2 batches of agarose films were measured, and 
were determined to be 0.098 EU/ ml and 0.17 EU/ ml, respectively for a film of 5.6 mm 





Dendritic cell culture 
 Human blood was obtained from volunteers with informed consent, according to a 
protocol approved by the Institutional Review Board of Georgia Institute of Technology, 
#00A018.  Dendritic cells were derived from human peripheral blood mononuclear cells 
(PBMCs) using a previously described method (Romani et al., 1996) with some 
modifications, as previously reported (Yoshida and Babensee, 2004).  Briefly, PBMCs 
were isolated from blood by differential centrifugation using Histopaque (Sigma).  Upon 
lysing erythrocytes and washing, PBMCs were resuspended at a concentration of 5x106 
cells/ ml in RPMI-1640 containing 25 mM HEPES and L-glutamine (Gibco BRL, Grand 
Island, NY) with 100 U/ ml penicillin-streptomycin (Cellgro, Herndon, VA) and 10% 
(v/v) heat inactivated filter sterilized fetal bovine serum (Invitrogen, Carlsbad, CA) (DC 
media).  Cells were plated in a volume of 10 ml/ plate in a 100x20 mm tissue culture 
plate (Becton Dickinson, Franklin Lakes, NJ) and incubated for 2 hrs to select for 
adherent monocytes.  After the incubation, plates were washed 3 times with warm DC 
media to remove non-adherent cells, and the remaining adherent cells were supplied with 
10 ml DC media and incubated with 2000 U/ ml GM-CSF and 1600 U/ ml IL-4 
(Peprotech, Rocky Hill, NJ).  On day 5 of culture, loosely- and non-adherent cells 
containing DCs were collected by centrifugation for 10 min at 1100 rpm, resuspended in 
DC media with 1000 U/ ml GM-CSF and 800 U/ ml IL-4, and plated in a 6 well plate 
(Corning, Corning, NY) at a concentration of 5x105 cells/ well in 3 ml with or without 
stimulants.  For the induction of mature DCs (mDCs), 1 µg/ ml lipopolysaccharide (LPS) 
(E. Coli 055:B5) (Sigma) was added, and cells with no additional maturation stimulants 
were used as iDCs.  The effect of treatment of iDCs with biomaterial MPs or films was 
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tested by adding MP suspension at indicated MP:cell ratios or by plating cells onto a 
PLGA or agarose film.  After 24 hrs of DC treatment with the biomaterial, DCs were 
collected for further analysis, and cell culture supernatant was collected, cleared by 
centrifugation, and stored at -20°C until analysis. 
 
Cell morphology 
 Morphology was monitored throughout the duration of culture by phase contrast 
microscopy of cells in culture.  Dendritic cells treated with biomaterials were processed 
for Cytospin preparations (Cytospin Cytocentrifuge, Thermo Shandon, Pittsburgh, PA), 
stained with Differential Hematology Stain (Astral Diagnostics, West Deptford, NJ), and 
analyzed by light microscopy.   
 Number of MPs ingested by DCs was determined by counting the number of MPs 
associated with DCs from 6 different Cytospin preparations from 6 separate experiments.   
 
Cell surface marker expression 
 Levels of surface marker expression were monitored throughout the culture using 
by flow cytometry as previously described (Yoshida and Babensee, 2004).  Dendritic 
cells were stained with mouse anti-human monoclonal antibody against CD40 (clone B-
B20; IgG1κ), CD80 (clone BB1; IgMκ), CD86 (clone BU63; IgG1κ) (Southern Biotech, 
Birmingham, AL), CD83 (clone HB15a; IgG2b) (IO Test Immunotech Beckman Coulter, 
Marseille, France), HLA-DQ (clone TU169; IgG2aκ), or HLA-DR (clone TU36; 
IgG2aκ) (Becton Dickinson Pharmingen, San Diego, CA) and analyzed using BD LSR 
flow cytometer (Becton Dickinson, San Jose, CA).  Data analysis was performed using 
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WinMDI 2.8 (Scripps Research Institute, La Jolla, CA) and BD FACS DiVa Option 2.0 
(Becton Dickinson Biosciences, San Jose, CA).     
 
Tumor Necrosis Factor α (TNFα) ELISA 
 The amount of TNFα produced by DCs in the cell culture supernatant was 
analyzed by ELISA (R&D Systems, Minneapolis, MN) according to manufacturer’s 
directions.  Cell culture supernatant was cleared by centrifugation and stored at -20°C 
until analysis.  Dendritic cells recovered from each treatment groups were collected, 
counted, and viability assessed.  In addition, DNA content was analyzed for each 
treatment group using picoGreen dsDNA quantification kit (Invitrogen) per 
manufactuer’s directions and amount of TNFα secreted reported per µg DNA. 
 
Mixed lymphocyte reaction (MLR) 
 The effect of biomaterials in inducing DCs to become efficient antigen presenting 
cells was measured by their allostimulatory capacity of DCs to stimulate T cell 
proliferation was assessed using an allogeneic MLR as previously described (Yoshida 
and Babensee, 2004).  On day 5 of DC culture, allogeneic T cells were isolated from 
PBMCs by negative selection using Pan T cell magnetic isolation (Miltenyi Biotech, 
Auburn, CA) according to manufacturer’s protocols, and used as responder cells.  T cells 
were resuspended in RPMI-1640 with 25 mM HEPES and L-glutamine (Gibco BRL) 
with 100 U/ ml penicillin-streptomycin (Cellgro) and heat inactivated filter sterilized 
10% (v/v) human AB serum (Biowhittaker, Walkersville, MD) (complete RPMI-10 
media) and plated at a concentration of 1x105 cells/ well in a 96 well flat-bottomed plate 
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(Corning).  Dendritic cells treated or not with biomaterials or LPS were resuspended at 
1.6x105 cells/ ml, and treated with 25 µg/ ml mitomycin C (Sigma) for 30 minutes to 
prevent their proliferation.  Upon extensive washing with complete RPMI-10 media, DCs 
were resuspended in complete RPMI-10 media and added to responder cells in triplicates 
at graded DC: T cell ratios.  Cells were co-cultured for 4 days, and the DC-induced T cell 
proliferation was measured using BrdU incorporation by colorimetric ELISA (Roche 
Applied Science, Indianapolis, IN) according to manufacturer’s directions.   
 
Preparation of DC nuclear extract and measurement of activity of NFκB family of 
transcription factors 
 Nuclear extracts from differentially treated DCs were prepared using TransFactor 
Extraction kit (Becton Dickinson Clontech, Palo Alto, CA) according to manufacturer’s 
directions.  Briefly, DCs were collected and washed twice with ice cold PBS by 
centrifugation at 450 x g for 5 min at 4°C.  The cell pellet was resuspended in lysis buffer 
containing protease inhibitors and allowed to incubate for 15 min on ice.  After 
incubation, the suspension was centrifuged, and the particulate fraction was resuspended 
in lysis buffer.  The cells were disrupted by forcing the suspension through a 27 gauge 
needle.  The resulting suspension was centrifuged at 11,000 x g for 20 min at 4°C.  The 
supernatant and the pellet from this centrifugation were considered to be cytosolic and 
nuclear fractions, respectively.  The pellet containing the cell nuclei was resuspended in 
an extraction buffer containing protease inhibitors, and nuclear membrane disrupted by 
forcing the suspension through at 27 gauge needle.  The suspension was centrifuged at 
21,000 x g for 5 min at 4°C, and the supernatant from this centrifugation was considered 
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to be the nuclear extract, transferred to a chilled new tube, and stored at -70°C until 
analysis.  
 Activities of members of NFκB family of nuclear transcription factor were 
assessed using TransFactor NFκB Family kit (Becton Dickinson Clontech), an ELISA-
based method of detecting transcription factor activities, per manufacturer’s protocol.  In 
brief, nuclear extracts were incubated for 60 min in a well pre-coated with consensus 
binding sequence.  Upon washing, primary antibodies corresponding to each member of 
NFκB family was added, and allowed to incubate for 60 min.  The plate was washed, and 
incubated for additional 30 min with the secondary antibody.  The detection of binding 
was measured by the addition of tetramethylbenzidine substrate, and measuring the 
colorimetric development at 655 nm. 
 
Statistical Analysis 
Statistical analysis was performed using general linear model ANOVA with 
Minitab software (Version 13.20, Minitab Inc., State College, PA), and pairwise 
comparison to appropriate control group as indicated was made, unless otherwise 





Dendritic cells treated with agarose or PLGA microparticles or films exhibit similar 
morphology 
 Immature DCs (iDCs) derived from PBMCs were cultured either with agarose or 
PLGA MPs or on films, and their morphology was assessed by phase contrast 
microscopy and Cytospin preparations.  Phase contrast microscopy of cells in culture 
revealed that culturing peripheral blood monocytes with GM-CSF and IL-4 resulted in 
the detachment of cells from the culture plate and formation of cell clusters, hallmarks of 
DC development; in particular, DCs cultured on agarose films showed most detachment 
and formation of visible cellular clumps, likely due to the hydrophilic nature of the 
agarose film on which the cells were plated (data not shown).  Dendritic cells treated with 
the biomaterial MPs or films as well as those treated with LPS to yield mature DCs 
(mDCs) as positive control exhibited dendrite processes to similar extent (Figure 7-1).  
Microparticles of PLGA or agarose were associated with DCs, and were likely 
phagocytosed.  Internalization of PLGA MPs has been previously confirmed by confocal 
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Figure 7-1: Dendritic cells treated with agarose or PLGA MPs or films exhibit 
similar morphology.  
Immature DCs derived from peripheral blood monocytes in the presence of GM-CSF 
and IL- 4 (a), cultured with agarose MPs (c) or film (e) or PLGA MPs (d) or film (f) 
showed similar morphology to that of DCs matured by LPS (b), with the presence of 
dendritic processes.  Agarose and PLGA MPs used to treat DCs are associated with 
the cells. Original magnification: 40x.  
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Dendritic cells treated with PLGA film express higher levels of co-stimulatory and MHC 
molecules than DCs treated with agarose film 
 As a measure of maturation, DCs treated with biomaterial MPs or films were 
analyzed by flow cytometry for their surface expression of co-stimulatory and MHC 
molecules.  Co-stimulatory molecules such as CD40, CD80, and CD86, and MHC class 
II molecules such as HLA-DQ and HLA-DR, as well as CD83, increase upon DC 
maturation (Zhou and Tedder, 1995; Banchereau and Steinman, 1998).  Dendritic cells 
treated with PLGA films increased the expression levels of markers evaluated, whereas 
DCs treated with agarose film did not, or did so to a lesser extent (Figure 7-2a).  In 
particular, higher expression of CD80 and CD86 as measured as fold increase above iDC 
levels was induced by PLGA film treatment as compared to agarose film treatment at a 
statistically significant level (Figure 7-2b).  Similarly, DCs cells treated with PLGA MPs 
were previously shown to increase the expression of these molecules (Yoshida and 
Babensee, 2004) while those treated with agarose MPs at the same MP: cell ratio did not 










Figure 7-2: Dendritic cells treated with PLGA express higher levels of co-
stimulatory and MHC molecules than DCs treated with agarose.  
Expression levels of co-stimulatory and MHC molecules of DCs treated with PLGA 
or agarose films were measured using flow cytometry.  Dendritic cells treated with 
PLGA film expressed higher levels of CD80, CD86, and HLA-DR than DCs cultured 
on agarose film. This experiment was repeated three times with similar results, and 
representative results are shown (a).  Fold increase in gMFI values for each treatment 
group as compared to that of iDC control corroborate enhanced marker expression; 
PLGA-treated DCs showed higher fold increase in marker expression than did 
agarose-treated DCs at a statistically significant level (b). mean±SD, n=3. */+: p<0.05 
compared to iDC (above/ below iDC, respectively).  Brackets indicate comparison 



































































































































































































































































































































































































































































































Microparticle dose, but not size, affects PLGA MP-induced DC maturation 
 To determine whether the phagocytosis of MPs contributed to PLGA-induced DC 
maturation previously observed, DCs were cultured with PLGA or agarose MPs of 
phagocytosable (2 µm) or non-phagocytosable (20 µm or 30 µm) sizes while maintaining 
constant exposed surface area.  This approach of assessing the role of phagocytosis on 
DC maturation was chosen as use of phagocytosis and macropinocytosis inhibitors 
cytochalasin D or amiloride alone increased expression of several co-stimulatory markers 
in our hands (Figure A2, APPENDIX).  Use of MPs of differing sizes with constant 
biomaterial surface area provided a cleaner system in which to assess the role of 
biomaterial MP phagocytosis on DC maturation.    
 For DCs treated with PLGA MPs, the expression levels of co-stimulatory and 
MHC class II molecules increased in a MP-dose dependent manner, but were not affected 
by the MP size (Figure 7-3a).  In contrast, the expression levels of markers by DCs 
treated with agarose MPs were not increased above that of iDCs regardless of MP dose or 
size, within the range tested (Figure 7-3a).  In addition, significant fold increase in 
marker expression was induced by treatment of DCs with PLGA MP at both sizes and 
doses, whereas with agarose MPs, only 30 µm MPs at the higher dose increased CD80 
exprssion (Figure 7-3b).  While the difference in size of PLGA MPs did not alter the 
expression of maturation markers, at the higher dose, treatment with large PLGA MPs 





To ascertain that this difference in MP-induced DC maturation was not due to the 
difference in the number of phagocytosed MPs, distribution of MPs ingested by DCs 
were tabulated based on Cytospin preparations (Table 4).  For both agarose and PLGA 
MP-treated cells, over 70% of the DCs ingested fewer than 5 MPs, with agarose MP-







Table 4: Fraction of DCs with phagocytosed 2 µm MPs 
MPs ingested 0 1-5 6-10 11-15 16-20 >20
agarose 27.0% 44.6% 13.3% 5.9% 2.1% 7.0%
PLGA 40.0% 53.5% 6.5% 0.0% 0.0% 0.0%
 
 111
Figure 7-3: Dose of MPs, but not size, affects PLGA MP-induced DC maturation.  
Dendritic cells were treated with PLGA or agarose MPs of different sizes (small MPs: 
2 µm, large MPs: 20 µm or 30 µm) at two different doses.  Cells exposed to the same 
biomaterial surface area (same dose) but with different MP sizes showed same level of 
CD80 and CD83 expression for both agarose and PLGA MPs.  Increasing the dose of 
PLGA MPs resulted in increased expression of CD80 and CD83, whereas increasing 
the dose of agarose MPs did not.  This experiment was repeated three times with 
similar results, and representative results are shown (a). Fold increase in gMFI values 
for each treatment group as compared to that of iDC control show that treatment of 
DCs with PLGA but not agarose MPs at both sizes and doses induce increased 
expression of CD80 and CD83; additionally, for PLGA MPs of both sizes, increasing 
the dose of MPs also increased the fold increase of marker expression (b).  mean±SD, 
n=3. *: p<0.05 compared to iDC.  Bracket indicates statistically significant difference 
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Dendritic cells treated with PLGA are more allostimulatory than DCs treated with 
agarose in a mixed lymphocyte reaction (MLR) 
 To evaluate the maturation functionality of DCs treated with PLGA or agarose as 
antigen presenting cells, differentially treated DCs were co-cultured with allogeneic T 
cells and the proliferation of T cells measured in an MLR.  Dendritic cells treated with 
PLGA, in particular those treated with MPs, induced proliferation of allogeneic T cells, 
whereas those treated with agarose did not (Figure 7-4).  In a direct comparison of DCs 
treated with agarose or PLGA films, cells treated with PLGA films induced proliferation 











































DCs: T cells DCs: T cells
Figure 7-4: Dendritic cells treated with PLGA are more allostimulatory than 
DCs treated with agarose in a mixed lymphocyte reaction (MLR).
Differentially treated DCs were co-cultured for 4 days with allogeneic T cell to 
measure their allostimulatory capacity.  The proliferation of  T cells was measured 
using BrdU incorporation.  Dendritic cells treated with PLGA MPs were 
allostimulatory whereas those treated with agarose MPs or films were not. This 
experiment was repeated three times with various responder: stimulator cell donors 
pairs with similar results, and representative results are shown. mean±SD, n=3 wells, 























Dendritic cells treated with PLGA film secrete more TNFα than DCs treated with 
agarose film 
 As another functional evaluation of DC maturation, amounts of TNFα secreted in 
the cell culture supernatant of differentially treated DCs were measured.  Cell culture 
supernatants from iDCs left untreated, treated with PLGA or agarose films, or matured 
with LPS were collected, cleared by centrifugation, and stored at -20°C until analysis by 
ELISA.  For each treatment group, DCs were retrieved, and assessed for viability and 
DNA content, and amount of TNFα secreted by DCs reported based on DNA content to 
account for any variations in cell count or DNA content due to treatment.  As expected, 
iDCs and LPS-matured DCs secreted very low or high amounts of TNFα, respectively, 
suggestive of their maturation state (Figure 7-5).  While not as high as LPS-induced DC 
secretion, PLGA films treatment induced secretion of TNFα above that released by iDCs, 
with PLGA-treated DCs secreting more TNFα than agarose-treated DCs.   
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Figure 7-5: Dendritic cells treated with PLGA film secrete more TNFα than DCs 
treated with agarose film.
Cell culture supernatants from iDCs left untreated or treated with PLGA film, agarose 
film, or LPS were assessed for level of TNFα. Immature DCs and agarose film-
treated DCs did not produce appreciable levels of TNFα whereas LPS-matured DCs 
and PLGA film-treated DCs produced a significantly higher amount of the cytokine.  
Dendritic cells treated with PLGA film secreted higher amounts of TNFα than did 
DCs treated with agarose film. mean±SD, n=3.  *: p<0.05 compared to iDC, +: p<0.05 











































Dendritic cells treated with agarose film show higher activation of NFκB family members 
than DCs treated with PLGA film 
 Activation of NFκB, family of a transcription factors composed of homo- and 
heterodimers of p50, p52, p65/RelA, RelB, and cRel, is one of the signaling pathways 
that controls genes involved in inflammatory and immune responses (Baeuerle and 
Henkel, 1994; Ghosh et al., 1998).  In addition, NFκB has been shown to play a role in 
the regulation of DC maturation, including increased expression of co-stimulatory and 
MHC class II molecules and cytokine production (Rescigno et al., 1998; Ouazz et al., 
2002).  To begin to address the mechanism of biomaterial-induced DC maturation, 
activation levels of members of NFκB family in differentially treated DCs were 
evaluated.  Dendritic cells treated with agarose or PLGA film showed levels of NFκB 
activation in between those of iDCs and LPS-matured DCs (Figure 7-6).  However, DCs 
treated with agarose showed higher activation levels of all members of NFκB family 
assessed, as compared to PLGA-treated DCs.       
Figure 7-6: Dendritic cells treated with agarose film show higher activation of 
NFκB than DCs treated with PLGA film after 24 hrs of treatment.
Activation of members of NFκB family of nuclear transcription factor was measured 
in the nuclear extracts from differentially treated DCs.  LPS- matured DCs showed 
significantly high activation of all members of the family evaluated.  Treatment of 
DCs with agarose or PLGA films resulted in higher activation of NFκB family 
members as compared to iDCs, with agarose treatment resulting in higher activation. 


































 Use of biomaterials in combination products in which the material component is 
delivered together with a biological component requires the understanding of biomaterial 
adjuvant effect in potentiating the immune response against biological component of the 
product.  The desired level of biomaterial adjuvanticity varies by application and thus a 
clear definition for the role of the biomaterial in supporting or not supporting the immune 
response towards the product is fundamental in effective design and selection of a 
material that is most suitable for a given application.   
 In this study, the adjuvant effect of two model biomaterials, agarose and PLGA, 
as measured by phenotypes of DC maturation was compared.  We have previously shown 
that PLGA acts as an adjuvant in enhancing the humoral response against a co-delivered 
model antigen (Matzelle and Babensee, 2004; Bennewitz and Babensee, 2005), and that 
this adjuvant effect, at least in part, was explained by the induced maturation of DCs 
when treated with PLGA MPs or film (Yoshida and Babensee, 2004).  These results led 
to the study of differential effects of biomaterials on DC maturation, specifically, the 
comparison of the effect of PLGA on DC maturation with a biomaterial commonly used 
in tissue engineering applications that has been shown to provoke little inflammation to 
provide a basis for the differential effects of biomaterial adjuvant effect.  For this reason, 
agarose was chosen as a model biomaterial for comparison with PLGA.  We have 
observed in this study that PLGA presented higher adjuvant effect as measured by many 
of the phenotypes associated with mature DCs.  In particular, DCs treated with PLGA 
MPs or films showed higher expression of co-stimulatory and MHC molecules, 
allostimulatory capacity, and cytokine production, as compared to DCs treated with 
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agarose MPs or films.  Further, DC maturation induced by PLGA MPs was shown to be 
independent of phagocytosis, at least in the capacity evaluated, as treating DCs with MPs 
of unphagocytosable size with same exposed surface area resulted in the same level of 
marker expression as compared to DCs treated with phagocytosable MPs.  In contrast, 
agarose-treated DCs consistently showed higher activation of all members of NFκB 
family evaluated.  While the degree of maturation as measured by DC phenotypes varied 
amongst donors in our hands, the trends were consistent.  The induction of DC 
maturation by PLGA is unlikely due to endotoxin contamination, as PLGA MPs and 
films showed below detectable levels of endotoxin.  In contrast, agarose MPs and films 
had measurable amounts of endotoxin present, but likely in a dose lower than that 
necessary to induce DC maturation, substantiating the significance of PLGA-induced DC 
maturation. 
 The differential expression of maturation markers by DCs treated with agarose or 
PLGA (Figure 7-2) is in accord with previously published results (Babensee and 
Paranjpe, 2005) and with other assessment of maturation including allostimulatory 
capacity (Figure 7-4) and TNFα production (Figure 7-5).  The amount of TNFα measured 
in this study presented here is reported based on cellular DNA content, to account for any 
effect of treatment on cell viability.  The viability of cells upon treatment was assessed, 
and was not different amongst the treatment groups, and was always higher than 97% 
(data not shown).   
Cell culture supernatants from DCs treated with PLGA or agarose MPs collected 
24 hrs post-treatment in separate experiments, although not in direct comparison, was 
measured by Cytometric Bead Array Human Inflammation kit (Becton Dickinson 
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Pharmingen).  These results also showed that DCs treated with PLGA secreted higher 
amounts of cytokines (IL-12p70, IL-1, IL-6, TNFα, IL-8, IL-10) than those secreted by 
agarose treated DCs (Figure A3, APPENDIX).  In general, the cytokine profile trends of 
DCs treated by agarose or PLGA were similar, with increasing concentrations of 
inflammatory cytokines, TNFα, IL-8 and IL-6 in a MP-dose dependent manner, while IL-
12p70 was detected at a very low level, comparable to that released by iDCs.  Secretion 
of IL-10 by DCs treated with agarose or PLGA was measurable but low, and increased 
with PLGA but not agarose MP dose.  Dendritic cells treated with agarose or PLGA MPs 
secreted low amounts of IL-1β, which did not correlate with MP dose.  While no direct 
comparison of agarose- and PLGA-treated DCs was made in the measurement of these 
cytokines, higher levels of TNFα, IL-8, and IL-6 induced suggest a Th1 skewed response 
of biomaterial-treated DCs.  This result is in agreement with another study where the 
delivery of a model antigen with PLGA MPs resulted in a Th1 response as measured by 
production of IgG2 isotype antibody against the antigen (Newman et al., 1998).  In our 
experiments, production levels of both IL-10 and IL-12p70 by DCs treated with agarose 
or PLGA were low.  As IL-12 production is upregulated by MHC class II and CD40 
ligation, and is downregulated by Th2 cytokine such as IL-10 (Koch et al., 1996), 
opposite trends in the levels of these two cytokines would have been more revealing of 
the Th polarization induced by the biomaterial treatment of DCs.  A thorough analysis of 
time course of cytokine production as well as mRNA levels of these cytokines may help 
provide additional information on this aspect of biomaterial-induced DC maturation.  The 
elucidation of differential cytokine profiles produced by biomaterials, and the types of T 
cell response induced by DCs treated with such biomaterials can guide the development 
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of novel biomaterials that can appropriately influence Th polarization for controlled host 
tolerance of tissue engineered grafts or combination products or protective immunity. 
 The lack of maturation effect observed on DCs treated with agarose is not 
surprising given that it elicits minimal inflammation upon implantation (Starke et al., 
1987; Cadic-Amadeuf et al., 1992; Rollwagen et al., 1993; Spargo et al., 1994; Rahfoth et 
al., 1998; van Heeckeren et al., 2000).  There are several differences between agarose and 
PLGA to which the differential DC maturation effects can be attributed.  The first and 
foremost is the difference in the chemical composition of the two biomaterials.  Agarose 
is a natural polysaccharide-derived from seaweed, composed of repeating β-D-
galactopyranosyl and 3,6-anhydro-α-L-galactopyranosyl units.  Its gellation properties 
are thermoreversible due to hydrogen bond formation, facilitated by alignment of the 
agarobiose molecules (Shoichet et al., 1996).  In contrast, PLGA is a synthetic polyester 
composed of variable molar ratios of lactic and glycolic acid, degradation products of 
PLGA which can be metabolized and excreted (Athanasiou et al., 1996).  In the physical 
forms of MPs and films investigated in this study, films provide a more direct 
comparison of the materials, as they were made without any reagents other than the 
material itself and the solvent.  While the weight per volume fractions of PLGA and 
agarose in their solvents were 10% and 3%, respectively, X-ray photon spectroscopy 
analysis of surface chemistry of the films showed theoretical compositions of carbon 
environment, as measured by percent carbon bonding in the three forms of C-C/H, C-O, 
or O-C=O (Figures 4-2c, 4-5b).  The hydrophobicity of PLGA as compared to agarose 
implies that PLGA film likely adsorbed more proteins present in the cell culture, which 
may facilitate the interaction between the film and the DCs and the observed maturation.   
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Currently in our laboratory, efforts are being made to correlate adsorbed proteins on 
surfaces with self-assembled monolayers presenting methyl (CH3), amine (NH2), 
hydroxyl (OH), or carboxyl (COOH) terminal groups.  In particular, quantification and 
identification of carbohydrate modifications of these adsorbed proteins and their effects 
on DC maturation via recognition by lectin receptors is under investigation.    
 While almost all of our assessment of differential effects of agarose and PLGA 
indicated that PLGA induced higher degree of DC maturation, agarose-treated DCs 
consistently showed higher activation of NFκB.  NFκB family of transcription factors are 
composed of homo- and heterodimers of five proteins (p50, p52, p65/RelA, RelB, cRel), 
and regulates many of the genes involved in inflammatory and immune responses 
(Baeuerle and Henkel, 1994; Ghosh et al., 1998).  Activation of NFκB pathway is 
involved in LPS- and bacteria-induced DC maturation, and is independent of MAPK 
activation (Rescigno et al., 1998; Rescigno et al., 1999; Arrighi et al., 2001).  Similarly, 
recent studies have shown that polyunsaturated fatty acids can block the maturation of 
DCs and function independently of NFκB activation, suggesting another mechanism by 
which DCs can be matured independent of NFκB (Zeyda et al., 2005).  The existence of 
DC maturation pathways independent of NFκB suggests that PLGA may induce DC 
maturation in such manner.  Other studies have demonstrated that DCs lacking particular 
members of NFκB family, namely p50, RelA (p65), or cRel exhibited impaired DNA 
binding activity with no obvious defects in expression of MHC class I and II molecules 
as well as CD80 or CD86, or defects in response to LPS or TNFα (Ouazz et al., 2002), 
suggesting a disparity between co-stimulatory and MHC molecule expression and NFκB 
activation, as observed in our study.   
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 In investigations of biomaterial-induced NFκB activation, hyaluronic acid and 
chondroitin sulphate A, both of which are naturally occurring glycosaminoglycans, have 
been shown to be increase DC maturation and NFκB activation (Yang et al., 2002).  More 
interestingly, HeLa cells cultured on lipid films and hydrophilic surfaces exhibited 
different time course of NFκB activation (Kishida et al., 2001).  Cells cultured on lipid 
and hydrophilic surfaces reached comparable levels of activation, but exhibited different 
time course of activation; HeLa cells cultured on lipid film reached peak activation after 
15 min of cell culture which was reduced by 24 hrs post-treatment, whereas cells cultured 
on hydrophilic surfaces of polyacrylamide grafted with polyethylene or cellulose showed 
maximal activation at 24 hrs.  A similar phenomenon may have occurred with PLGA and 
agarose treated DCs.  In our study, NFκB activation was measured 24 hrs after the 
treatment with the biomaterial; this time point may have been optimal for hydrophilic 
agarose-treated DCs but too long to observe any activation of NFκB in hydrophobic 
PLGA-treated DCs which may have already peaked and declined.   
 Studies presented herein begin to address the differential effects of biomaterials 
on DC maturation, and the associated adjuvant effect and immune and inflammatory 
responses.  While most assessments as measured by DC maturation indicated that PLGA 
produced higher adjuvant effect than did agarose, the incongruence of NFκB activation 
underscores the need to evaluate various aspects of material biocompatibility and its 
effect on cell behavior to fully appreciate the complex events that occur in vivo when 
products containing such biomaterials are implanted and encountered by the host defense 
mechanisms.  Elucidation of differential biomaterial adjuvant effect and the material 
physicochemical properties which influence the adjuvanticity can help guide the 
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development of novel materials and define design and selection criteria for biomaterials 





ROLE OF TOLL-LIKE RECEPTORS IN POLY(LACTIC-CO-GLYCOLIC ACID) 
INDUCED DENDRITIC CELL MATURATION 
 
INTRODUCTION: 
 The development of combination products such as tissue engineered constructs 
which combine biomaterials with biological components have prompted the 
understanding for the role of the biomaterial component in the host immune response 
encountered upon implantation.  Depending on the application of the device, the purpose 
of the biological component may be to induce immunogenicity, as in the case of vaccines, 
or to aid in tissue regeneration, as in the case of tissue engineering.  While inflammation 
associated with biomaterial implantation in the context of tissue engineering has gained 
much focus (reviewed in (Tang and Eaton, 1995; Babensee et al., 1998; Rihova, 2000)), 
the effect of biomaterial on the host response with simultaneous introduction of a 
biological component and the interconnections between the reactions elicited by the 
biomaterial and the biological components are yet to be fully characterized.  The 
inflammatory response elicited by the presence of the biomaterial component may 
augment the immune response against the biological component through an adjuvant 
effect, and lead to unanticipated aggravation of the immune response.  Especially as some 
biomaterials are explored for application in situations where high or low biomaterial 
adjuvant effect is desired, the understanding of the biomaterial adjuvant effect and its 




 Poly(lactic-co-glycolic acid) (PLGA) is one such material, widely studied for 
many applications, in which its adjuvant effect may or may not be desired.  Poly(lactic-
co-glycolic acid) is a synthetic polymer composed of variable molar ratios of lactic and 
glycolic acids.  Because its degradation can be controlled through polymer composition 
and its degradation products are biocompatible, PLGA has been extensively investigated 
(Hutchinson and Furr, 1986; Eldridge et al., 1991; Athanasiou et al., 1996; Mikos and 
Temenoff, 2000).  The adjuvant effect of PLGA, as measured by antibody responses 
against antigens delivered with PLGA, has been evaluated as at least comparable if not 
greater than that elicited by known adjuvants such as alum and Complete Freund’s 
Adjuvant (Ertl et al., 1996; Walker et al., 1998; Raghuvanshi et al., 2001).   
 Adjuvants produce their immunostimulatory effect through antigen presenting 
cells (APCs) such as the dendritic cells (DCs) (Singh and O'Hagan, 1999).  Particulate 
adjuvants, including polymeric microparticles, are internalized by APCs, thereby 
activating them, inducing an immune response, or by creating a depot of antigen at the 
site of injection to prolong exposure (Hunter, 2002).  In addition, adjuvants, especially 
those of bacterial origin, can enhance the immune response by activating APCs resulting 
in higher levels of expression of MHC and co-stimulatory molecules or by affecting 
cytokine release (Singh and O'Hagan, 1999).  Interestingly, PLGA has been shown to act 
as an adjuvant through the induction of DC maturation (Jilek et al., 2004; Yoshida and 
Babensee, 2004).   
   Dendritic cells are professional APCs that bridge innate immunity, including 
inflammation, and adaptive immunity (Banchereau and Steinman, 1998; Banchereau et 
al., 2000).  Upon encountering pathogen-associated molecular patterns, inflammatory 
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cytokines or other “danger signals”, DCs undergo maturation.  The state of maturation is 
characterized by loss of phagocytic and endocytic receptors, and downregulated 
pinocytosis, and upregulation of MHC and co-stimulatory molecules such as CD40, 
CD80, and CD86 (Sallusto et al., 1995; Winzler et al., 1997; Banchereau and Steinman, 
1998; Banchereau et al., 2000).  Maturing DCs migrate to lymphoid organs where they 
activate T cells for the initiation of the adaptive immune response (Banchereau and 
Steinman, 1998; Banchereau et al., 2000), and in this way bridge innate and adaptive 
immunity.   
 Many of stimulators of DC maturation, including adjuvants, activate DCs via a 
family of receptors known as the Toll-like receptors (TLRs).  In particular, TLR2 and 
TLR4 have been implicated in the activation of DCs by endogenous and exogenous 
adjuvants.  Poly-mannuronic acid, a component of a natural biomaterial, alginate, has 
been shown to activate DCs via TLRs 2 and 4 (Flo et al., 2002).  Endogenous cell- or 
tissue-derived adjuvants such as heat shock proteins (Basu et al., 2000; Bethke, 2002) and 
degraded proteins that only appear upon tissue injury such as oligosaccharides of 
hyaluronan also activate DCs via TLR 4 (Termeer et al., 2000; Johnson et al., 2002; 
Termeer et al., 2002).  As we have previously observed that PLGA activates human DCs 
as measured by increase in co-stimulatory and MHC molecule expression, inflammatory 
cytokine release, and allostimulatory capacity, this study sought to investigate the 
receptors involved in PLGA-induced maturation of DCs by focusing on TLRs.  Because 
introduction of biomaterials into environment where proteins are present, both in vivo and 
in vitro, leads to instantaneous protein adsorption to material surface, PLGA-induced DC 
maturation is likely mediated by such adsorbed proteins.  While studies demonstrating 
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PLGA-induced DC maturation were performed in vitro, the activation of DCs by PLGA 
in vivo is thought to be mediated by endogenous proteins.  As such, we focused on the 
investigation of the roles of TLR2 and TLR4 on PLGA-induced maturation through 




Poly(lactic-co-glycolic acid) microparticle and film preparation 
 Poly(lactic-co-glycolic acid) microparticles (MPs) were prepared by a single 
emulsion solvent evaporation technique adapted from a previously described method 
(Wake et al., 1998; Yoshida and Babensee, 2004).   Briefly, 500 mg of PLGA (molar 
ratio: 75:25, inherent viscosity: 0.69 dL/g in trichloromethane) (Birmingham Polymers, 
Birmingham, AL) was dissolved in 20 ml dichloromethane (DCM) (Sigma, St. Louis, 
MO) overnight at room temperature.  On the second day, the PLGA-DCM solution was 
added to 200 ml 0.3% v/v aqueous poly(vinyl alcohol) (PVA) (Sigma), and homogenized 
for 2 min at 9000 rpm.  Immediately after homogenization, 200 ml 2% (v/v) aqueous 
isopropanol (Sigma) was added to initiate precipitation, and the mixture stirred overnight 
at room temperature to evaporate the solvent.  Resulting MPs were collected by 
centrifugation at 1000 rpm for 10 minutes, washed twice in 2% isopropanol, and three 
times in distilled deionized H2O (ddH2O).  Microparticles were resuspended in ddH2O 
and their size distribution characterized using a Coulter Multisizer II (Coulter 
Corporation, Miami, FL).  Prior to use, the MP suspension was UV sterilized for 1 hr, 
and stored at 4°C for no longer than 3 days.  Endotoxin content of PLGA MPs was 
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determined to below detection limit of the assay used (QCL-1000, Cambrex, 
Walkersville, MD). 
 Poly(lactic-co-glycolic acid) films were fabricated using a previously described 
casting technique without a porogen (Ishaug et al., 1997; Yoshida and Babensee, 2004).   
Briefly, 10% w/v 75:25 PLGA was dissolved in DCM overnight at room temperature. 
Solution of PLGA-DCM was poured onto a 50 mm Teflon Petri dish (Cole-Parmer, 
Vernon Hills, Illinois).  Upon evaporation of the solvent and drying, the film was 
punched into an appropriate size, and washed for 1 hr in ddH2O, changing water every 15 
min.  The film was dried 30 min per side in a sterile laminar flow hood, and UV sterilized 
for 30 min per side prior to use.  For culturing with cells, the film was secured to the 
bottom of the tissue culture plate with a segment of sterile silicone tubing (Cole-Parmer).  
Endotoxin level of 4.5 mm diameter film was below limits of detection by QCL-1000 
endotoxin assay (Cambrex). 
 
Human dendritic cell culture 
 Human blood was obtained from volunteers with informed consent, according to a 
protocol approved by the Institutional Review Board of Georgia Institute of Technology, 
#00A018.  Dendritic cells were derived from human peripheral blood mononuclear cells 
(PBMCs) using a previously described method (Romani et al., 1996) with some 
modifications, as previously reported (Yoshida and Babensee, 2004).  Briefly, PBMCs 
were isolated from blood by differential centrifugation using Histopaque (Sigma).  Upon 
lysing erythrocytes and washing, PBMCs were resuspended at a concentration of 5x106 
cells/ ml in RPMI-1640 containing 25 mM HEPES and L-glutamine (Gibco BRL, Grand 
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Island, NY) with 100 U/ ml penicillin-streptomycin (Cellgro, Herndon, VA) and 10% 
(v/v) heat inactivated filter sterilized fetal bovine serum (Invitrogen, Carlsbad, CA) (DC 
media).  Cells were plated in a volume of 10 ml/ plate in a 100 x 20 mm tissue culture 
plate (Becton Dickinson, Franklin Lakes, NJ) and incubated for 2 hrs to select for 
adherent monocytes.  After the incubation, plates were washed 3 times with warm DC 
media to remove non-adherent cells, and the remaining adherent cells were supplied with 
10 ml DC media and incubated with 2000 U/ ml GM-CSF and 1600 U/ ml IL-4 
(Peprotech, Rocky Hill, NJ).  On day 5 of culture, loosely- and non-adherent cells 
containing DCs were collected by centrifugation for 10 min at 1100 rpm, and 
resuspended in DC media with 1000 U/ ml GM-CSF and 800 U/ ml IL-4 for use in 
various experiments. 
 
In vitro antibody blocking experiments 
 The role of particular receptors, namely CD14, TLR2, and TLR4, in PLGA-
induced human DC maturation was evaluated in vitro using blocking antibodies.  
Immature DCs collected on day 5 of culture were resuspended in DC media with 1000 U/ 
ml GM-CSF and 800 U/ ml IL-4 at a concentration of 1x106 cells/ well in 48 well plate 
(Becton Dickinson).  Dendritic cells were incubated with or without various blocking 
antibodies alone or in combination or with isotype control antibodies for 1 hr at room 
temperature.  Following antibodies were used: IgG1κ isotype (clone 107.3, no sodium 
azide, low endotoxin, Becton Dickinson Pharmingen, San Jose, CA), IgG2aκ isotype 
(clone G155-178, no sodium azide, low endotoxin, Becton Dickinson Pharmingen), 
CD14 (clone MEM-18, azide-free, Cell Sciences, Canton, MA), TLR2 (clone TL2.1, no 
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sodium azide, Biocarta, San Diego, CA), or TLR4 (clone HTA125, no sodium azide, 
Biocarta).  After blocking with the respective antibodies for 1 hr, DCs were treated with a 
maturation stimulus of 1 µg/ ml LPS (Sigma, St. Louis, MO), 5:1 MP: cell ratio of PLGA 
MPs, PLGA film, or left untreated for additional 24 hrs.   
 
Human Tumor Necrosis Factor α (TNFα) ELISA 
 Cell culture supernatant from human DC culture was collected at 5 hrs after the 
initial treatment with the maturation stimulants.  The supernatant was cleared and stored 
at -20°C until analysis.  The amount of TNFα produced by DCs in the cell culture 
supernatant was analyzed by ELISA (R&D Systems, Minneapolis, MN) according to 
manufacturer’s directions.   
 
Murine bone marrow-derived dendritic cell culture 
 Bone marrow-derived DCs were prepared from mice in accordance with protocol 
approved by Emory University IACUC (protocol number 034-2003), based on previously 
published methods with some modifications (Inaba et al., 1992).  Male, 5-7 week old 
C57BL6 (haplotype I-Ab), C3H/HeJ (haplotype I-Ak) and C3H/HeOuJ (haplotype I-Ak) 
were purchased from Jackson Laboratories (Bar Harbor, ME).  C3H/HeJ animals have a 
mutation in toll-like receptor 4 gene, Tlr4Lps-d, resulting in LPS hyporesponsivity, and 
have been extensively used as a model for TLR4 signaling (Ohashi et al., 2000; Takeuchi 
et al., 2000; Termeer et al., 2002).  Of the several corresponding wild type substrains of 
C3H, C3H/HeOuJ was selected, as both strains of mice were available from the same 
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commercial source.  For each strain, 6 animals were used for each experiment.  Femur 
and tibia from mice were dissected, and muscle and tissue removed.  Cleaned bones were 
placed in 70% ethanol in 60 mm suspension dish for 1 min, washed twice in PBS, and 
placed into culture media composed of DMEM (Cellgro, Herndon, VA) with 1% 
penicillin-streptomycin (Cellgro), 1% non-essential amino acids (Cellgro), 1% sodium 
pyruvate (Cellgro), 1% HEPES (Cellgro), 0.1% 2-mercaptoethanol (Invitrogen), with 
10% heat inactivated fetal bovine serum (Invitrogen).  Ends of the bones were cut, and 
bone marrow flushed with at least 5 ml of media using a 26G needle.  The bone marrow 
suspension was strained using a 70 µm cell strainer (Becton Dickinson), cells collected 
by centrifugation at 1500 rpm for 5 min, and erythrocytes lysed with ammonium chloride 
(155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA).  Bone marrow cell suspension was 
then washed twice in PBS with 10% FBS, resuspended at 1.5x106/ ml with 20 ng/ ml 
GM-CSF (Sigma) and 20 ng/ ml IL-4 (Sigma), and plate 3 ml/ well  into 6 well plates 
(Corning), and incubated at 37°C with 95% relative humidity and 5% CO2.  On day 3, 
cells were fed by exchanging half of the media with fresh media containing 20 ng/ ml 
GM-CSF and 20 ng/ ml IL-4.  On day 6 of culture, loosely- and non-adherent cells were 
collected, and washed twice in PBS with 2% FBS and 2 mM EDTA, and processed for 
CD11c+ magnetic separation per manufacturer’s directions (Miltenyi Biotech, Auburn, 
CA).   
 Cells positive for CD11c were considered as iDCs, and used for subsequent 
experiments.  These CD11c+ iDCs were resuspended at 1x106 cells/ ml, and plated at 1 
ml/ well in 24 well plate.  Effect of PLGA MPs or film on DC maturation was tested by 
treating the cells with 5:1 MP: cell ratio of PLGA MPs or with PLGA film placed at the 
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bottom of the well for 24 hrs.  For negative and positive controls, iDCs were left 
untreated or treated with 1 µg/ ml LPS, respectively for 24 hrs.     
 
Murine Tumor Necrosis Factor α (TNFα) and IL-6 ELISA 
 Cell culture supernatant from murine DC culture was collected at 4 hrs after the 
initial treatment with the maturation stimulants.  The supernatant was cleared and stored 
at -20°C until analysis.  The amount of TNFα and IL-6 produced by DCs in the cell 
culture supernatant was analyzed by ELISA (R&D Systems, Minneapolis, MN) 
according to manufacturer’s directions.   
 
Cell surface marker expression 
 Extent of DC maturation was assessed by measuring the expression of cell surface 
markers by flow cytometry.  Dendritic cells were harvested, and resuspended in Hank’s 
HEPES buffer (120 mM NaCl, 10 mM KCl, 10 mM MgCl2, 10 mM glucose, 30 mM 
HEPES) containing 1% (v/v) human serum albumin (HSA) and 1.5 mM CaCl2.  For 
human DCs, cells were stained with mouse anti-human monoclonal antibody against 
CD40 (clone B-B20; IgG1κ), CD80 (clone BB1; IgMκ), CD86 (clone BU63; IgG1κ) 
(Southern Biotech, Birmingham, AL), CD83 (clone HB15a; IgG2b) (IO Test Immunotech 
Beckman Coulter, Marseille, France), HLA-DQ (clone TU169; IgG2aκ), or HLA-DR 
(clone TU36; IgG2aκ) (Becton Dickinson Pharmingen, San Diego, CA) for 1 hr at 4°C.  
For murine DCs, cells were stained with antibodies against CD86 (clone GL1; IgG2aκ), 
CD80 (clone 16-10A1, IgG2κ), CD11c (clone HL3, IgG1λ2), I-Ab (clone AF6-120.1, 
IgG2aκ), or I-Ak (clone 10-3.6, IgG2aκ) (Becton Dickinson Pharmingen) for 1 hr at 4°C.  
 
 132
All cells were analyzed using BD LSR flow cytometer (Becton Dickinson, San Jose, 
CA).  Data analysis was performed using WinMDI 2.8 (Scripps Research Institute, La 




 Statistical analysis was performed using general linear model ANOVA with 
Minitab software (Version 13.20, Minitab Inc., State College, PA), and pairwise 
comparison to appropriate control group as indicated was made, unless otherwise 
indicated, with p-values of less than or equal to 0.05 considered to be significant.  Power 
analysis for sample size of animal studies was confirmed using 2-sample t test, with a 





Pretreatment of human immature dendritic cells with TLR2 blocking antibody enhances 
maturation 
 To investigate the receptors involved in PLGA-induced DC maturation, in vitro 
receptor blocking experiments were performed.  Receptors known to be involved in DC 
signaling and phagocytosis were evaluated to assess the mechanism of maturation as well 
as receptors that mediate PLGA MP uptake.  In particular, CD14, CD36, CD51, DC-
SIGN, mannose receptor, TLR2, and TLR4 were evaluated.  All of these receptors were 
present on DCs, as measured by flow cytometry (Figure A4, APPENDIX).  Blocking of 
receptors using antibodies or known ligands to these receptors within the range tested 
was not able to block the LPS- or PLGA MP-induced maturation (Figure A5, 
APPENDIX).  Likewise, blocking receptors by pretreating DCs with TLR2, TLR4, or 
CD14 antibody alone or in combination was unable to reduce LPS- or PLGA-induced DC 
maturation as measured by CD83 and CD86 expression (Figure 8-1).  However, blocking 
iDC receptors using TLR2 antibody alone resulted in enhanced expression of CD83 and 
CD86 without any additional maturation stimulus (Figure 8-1).  Similarly, pretreatment 
of DCs with these antibodies also increased the fold increase in the expression of these 
markers (Figure 8-1b).  Because many of the DC agonists exert their maturation effect by 
signaling through TLR4 alone or in combination with other receptors such as CD14 and 
TLR2, the effect of simultaneously blocking these receptors in combination was 
examined.  Blocking of receptors in combination did not greatly affect the LPS- or 
PLGA-induced increase in marker expression.  However, with antibody combinations in 
which anti-TLR2 or anti-CD14 antibody was present, iDCs expressed higher than 
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expected levels of CD83 and/ or CD86 as observed with blocking receptor with TLR2 
antibody alone (Figure 8-1a, b).    
 Similar to the observation with maturation marker expression, pretreatment of 
iDCs with TLR2 antibody and combinations thereof, without additional maturation 
stimulus resulted in increased release of TNFα (Figure 8-2).  The increase in TNFα 
released with the addition of LPS as maturation stimulants was not significantly altered 
by the pretreatment of DCs with any of the blocking antibodies alone or in combination.  
PLGA MP-induced increase in TNFα release was further enhanced by the pretreatment 





Figure 8-1:  Pretreatment of iDCs with TLR2 blocking antibody increases 
marker expression.
Immature DCs were pretreated with isotype control antibody or antibodies against 
respective receptors for 1 hr at room temperature, and left untreated or treated with 
LPS or PLGA MPs for additional 24 hrs.  LPS- and PLGA MP- treated DCs increased 
their expression of CD83 and CD86.  Pretreatment of iDCs with TLR2 antibody alone 
or in combination increased the expression of CD83 and CD86 above those expressed 
by isotype control antibody-pretreated cells. This experiment was repeated three times 
with similar results, and representative results are shown (a). Fold increase in gMFI
values for each pretreatment groups as compared to that of no antibody pretreatment 
control (none) revealed statistical significance of the findings (b). mean±SD, n=3. */+: 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 8-2: Pretreatment of iDCs with TLR2 blocking antibody increases TNFα
release.
Immature DCs were pretreated with isotype control antibody or antibodies against 
respective receptors for 1 hr at room temperature, and left untreated or treated with 
LPS or PLGA MPs for additional 24 hrs.  LPS- and PLGA MP- treated DCs secreted 
increased amount of TNFα in comparison to iDCs.  Increase in TNFα production 
induced by LPS was not blocked by pretreatment of DCs with the blocking antibodies.  
Production of TNFa by iDCs was enhanced by addition of TLR antibodies. mean±SD, 

















































































































































































































































































































































































































































































Bone marrow-derived DCs from C57BL6 mice increase CD86 expression and cytokine 
secretion  
 As results from in vitro blocking studies of human DCs were conflicting, with 
increased DC maturation due to pretreatment of antibodies alone without maturation 
stimulants and the lack of blocking effect on LPS-induced maturation, another approach 
was taken to further investigate the role of CD14, TLR2, and TLR4 in the PLGA-induced 
DC maturation.  Commercially available murine model of LPS-dependent signaling, 
C3H/HeJ strain was chosen for this purpose.  Prior to using DCs derived from C3H/HeJ 
mice, ability of PLGA to induce DC maturation in wild type C57BL6 strain was 
evaluated.  Morphology of bone marrow-derived DCs from C57BL6 mice treated with 
PLGA MPs or film were similar to that of LPS-matured DCs with dendritic processes 
(Figure 8-3).   
a b c d 
Figure 8-3: Bone marrow-derived DCs from C57BL6 mice treated with PLGA 
MPs or film possess morphology similar to DCs matured with LPS.  
Bone marrow-derived iDCs from C57BL6 mice were left untreated (a) or treated with 
LPS (b), PLGA MPs (c), or PLGA film (d) for 24 hrs.  Dendritic cells treated with 
PLGA MPs or films show dendrites as do LPS-matured DCs and iDCs to a lesser 
extent. This experiment was repeated six times with similar results, and representative 
results are shown. 
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Expression levels of co-stimulatory molecules CD80 and CD86, as well as DC marker 
CD11c and murine MHC molecule I-Ab were measured.  Expectedly, expression levels of 
CD11c and I-Ab were not greatly altered by the treatment of DCs with LPS or PLGA 
MPs or films (Figure 8-4a).  Bone marrow-derived DCs from C57BL6 animals increased 
expression of CD80 and CD86 in response to treatment with LPS, PLGA MP, or PLGA 
film.  However, changes in fold increase were not readily observed with the different 
treatment groups (Figure 8-4b). 
As one important consequence of activation of DCs via TLRs is the production of 
pro-inflammatory cytokines (Akira et al., 2001), cell culture supernatants from DCs 
treated with or without LPS, PLGA MPs or PLGA film were analyzed for levels IL-6 and 
TNFα using ELISA.  As expected, LPS-matured DCs secreted high amounts of TNFα 
and IL-6 in comparison to iDCs (Figure 8-5a, b).  In addition, PLGA MP- and PLGA 
film-treated DCs also released substantially higher amounts of TNFα and IL-6 above 
those secreted by iDCs (Figure 8-6).  Taken together, these results suggest that treatment 












Figure 8-4: PLGA induces increased expression of CD86 on bone marrow-
derived DCs from C57BL6 mice.  
Bone marrow-derived iDCs from C57BL6 mice were left untreated or treated with 
LPS, PLGA MPs, or PLGA film for 24 hrs.  Expression of DC markers were 
measured by flow cytometry.  Treatment of iDCs with PLGA MPs enhanced 
expression of CD86, whereas the expression of other markers was not noticeably 
changed.  This experiment was repeated six times with similar results, and 
representative results are shown (a).  Fold increase in gMFI values for each treatment 
groups as compared to that of iDC control revealed statistical significance of the 










































































































































































































Figure 8-5: PLGA induces increased secretion of TNFα and IL-6 by bone 
marrow-derived DCs from C57BL6 mice.  
Bone marrow-derived iDCs from C57BL6 mice were either left untreated or treated 
with LPS, PLGA MPs, or with PLGA film for 24h.  Cell culture supernatant at 4 hrs 
after the initial treatment of DCs was assessed for TNFα (a) or IL-6 (b) content.  
Dendritic cells treated with LPS secreted high amount of both cytokines.  As 
compared to iDCs, PLGA MP-treated DCs secreted higher amounts of both TNFα and 
IL-6, whereas PLGA film induced higher secretion of IL-6 but not TNFα.  mean±SD, 

































































Bone marrow-derived DCs from C3H/HeOuJ or C3H/HeJ mice do not mature in 
response to treatment with PLGA MPs or film 
 As enhanced maturation in response to treatment with PLGA was observed with 
murine DCs derived from the bone marrow of C57BL6 mice, role of TLR4 in particular 
was further investigated.  For this purpose, bone marrow-derived DCs from commercially 
available murine model, C3H/HeJ strain, were used.  C3H/HeJ mice have a mutation in 
toll-like receptor 4 gene, Tlr4Lps-d, are LPS hyporesponsive, and have been used as a 
model for investigating the involvement of TLR4 in signaling (Ohashi et al., 2000; 
Takeuchi et al., 2000; Termeer et al., 2002).  Several corresponding wild type substrains 
of C3H are used in parallel to studies of C3H/HeJ mice, but for this application, 
C3H/HeOuJ was selected, as both strains of mice were available from the same 
commercial source.  Treatment of DCs from C3H/HeJ or C3H/HeOuJ mice with LPS, 
PLGA MPs, or PLGA film did not result in any difference in cell morphology (Figure 8-
6).   
Expression of maturation markers surveyed as compared to iDCs was not changed 
in DCs from C3H/HeJ nor C3H/HeOuJ mice upon PLGA treatment (Figure 8-7a, b).  
Similarly, changes in fold increase in the expression of these markers were not observed 
to be significant, except for a slight increase in I-Ak and CD86 expression in response to 
LPS for DCs derived from C3H/HeJ animals (Figure 8-7c, d). 
 To further evaluate the role of TLR4 in PLGA-induced murine DC maturation, 
secretion of pro-inflammatory cytokines TNFα and IL-6 was measured.  Dendritic cells 
derived from C3H/HeOuJ animals treated with LPS increased secretion of both TNFα 
and IL-6 as expected (Figures 8-8c ,d).  In particular, the secretion of IL-6 was at a level 
 
 142
comparable to that secreted by DCs derived from C57BL6 mice.  While at a statistically 
significantly lower extent (p<0.01 for both TNFα and IL-6), DCs derived from C3H/HeJ 
animals also secreted TNFα and IL-6 in response to LPS (Figures 8-8a, b).  Dendritic 
cells from neither strain responded to treatment with PLGA MPs, but did so to a very low 
extent in response to PLGA film (Figure 8-8a, d), in agreement with results from marker 




Figure 8-6: Bone marrow-derived DCs from C3H/HeJ (a-d) and C3H/HeOuJ (e-
h) mice treated with PLGA MPs or film possess morphology similar to DCs 
matured with LPS. 
Bone marrow-derived iDCs from C3H/HeJ or C3H/HeOuJ mice were left untreated 
(a,e) or treated with LPS (b,f), PLGA MPs (c,g), or PLGA film (d,h) for 24 hrs.  
Dendritic cells treated with PLGA MPs or films show veils as do LPS-matured DCs 
and iDCs to a lesser extent. This experiment was repeated six times with similar 
results, and representative results are shown.
a b c d
e f g h
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Figure 8-7: PLGA does not affect expression of DC markers on bone marrow-
derived DCs from C3H/HeJ or C3H/HeOuJ mice.  
Bone marrow-derived iDCs from C3H/HeJ (a, c) or C3H/HeOuJ (b, d) mice were 
either left untreated or treated with LPS, PLGA MPs, or with PLGA film for 24 hrs.  
Expression of DC markers were measured by flow cytometry (a, b). Treatment of 
C3H/HeJ DCs with any of the maturation stimulants, LPS, PLGA MPs, or PLGA film 
did not significantly alter the expression of the DC markers measured.  This 
experiment was repeated 6 times with similar results, and representative results are 
shown (a, b).  Fold increase in gMFI values for each treatment groups as compared to 
that of iDC control revealed statistical significance of the findings (c, d). mean±SD, 






















































































































































































































































































































































Figure 8-8: PLGA does not greatly alter secretion of TNFα and IL-6 by bone 
marrow-derived DCs from C3H/HeJ or C3H/HeOuJ mice.  
Bone marrow-derived iDCs from C3H/HeJ (a, b) or C3H/HeOuJ (c, d) mice were 
either left untreated or treated with LPS, PLGA MPs, or with PLGA film for 24 hrs.  
Cell culture supernatant at 4 hrs after the initial treatment of DCs was assessed for 
TNFα (a, c) or IL-6 (b, d) content.  However, DCs from C3H/HeOuJ animals 
consistently secreted higher amounts of both TNFα (c) and IL-6 (d) as compared to 
cells from C3H/HeJ animals (a, b).  mean±SD, n=6. *: p<0.01 compared to iDCs for 
each respective graph.  +: p<0.01 compared to LPS treatment group of DCs derived 
from C3H/HeJ animals.  TNFα and IL-6 secretion by LPS-treated DCs were 
significantly higher by DCs derived from C3H/HeOuJ mice as compared to those 


























































































































 Poly(lactic-co-glycolic acid) is widely explored for various applications in which 
its adjuvant effect may or may not be desirable.  As PLGA has been previously shown to 
induce DC maturation (Jilek et al., 2004; Yoshida and Babensee, 2004), the aim of this 
study was to investigate the receptors that may be involved in this PLGA-induced DC 
maturation.  Within the concentrations tested, none of the antibodies or ligands used to 
block receptors of human DCs revealed clear indication of the role of particular receptors 
in PLGA-induced DC maturation.  Moreover, blocking of human iDC receptors with 
some of the TLR antibodies resulted in increased expression of maturation markers and 
cytokine release, suggesting that the pretreatment by antibody alone activated the DCs 
(Figures 8-1, 8-2).  This activation of human DCs in presence of antibodies may be 
attributed to a few factors.  First is that although unlikely, there may have been 
contaminating endotoxin present in the antibody preparation.  A second speculation is 
that blocking antibodies may have resulted in crosslinking of the Fc portion of 
immunoglobulin (Ig) G receptor (FcγR) on DCs, resulting in their activation.  Such 
activation of leukocytes by antibody crosslinking has been observed with DCs (Regnault 
et al., 1999; Banki et al., 2003) as well as with neutrophils (Simon et al., 1995) and 
monocytes (Drechsler et al., 2002).  In particular, crosslinking of CD32, or FcγRII, using 
immobilized IgG has been shown to induce maturation of human monocyte-derived DCs 
via activation of NFκB pathway (Banki et al., 2003).  Dendritic cells matured by this 
crosslinking of FcγRII were functionally mature, as indicated by their ability to induce 
allogeneic T cell proliferation and cytokine production, which could be inhibited by the 
addition of FcγRII-blocking monoclonal antibody.  In accord with other studies (Sallusto 
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and Lanzavecchia, 1994; Banki et al., 2003), this particular Fcγ receptor, CD32, has been 
confirmed to be present on our DC preparation by flow cytometry (Figure A4, 
APPENDIX).  The binding of anti-TLR antibody to DCs and subsequent crosslinking of 
Fc portions via DC-bound immunoglobulin may have led to the unexpectedly high 
expression of CD86 and TNFα production by DCs upon pretreatment with this antibody.  
In another study, polymeric microspheres with covalently attached IgG on the surface, 
similar to cell-bound IgG, has been shown to increase CD83 expression (Kempf et al., 
2003), supporting the hypothesis of DC maturation due to cell-bound TLR2 antibody in 
our study.  Although blockade of FcγR may obstruct the enhanced DC maturation effects 
observed, a recent study has demonstrated that blocking of inhibitory FcγRII, specifically 
FcγRIIb, induces human DC maturation as measured by increased co-stimulatory 
molecule expression and IL-12p70 secretion (Dhodapkar et al., 2005).  As immune 
complexes and cell-bound immunoglobulins present in normal human serum may be 
enough stimulus to induce DC maturation via FcγR (Regnault et al., 1999), such studies 
underscore the complexities of different FcγRs and other factors involved in DC 
maturation.  Another possibility to obviate the blocking antibody-induced DC maturation 
may be to prepare Fab fragments to avoid crosslinking of Fc portion of the IgG. 
 As expected, LPS-induced production of IL-6 and TNFα by DCs from 
C3H/HeOuJ mice was consistently higher than those produced by DCs from C3H/HeJ 
mice.  However, while at a lower level, DCs from C3H/HeJ mice did secrete measurable 
amounts of TNFα and IL-6 in response to LPS.  Similarly, secretion of low amounts of 
LPS-induced MIP-2, but not complete abrogation, by cells from C3H/HeJ strains as 
compared to the control C3H/HeN strain has been observed (Nikulina et al., 2004).  This 
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response to LPS in cytokine production may have been due to unintentional favorable 
environmental conditions for induction of DC maturation, resulting in generally elevated 
state of DC maturation.  This may be likely since while cytokine secretion by iDCs from 
C3H/HeJ mice was low, CD86, whose expression is upregulated on maturation, was 
already fairly highly expressed by iDCs.  Another potential cause for the secretion of 
cytokines in response to LPS in this strain may be due to the presence of impurities in the 
LPS preparation used in this study.  Presence of DC maturation agonists that act via 
receptors other than TLR4 may have caused the production of TNFα and IL-6 without 
greatly affecting co-stimulatory marker expression.  Use of ultra-pure grades of LPS, as 
well as confirming the LPS-hyporesponsiveness of this strain using cells other than DCs, 
such as T cell proliferative capacity in response to LPS, may help address this issue, and 
validate utilization of C3H/HeJ strain to further investigate the role of TLR4. 
 While PLGA was capable of inducing maturation of bone marrow-derived DCs of 
C57BL6 mice, PLGA MPs or film were unable to induce maturation of DCs from 
C3H/HeOuJ mice.  This result is peculiar, given that LPS-induced signaling in DCs from 
C3H/HeOuJ mice was intact, as supported by increased expression of co-stimulatory 
molecules and TNFα and IL-6 production in response to LPS.  Moreover, while LPS-
induced production of IL-6 by DCs from C3H/HeOuJ mice was comparable to that 
produced by DCs from C57BL6 mice, production of TNFα was substantially lower.  This 
difference in cytokine production in response to LPS may be attributed to the difference 
in MHC haplotypes of the 2 strains of mice.  Haplotypes of MHC have been shown to 
differentially regulate production of cytokines (Dieli et al., 1995; Caruso et al., 1996) as 
well as T cell recognition of bacterial antigens (Pichugin et al., 1998; Kamath et al., 
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2004).  Specifically, production of TNFα by T cells from bacteria-infected animals upon 
in vitro restimulation with bacterial antigens has been shown to be significantly lower by 
cells from BALB/c (H-2k) as compared to those secreted by T cells from MHC congenic 
BALB.B10 (H-2b) or C57BL6 (H-2b) (Huygen et al., 1992).   
 Because cytokine secretion may be under regulation of MHC complexes, 
comparison between C57BL6 and C3H substrains may be complicated by the differing 
haplotypes of these two strains.  Even within the C3H strains, the heterogeneity in the 
substrains makes the selection of appropriate control strain for the HeJ substrain difficult; 
significant heterogeneity in morbidity to M. tuberculosis infection amongst four 
substrains of C3H including HeJ and HeOuJ (Kamath et al., 2003), as well as differing 
susceptibility to autoimmune diseases (Glant et al., 2001) have been documented.  As we 
have tried to control for as many environmental factors as possible, by housing the 
animals in the same facility under the same conditions, handling the mice in the same 
manner, obtaining all strains from the same vendor, the factors that may have caused this 
unforeseen difference in results obtained from C57BL6 and C3H animals are likely 
genetic.  With these differences regulated by MHC haplotypes, it may be worthwhile to 
investigate the effect of PLGA on murine DC maturation using other strains of mice as 
controls.  Furthermore, because the differences observed were in the production of 
cytokines, investigation of polarization of T cells by cytokines would also be of interest.  
Ultimately, the relative effect observed with cells from C3H/HeJ in response to any 
stimulants, in this case effect of PLGA contact on DC maturation, will depend in part on 
the choice of the control strain (Kamath et al., 2003).   
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As such, repeating these experiments using DCs from other C3H substrain(s) of 
wild type controls may be necessary to provide conclusive results to either delineate or 
rule out the role of TLR4 in PLGA-induced DC maturation.  In addition, experiments 
using DCs derived from transgenic animal models of MyD88 or TLR2 deficiency would 
be of interest.  Originally, our intent was to investigate the role of MyD88 first, as this 
adaptor protein associates with TLR2 and TLR4 and is implicated in the intracellular 
signaling mediated by these 2 TLRs (Kaisho and Akira, 2001).  However, logistical 
inaccessibility to this particular animal model has prompted us to study the role of TLR4 
using commercially available C3H/HeJ strain.  Because there exist MyD88-dependent 
and independent pathways of DC activation via TLRs (Kaisho and Akira, 2001), lack of 
response by DCs from MyD88-deficient murine models would not necessarily rule out 
the role of TLR2 and TLR4.  To specifically study the contributions of particular TLRs in 
mediating biomaterial-induced DC maturation, one may need to use a multivariate 
approach of in vitro and in vivo methods, using model cell lines lacking particular 
receptors and cells from animal models with deficiencies in particular receptors.  If 
results from additional investigations do not support the involvement of TLR2 or TLR4 
in the PLGA-induced DC maturation, focused efforts on receptors known to mediate 
activation by proteins adsorbed on material surfaces such as FcγR, integrins, or 
phagocytic receptors that may play a role in the internalization of PLGA MPs may 




CONCLUSIONS AND FUTURE WORK 
 
 Characterization of biomaterials and their associated immune and inflammatory 
responses in the context appropriate for their intended use is of critical relevance to the 
development of novel biomaterials and modifications to currently existing biomaterials.  
This thesis research contributed to the field of biomaterial science in modern medicine by 
assessing and demonstrating differential adjuvant effects of two model biomaterials, 
agarose and PLGA, focusing on DC maturation.  In addition, panel of assays that can be 
utilized for screening biomaterials to be used in multiple applications were developed.  
As DCs can initiate adaptive immune response upon maturation, evaluation of DC 
maturation in vitro provides a basis for the biomaterial adjuvant effect in vivo and the 
predisposition of a biomaterial to induce adaptive immunity to associated biological 
components, which may result in graft rejection.   
 Studies presented herein provide a framework for assessing biomaterial adjuvant 
effect and its associated mechanisms.  Short-term, immediate experiments that can help 
address particular issues have been suggested throughout this thesis.  However, to further 
develop biomaterial-screening protocols towards the development of biomaterial-
centered immunomodulatory strategies via control of DC phenotype, as well as 
understand the mechanisms by which biomaterials are recognized by DCs to result in 
their maturation, several key areas may be investigated.   
 While investigations summarized in this thesis evaluated several DC phenotypes 
to exemplify maturation, a more in-depth characterization of this maturation as well as 
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the subsequent immune response elicited would be of benefit.  For example, given the 
functionally different subsets of DCs and the differential response they elicit, 
characterization of DC subset induced by biomaterials would be important.  Specifically, 
the types of cytokines released by DCs cultured in contact with biomaterials, as well as 
those released by T cells stimulated by the biomaterial-treated DCs may begin to 
elucidate the type of response that can be expected when such biomaterials are introduced 
in vivo.  In this project, analysis of inflammatory cytokines secreted by DCs cultured with 
PLGA or with agarose was assessed, but only at one time point of 24 hrs after stimulation 
(Figure A3, APPENDIX).  A time course of cytokine secretion, as well as mRNA levels 
of these cytokines as well as DNA microarray analyses of regulation at the genetic level, 
may reveal more differential effects of biomaterials.  Using the cytokine profile and 
determining the ensuing immune response elicited via T cells, either through Th1/ Th2 
polarization or regulatory mechanisms may provide means of inducing host acceptance 
and tolerance of tissue engineered grafts.  In addition, the maturation state of DCs can 
also be evaluated through their ability for migration.  Specifically, measurment of 
expression of CCR7 on DCs required for migration (Forster et al., 1993), as well as their 
propensity for migration towards CCR7 ligands such as CCL19 and CCL21 using a 
transwell system would be of importance in better understanding the effect of 
biomaterials on state of DC maturation. 
 Moreover, in vivo characterizations of biomaterial-induced DC maturation may 
offer insight into mechanisms of DC maturation.  In our study, DTH was used as a gauge 
of in vivo induced DC maturation, and showed that OVA delivered with PLGA MPs 
induced comparable degree of response than did OVA delivered with known adjuvant 
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CFA (CHAPTER 5).  Other aspects of biomaterial adjuvant effect to be evaluated may 
include introduction of biomaterial with a model antigen into a host, and measuring 
subsequent production of cytokines and proliferation of cells from the draining lymph 
nodes in response to re-stimulation with the model antigen, as well as assessing systemic 
antibody responses and isotypes as compared to appropriate controls.  The antigen-
specific proliferation of T cells would be indicative of CD4 T cell immunity.  While this 
study attempted to assess the relative effectiveness of PLGA MPs to complete Freund’s 
adjuvant, standard adjuvant used in experimental animal models, both in vivo 
(CHAPTER 5) and in vitro (APPENDIX), in vitro evaluation of adjuvant effect elicited 
by biomaterial MPs as compared to clinically used particulate adjuvant such as alum 
could provide insight into clinical relevance of PLGA MPs as vaccine adjuvant. 
 Although these additional characterizations may provide further evidence that 
may begin to elucidate the mechanisms of biomaterial-induced DC maturation, it would 
be of great interest to identify the molecules involved in the biomaterial-induced 
maturation.  In this thesis project, the role of TLRs was examined in vitro using blocking 
antibodies and animal models deficient in the particular receptor of interest (CHAPTER 
8).  In our hands, the specific antibodies reported herein were unable to be fully utilized 
for blocking studies as is as their presence resulted in unintentional activation of the cells 
as measured by increased maturation marker expression and cytokine release.  This 
activation was thought to be due to the crosslinking of Fc receptors, which may be 
alleviated by use of Fab fragments of antibodies, and titration to determine the 
appropriate concentration required for blocking the function of these receptors.  
Alternatively, as other groups have reported successful use of blocking antibodies against 
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these same receptors, a different source of antibody, likely not commercial, may need to 
be acquired (Akashi et al., 2000).   
In this study, fragmentation of antibody was not pursued; rather, efforts were 
focused on the elucidation of the role of TLR4 using DCs from animal models of TLR4 
deficiency.  However this study was made complicated by high baseline activation of 
iDCs from C3H/HeJ animals as measured by maturation marker expression, and 
significantly lower extent of maturation response to LPS or PLGA by DCs from 
C3H/HeOuJ control animals as compared to DCs from C57BL6 animals as measured by 
marker expression and inflammatory cytokine release.  To further pursue this approach in 
the determination of the role of TLR4 in PLGA-induced DC maturation, several 
experimental methods can be taken.  Prior to using cells of C3H/HeJ strain, it may be of 
benefit to determine the baseline level of DC activation in response to LPS in the control 
strains.  Cells from C3H/HeOuJ mice or other C3H substrains such as C3H/HeSnJ and 
C3HeB/FeJ which originated from the same stock as C3H/HeJ strain and carry the Lpsn 
allele (Qureshi et al., 1999) may be used.  As mentioned in CHAPTER 8, as the C3H 
substrains have differing haplotypes than C57BL6 mice, comparison between these two 
different strains may not be appropriate.  For this and subsequent application, the use of 
ultra-pure grades of LPS is vital given that TLR4 deficiency confers LPS 
hyporesponsiveness, and presence of any impurities present in the LPS preparation may 
act as agonists for other receptors and activate cells.  In addition, waiting longer for the 
animals to quiesce in the new environment after shipment may aid to minimize the 
baseline activation of cells.   
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Upon confirming that the control strains do respond to LPS as expected, LPS-
hyporesponsiveness of C3H/HeJ strains need to be verified, and compared to the level of 
LPS-induced maturation in by cells from the control strain(s).  Readouts for LPS-
hyporesponsiveness should include not only phenotypical assessments of DCs such as 
maturation marker expression but also functional assessments, including cytokine 
production by DCs in response to LPS and by T cells in response to LPS-treated DCs,  as 
well as proliferation of allogeneic T cells in response to LPS-stimulated DCs from the 
LPS-hyporesponsive strain.  Similar to the blocking of receptors using blocking 
antibodies, soluble forms of TLRs can be used to block TLR signaling; soluble forms of 
TLR4 have been reported in mice, and recombinant soluble form of this receptor 
decreased NFκB activation and TNCα release in response to in vitro LPS stimulation 
(Iwami et al., 2000).  As multiple products of TLR4 mRNA exist in humans, soluble 
forms of TLR4 is thought to exist in humans as well, and may be used to block signaling 
mediated by membrane-bound TLR4 (Iwami et al., 2000).  In addition, to reduce 
experimental variance, cells from individual animals may be pooled for replicates, rather 
than using cells from a given animal for a given replicate.  Although pooling of cells is 
not appropriate for human studies, it is acceptable for this particular study as these 
animals are syngeneic.  While these experiments focus on the elucidation of TLR4, other 
related candidates of receptors and molecules involved in biomaterial-induced DC 
maturation include MyD88 and TLR2.  Another approach to studying the role of these 
receptors may be to transfect cells to stably express these receptors.  Such studies using 
TLR2- or TLR4-transfected HEK293 cells have been describeded for other applications 
studying the role of these receptors (Kurt-Jones et al., 2002; Mandell et al., 2004).   
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     As biomaterials introduced into protein-containing environment are 
instantaneously adsorbed with proteins, DC maturation in response to the presence of 
biomaterial is most likely mediated by such adsorbed protein layer.  However, in the 
context of clinical applications, it is important to be congnisant of the absence of serum in 
DC preparations generated for clinical applications.  In all of the in vitro studies 
presented in this thesis, DCs were cultured in presence of autologous plasma or FBS.  
Thus it may be worthwhile to determine in vitro whether biomaterial contact induces DC 
maturation in such serum-free environment.  With this caveat, nevertheless, biomaterials 
integrated as a part of combination product are introduced into the host, where host 
proteins will be encountered.  As such, identification of proteins adsorbed to the 
biomaterial may direct identification of receptors, other that mediate biomaterial-induced 
DC maturation or uptake of biomaterial MPs or degradation particles generated from a 
larger biomaterial implant.  Given the wide spectrum of proteins that may adsorb to the 
biomaterial, it is likely that receptors other than or in addition to TLR family of receptors 
may be involved in the biomaterial-induced DC maturation.  This approach of receptor 
identification may be more direct in that knowing the proteins adsorbed to the 
biomaterial, likely canddate receptors should emerge, as many of the protein ligand and 
receptor interactions as well as the ensuing effects on cellular behavior in the context of 
protein adsorption on biomaterials have been well characterized.   
 One significant factor in studying DC maturation is the presence of endotoxin.  
Content of endotoxin present in the biomaterial MPs and films used in the studies 
presented here were quantified using a commercially available chromogenic assay, and to 
the best of our ability, introduction of endotoxin was minimized through careful 
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procedures and use of materials designated as sterile and non-pyrogenic.  While 
polymyxin B has been shown to inhibit LPS-induced DC activation, in our hands, 
titration of polymyxin B was unable to reduce LPS-induced increase in co-stimulatory 
marker expression (Figure A6, APPENDIX).  This may have been due to purity of 
polymyxin B or LPS, inadequate reconstitution procedures, or insufficient range of 
concentrations tested relative to the amount of LPS present.  Troubleshooting of this 
assay to be able to use polymyxin B to eliminate possibility of maturation due to presence 
of endotoxin would great simplify any additional studies investigating the biomaterial 
effect on DC maturation.   
 While this study evaluated the adjuvant effect of biomaterials focusing on the 
level of DC maturation, further development of assays to screen for biomaterials for 
potential applications in combination products may require a higher throughput approach.  
This would require the confirmation of correlation between the DC maturation readouts 
used in this study to other readouts that are translatable to high throughput systems such 
as mRNA and protein expression using genomics and proteomics, respectively.  
Techniques such as DNA microarrays (Ahn et al., 2002; Edwards et al., 2003) and serial 
analysis of gene expression (Hashimoto et al., 1999), as well as proteomics (Richards et 
al., 2002) have recently been applied to DCs.  These techniques can assess a multitude of 
gene or protein expression simultaneously, making them indispensable for mass 
screening of identifying biomaterials that do or do not induce DC maturation, as well as 
for identification of signaling pathways involved in biomaterial-induced DC maturation.  
In addition, for the development of novel biomaterials and modifications to improve 
biomaterial compatibility, combinatorial libraries of chemical structures or high 
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throughput biomaterial systems with varying physicochemical properties associated with 
inducing certain cellular behavior may be developed, analogous to the identification of 
lead compounds used in drug development.  This would provide a systemic approach to 
evaluating chemical properties of biomaterials such as hydrophilicity, hydrophobicity, 
charge, and presence of certain chemical end groups on cell behavior.  For example, 
libraries containing multiple chemical modifications with increasing hydrophilicity may 
be screened for effects on DCs, and from such results, biomaterial modifications may be 
fine-tuned for desired outcome. 
 Research investigations presented in this thesis begin to address the differential 
immune and inflammatory responses associated with biomaterials in the context of 
combination products by focusing on the adjuvant effect at the level of DC maturation.  
Knowledge gained from this study combined with knowledge that may be gained from 
future studies may guide the development of biomaterial-centered strategies for the 






A.1 Titration of phagocytosis inhibitors and their effects on DC maturation 
 To investigate the contribution of phagocytosis on DC maturation, 
pharmacological agents known to block phagocytosis or macropinocytosis were titrated.  
Cytochalasin D was used to inhibit phagocytosis as it disrupts actin filaments and inhibits 
actin polymerization (Flanagan and Lin, 1980; Cooper, 1987), and amiloride was used to 
inhibit macropinocytosis as it blocks Na+/H+ channels (Maidorn et al., 1993; Xiao and 
Allen, 1999).  To find a working concentration for these agents to block MP 
internalization by DCs, varying concentrations of these agents were used.  Human DCs 
on day 5 of culture were pretreated with indicated concentrations of cytochalasin D or 
amiloride for 1 hr at 37°C, and 3 µm FYG microspheres added at 1:1 MP:cell ratio for 4 
hrs.  Cells were then washed in FACS buffer without CaCl2 and their fluorescence 
analyzed by flow cytometry.  Both cytochalasin D and amiloride decreased DC uptake of 
fluorospheres in a dose-dependent manner (Figure A1a, A1b). 
Figure A1: Dendritic cells treated with increasing concentrations of amiloride (a) 
or cytochalasinD (b) internalize decreasing numbers of fluorospheres.
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Contribution of phagocytosis on biomaterial-induced DC maturation was 
evaluated by pretreating DCs with the predetermined concentrations of cytochalasin D or 
amiloride, and then exposing DCs to 5:1 MPs: cell ratio of PLGA or agarose MPs, and 
assessing CD83 and CD86 expression.  As shown in Figure A2, pretreatment of iDCs 
with cytochalasin D or amiloride without any additional maturation stimulants resulted in 
increased expression of CD83 and CD86.  This result suggested that use of these 
inhibitors to assess DC maturation was not appropriate, as it would be difficult to 
determine the source of DC maturation if these agents alone induced increase in marker 
expression.  To further evaluate the contribution of phagocytosis on DC maturation, 
























Figure A2: Phagocytosis inhibitors amiloride (amil) and cytochalasin D (cytD) 
alters DC marker expression.
































































































































































































A.2 Inflammatory cytokine profile of DCs treated with PLGA or agarose MPs  
Profiles of inflammatory cytokines (IL-8, IL-1β, IL-6, IL-10, TNFα, and IL-
12p70), released by DCs in response to treatment with PLGA or agarose MPs or film 
were evaluated using Cytometric Bead Array Human Inflammation kit (Becton 
Dickinson Pharmingen).  Immature DCs were treated with the indicated materials (MPs 
at MP:cell ratios of 0.1:1, 1:1, 10:1, or with film) for 1 day, and the cell culture 
supernatants cleared and stored at -20°C until analysis according to the manufacturer’s 
directions.  In this assay, amounts of cytokine released are measured as fluorescence 
intensity, which is then converted into concentration units for each of the cytokines using 
a standard curve.  As some of the cytokines were below or above the concentration range 
provided by the standard curve, data is shown as graphs of raw fluorescence values 
(Figure A3).  In general, profiles of cytokines secreted by DCs treated by agarose or 
PLGA were similar.  Pro-inflammatory cytokines, TNFα, IL-8 and IL-6, were released in 
a MP-dose dependent manner, while IL-12p70 was detected at a very low level, 
comparable to that released by iDCs.  Dendritic cells treated with agarose or PLGA 
secreted low amounts of IL-10 and IL-1β.  Although not a direct comparison, DCs 














Figure A3: Dendritic cells treated with agarose or PLGA secrete inflammatory 
cytokines.  
Data reported as raw fluorescent intensity values (FL2).  MP:cell ratios indicated: 
0.1MP= 0.1:1, 1MP= 1:1, 10MP= 10:1.  mean±SD, n=3.  *: p<0.1 compared to LPS, 
+: p<0.1 compared to iDC.   
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A.3 In vitro blocking of endocytic and signaling receptors on iDCs 
 In vitro blocking of endocytic and signaling receptors was performed to evaluate 
the involvement of particular receptors on PLGA-induced DC maturation.  Receptors 
were chosen based on previous findings of their role in DC phagocytosis or maturation.  
Expression of CD11b (C3 complement receptor, Mac-1 subunit), CD32 (FcγRII), CD36 
(scavenger receptor), CD51 (αv integrin, combines with CD61 to form vitronectin 
receptor), CD61 (β3 integrin, combines with CD51 to form vitronectin receptor, combines 
with CD41 to form gpIIb/gpIIIa complex), CD64 (FcγRI), DC-SIGN, Scavenger 
Receptor A, mannose receptor, and TLR2 and TLR4 was measured using flow cytometry 






Figure A4: Immature DCs express endocytic and signaling receptors.
SR-A: scavenger receptor A, MR: mannose receptor, TLR2/4: Toll-like receptor 2/4.










As reported in CHAPTER 8, in vitro blocking experiments were performed using 
blocking antibodies against CD36, CD51, DC-SIGN, and mannose receptor in addition to 
CD14, TLR2, and TLR4.  For DC-SIGN and mannose receptors, both of which are lectin 
receptors, mannan was used as a ligand.  For CD36 (scavenger receptor), polyguanylic 
acid (polyG) was used as a ligand, as CD36 binds polyanionic ligands; polycytidylic acid 
(polyC) was used as a negative control for polyG.  As a ligand for CD51 (αv integrin), 
arginine-glycine-aspartic acid (RGD) peptide was used.  Blocking of receptors using 
antibodies or known ligands to these receptors within the range tested was not able to 
block the LPS- or PLGA MP-induced maturation, and in some situations increased the 
expression of CD83 (Figure A5a-c).  Where ligands were used to block the receptors, 
































































































Figure A5a: PLGA MP-induced CD83 upregulation is not altered by increasing 
concentrations of anti-mannose receptor or anti-DC-SIGN antibodies, but is 
increased by increasing mannan concentration.  
endotoxin contents: mannan: 3.056 EU/ ml (final)







































































































































































































































Figure A5b: PLGA MP-induced CD83 upregulation is not altered by increasing 
concentration of anti-CD36 antibody, but increased by increasing concentrations 
of polyG or polyC.  
endotoxin contents: polyG: 0.0076 EU/ ml (final), polyC: 0.099 EU/ ml (final)





























































































































































































Figure A5c: PLGA MP-induced CD83 upregulation is increased by increasing 
concentration of anti-CD51 antibody, but not altered by increasing concentration 
of RGD (arginine-glycine-aspartic acid peptide).  
endotoxin contents: RGD: <0.0001 EU/ ml (final)
























































































A.4 Titration of polymyxin B to reduce LPS-induced DC maturation 
To eliminate the possibility of DC maturation in response to presence of 
contaminating endotoxin in biomaterial preparations, addition of polymyxin B to DC 
culture was investigated.  Polymyxin B is an antibiotic which binds to the anionic lipid A 
moiety of LPS, and neutralizes the effects of LPS (Morrison and Jacobs, 1976).  Addition 
of polymyxin B alone has been shown to have no effect the expression of DC co-
stimulatory and MHC molecules, while addition of polymyxin B to LPS-treated cells 
resulted in abrogation of upregulation of co-stimulatory and MHC molecules (Yang et al., 
2002).  In our hands, addition of polymyxin B to DC culture was not able to reduce LPS-
induced increase in maturation marker expression (Figure A6).  However, in our 
experiments, DC maturation was induced by PLGA, which contained endotoxin contents 
below the detection limit of the assay, whereas agarose, which had higher amounts of 




















Figure A6: Dendritic cells treated with LPS in the presence of increasing 
polymyxin B concentrations do not alter their expression of maturation markers. 












































































































































A.5 Comparison of increase in DC maturation marker expression induced by 
Complete Freund’s Adjuvant and LPS  
To gauge the relative DC maturation effect of LPS, commonly used as a positive 
control for DC maturation in vitro to the adjuvant effect of Complete Freund’s Adjuvant 
(CFA), commonly used adjuvant in vivo, DC maturation in response to CFA and LPS 
were compared in vitro.  Human iDCs were left untreated or treated LPS, CFA emulsion 
(1:1 with PBS) (1 µl/ ml or 10 µl/ ml), or with PLGA MPs, and expression of co-
stimulatory and MHC molecules measured to gauge the extent of maturation induced by 
CFA.  No DC maturation as measured by expression of co-stimulatory and MHC 
molecules was observed for these CFA-treated DCs (Figure A7).  This lack of increase in 
maturation markers may be due to the difficulty in delivering CFA emulsion in vitro 
because of its hydrophobicity (formation of floating clumps on surface of cell culture 
well).  A modification was made to this experiment, and CFA was used without any 
emulsification (without any dilution).  At concentrations tested (1 µl CFA/ ml cell 
culture, 10 µl CFA / ml cell culture, 100 µl CFA/ ml cell culture), dose-dependent 
increase in the expression of co-stimulatory and MHC molecules were observed (Figure 
A8).  However, even at the highest dose of 100 µl CFA/ ml cell culture, the extent of 
maturation induced as measured by the expression levels of these surface markers was 
















Figure A7: Increase in DC maturation marker expression in response to CFA is 
lower than that induced by PLGA MPs.































































































































Figure A8: Increase in DC maturation marker expression in response to CFA is 
lower than that induced by LPS.
This experiment was repeated three times with similar results, and representative 
results are shown.
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